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Abstract 
 
  In recent years, there has been an increasing focus on the design and synthesis of 
electrochemical biosensors, as they can lead to the analytical determination of biological and 
organic analytes.  As amino acids and peptides play such a diverse role within biological 
systems, incorporation of a redox active, chromophoric group into these compounds is of 
particular interest.  This coupling is usually carried out as the last step in the preparation of 
such bioorganometallic compounds, as work the ferrocene moiety can prove sensitive to the 
conditions  employed during peptide synthesis.  To this end, novel N-ferrocenoyl mono and 
dipeptide derivatives, with varying structural motifs, have been prepared using a variety of 
coupling methods, and the conditions for their preparation optimised.  All compounds were 
characterized by 1H, 13C, 135DEPT and HMQC NMR, I.R., optical rotation, and UV-Vis 
spectroscopy, as well as cyclic voltammetry. The preparation of asymmetrically di-
substituted ferrocene derivatives (140-146), without isolation of intermediates, is also 
reported. 
  The anion binding abilities of selected compounds is reported, capitalising on the presence 
of the 1H NMR-detectable amide protons within these compounds, as well as the 
electroactive ferrocene group.  All compounds selected for these studies showed, to varying 
degrees, downfield chemical shifts in their 1H-NMR spectra in the presence of anions, as well 
as cathodic shifts in their cyclic voltammograms.  The number of amide groups, as well as 
their relative orientation within the compound, is considered to be of prime importance.  The 
N-ferrocenoyl mono-peptide derivatives are seen to exhibit reversible electrochemical 
behaviour in the presence of halide ions, while the dipeptides, both mono and 1, 1’ 
disubstituted, bind these anions irreversibly. 
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Chapter I 
 
Literature Survey 
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1.1: Ferrocene 
 
F e
1  
 
 
  Ferrocene (1) was first isolated in 1951 by two independent research groups.  The orange 
compound was found to be air-stable, insoluble in water, and had a melting point of 1730C [1, 
2].  These observations precluded the possibility that the bonding within the molecule was 
purely a result of either C-Fe σ-bonds or ionic interactions.   The following year, the correct 
structure of ferrocene was elucidated, again by two independent groups.  Wilkinson 
concluded that since all the carbons were electronically equivalent, and, as there was only one 
C-H stretching frequency observed in the I.R. spectrum, all carbons must contribute equally in 
bonding to the iron atom [2].  X-ray diffraction studies by Fischer and Pfab [3] confirmed the 
proposed sandwich structure, in which a central iron atom was located between two 
cyclopentadienyl rings.  The aromaticity of the compound was confirmed by Woodward, who 
performed electrophilic aromatic substitution reactions, such as the Friedel-Crafts acylation 
with aluminium trichloride, on the compound (ferrocene was found to react 3 x 106 times 
faster than benzene) [4]. 
  The two cyclopentadienyl (Cp) rings of ferrocene may be orientated in two extremes of 
either an eclipsed (D5h) or staggered (D5d) conformation.  The energy of rotation about the 
Fe-Cp axis is very small (~ 4kJmol-1) and the ground state structures of ferrocene may show 
either of these conformations. 
 
1.2: The Chemistry of Ferrocene 
  Ferrocene (as well as other metallocenes) are usually prepared by one of three different 
synthetic routes.  The first of these involves the cracking of dicyclopentadiene (a retro Diels-
Alder reaction), followed by deprotonation of the weakly acidic cyclopentadiene with an 
alkali metal.  Treatment with iron (II) chloride then affords ferrocene: 
 2
FF  
eCl2 + 2NaC5H5 → [(η5- C5H5)2Fe] 
The second method is known as metal vapour synthesis; the reactants are heated to high 
temperatures, and then brought together on a cold surface: 
Fe + 2C5H6 → [(η5- C5H5)2Fe] + H2 
  Finally, ferrocene can also be prepared via the use of an auxiliary base, which generates the 
cyclopentadienyl anion in situ: 
eCl2 + 2C5H6 + 2C5H5NH → [(η5- C5H5)2Fe] + 2[C5H5NH3]Cl
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Scheme 1:  The organic reactions of ferrocene 
 
  Because of its stability, the ferrocene moiety can survive relatively harsh reaction conditions, 
making a wide range of organic transformations possible (scheme 1).  Ferrocene, having six 
 3
π-electrons delocalised over five atoms, is much more prone to electrophilic substitution than 
benzene.  The ferrocenyl group is also one of the strongest known electron-releasing groups 
(aminoferrocene is twenty times more basic than aniline).  Two main mechanistic routes have 
been proposed for the electrophilic substitution of ferrocene [5] (scheme 2). 
 
 
E
Fe Fe E
H
E
Fe Fe
E
Fe
H
E
FeFe
E+
E+
- H+
- H+
Scheme 2: Two mechanisms for electrophilic substitution of ferrocene
+ +
+
 
 
 In the first of these, the electrophile interacts with the central iron atom, before being 
transferred to the aromatic ring with subsequent deprotonation.  In the second, electrophilic 
attack takes place directly at the exo face of the ring, with no direct metal participation. 
  Friedel-Crafts acylation of ferrocene occurs readily, yielding both mono and 1, 1’-
disubstituted products.  Once acylation has occurred on one ring, the unsubstituted ring is 
deactivated towards further substitution by a factor of 2 x104, illustrating the electronic effects 
that are passed from one ring to another via the iron centre.  The Friedel-Crafts alkylation of 
 4
ferrocene is not a useful synthetic method because of poor yields, and the resultant mixture of 
poly-alkylated products results. 
  Lithiation of ferrocene also occurs readily, with t-BuLi or n-BuLi the preferred reagents.  As 
the protons of the aromatic rings of ferrocene are weakly acidic, it can be deprotonated by the 
hydrocarbon portion of the reagent, and the extent of lithiation can be controlled by choice of 
reaction conditions.  The mono-lithiated intermediate can be formed exclusively via treatment 
of ferrocene with a stoichiometric amount of t-BuLi or i-BuLi, whereas the 1, 1’-disubstituted 
product is formed when n-BuLi is used in conjunction with N,N,N',N', 
tetramethylethylenediamine (TMEDA).  No such selectivity is possible with either sodium or 
potassium reagents. 
  Unlike benzene, ferrocene can undergo the Mannich reaction with formaldehyde and an 
amine, and thus is more akin to thiophene than benzene in its reactivity.  Another important 
difference between benzene and ferrocene is the behaviour of the latter in the presence of 
oxidising agents (e.g. NO2+, H2SO4).  The iron centre is quite easily oxidized to the 
ferricenium ion, and so direct nitration, sulphonation, or halogenation cannot be carried out in 
a similar manner to benzene [1]. 
 
1.3: Electronic Structure of Ferrocene 
  Ferrocene can be considered as consisting of an Fe2+ ion (six d-electrons) bonded to two 
cyclopentadienyl anions (six π-electrons each), and thus it can be seen that ferrocene obeys 
the 18-electron rule – all valence electrons are located in bonding or non-bonding orbitals.  
The anti-bonding orbitals are left unpopulated, and hence the compound is stable.   
  A more informative picture of the bonding within ferrocene is provided by a molecular 
orbital diagram (Fig. 1), which shows the molecular orbitals which result from the 
interactions of the ligand and metal orbitals.  Symmetry considerations, the relative energies, 
and overlap integrals of the ligand π-orbitals and the 3d, 4s and 4p orbitals of the central iron 
can be used to predict which molecular orbitals will be formed.   
  The lowest-energy orbitals are ligand-based (a1g, a2u), as the metal orbitals with appropriate 
symmetry requirements (3dz2/4s, and 4pz respectively) are so much higher in energy.  The e2g 
orbitals remain essentially metal-based (dx2- y2, dxy), as their δ-overlap with the ligand e2g 
orbitals is poor.  The stability of the ferrocene molecule is largely due to the overlap of the 
ligand e1g orbitals with the dxz and dyz orbitals of the iron atom, which results in the formation 
of two strong π-bonds. 
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Fig. 1:  A qualitative molecular orbital diagram for the ferrocene molecule [1] 
 
    The frontier orbitals of ferrocene are the weakly bonding e2g, the non-bonding a’1g, and the 
weakly anti-bonding, unoccupied e’1g level.  Given that these orbitals are similar in energy, it 
can be seen that deviations from the 18-electron rule are possible (e.g. the 16-electron 
chromocene and the 20-electron nickelocene, both of which are more reactive than ferrocene).  
Depending on the method employed in calculating the relative energies of the frontier 
orbitals, the HOMO of ferrocene can be considered as being the a’1g (3dz2) [6], or the 
degenerate e2g (dx2- y2, dxy) pair [7].  This becomes important when considering the electronic 
structures of ferrocene derivatives, along with their spectroscopic and electrochemical 
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properties (section 1.4).  The LUMO of ferrocene is derived from an out of phase π-
interaction between the dxz/dyz iron orbitals, and the Cp e1g orbitals [8]. 
 
1.4: Electronic Structure of Substituted Ferrocenes 
  The π-system of the Cp rings can interact with the π-system of a substituent, such as an acyl 
group, or the highly conjugated systems employed in the study of non-linear optics.  The most 
significant perturbation to the molecular orbitals of ferrocene that occurs upon substitution 
with another π-system is not to the a’1g (dz2) metal-based orbital, but to the degenerate e2g (dx2- 
y
2, dxy) pair.  Upon substitution, the most important effect is the energy splitting between the 
two components of the e2g energy level.  One component of this degenerate pair will have the 
proper nodal characteristics to interact with the substituent-based orbitals, while the other 
component is non-interacting (Fig. 2). 
 
O
X
O
X
b
a
 
 
Fig 2: Cp – carbonyl orbital interactions 
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The ‘b’ component of the ferrocene HOMO has almost zero contribution from the C1 carbon 
atom, so overlap with the substituents pπ orbitals is greatly reduced.  The 'a' component, 
however, has significant contribution from the C1 carbon atom, and is thus stabilised by a 
contribution from the carbonyl oxygen pπ orbital.  In ferrocene carboxaldehyde, ferrocene 
carboxylic acid, and ferrocene carboxamide, these two components are split by 0.046, 0.082, 
and 0.065 eV respectively. (other Cp-based, lower energy degenerate pairs of orbitals are split 
even more upon acylation of a Cp ring).  The non-interacting 'b' component of the e2g energy 
level now becomes the HOMO of the substituted system. 
  Co-planarity of the Cp ring and substituent π-system will maximise their overlap, and for 
simple carbonyl-substituted systems such as ferrocene carboxylic acid, deviations from co-
planarity (the ‘twist’ angle) in the solid state have been shown to be < 6° [8].  However, when 
more bulky substituents are introduced, these deviations become more pronounced.  The 
isopropyl amide derivative (2), has a twist angle of 16.70 [9], while the macrocyclic system 
(3), has a twist angle of 50.2° [10].  Even at this large distortion from co-planarity, ca. 60% of 
the orbital overlap is maintained. 
 
CH
CH3
CH3
Fe
O
N
H Fe
O
N
O
O
N O
O
2 3
 
  Variations in the half wave potentials of ferrocene derivatives have proven to be an 
extremely sensitive technique in investigating the electronic effects of substituents on the 
frontier orbitals of ferrocene.  The presence of the electron-withdrawing acyl group, with its 
relatively low-lying LUMO, has the effect of lowering the energy of the ferrocene HOMO, 
making the molecule more difficult to oxidize [11], and there are consistent reports in the 
literature of mono-substituted amide ferrocenene derivatives with anodic shifts of their E1/2 
values in the +150-250mV range (vs. Fc/Fc+).  For 1, 1’-disubstituted ferrocene amides, this 
anodic shift becomes even more pronounced [12]. 
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 N OH
Fe
4          
H
Fe
5  
 
  For ferrocenes with an sp3 carbon substituent, such as the ferrocene alkyl-amines prepared 
by Hess et al. [13], there is very little difference in the reported E1/2 values vs. the Fc/Fc+ 
redox couple (< 20mV), indicating a far lesser degree of perturbation to the ferrocene frontier 
orbitals.  Other conjugated ferrocene systems, such as the ferrocenyl-imine compounds 
synthesized by Lopez et al. (4) [14] and the alkynyl derivatives prepared by Nolte’s group (5) 
[15], also display anodic shifts in their cyclic voltamogramms relative to the 
ferrocene/ferricenium cation redox couple, but to a lesser extent, as these groups are not as 
electron-withdrawing as acyl-substituted systems.   
 
1.5: Applications of Ferrocene 
  Because of the well defined electrochemical and spectroscopic behaviour, chemical stability 
and low toxicity of ferrocene, it has found applications in areas such as anion sensing, 
asymmetric catalysis, as a mediator between redox enzymes and electrodes, as liquid 
crystalline materials, and in materials with high second harmonic generation efficiencies for 
non-linear optics.  The incorporation of a ferrocene moiety into biomolecules is currently an 
area of intense research activity.  Owing to the ease with which electrophilic aromatic 
substitution can occur on the cyclopentadienyl rings, a vast array of ferrocene derivatives 
have been reported in the literature since it was first discovered over fifty years ago.   
 
1.5.1: Ferrocene and Asymmetric Catalysis 
  During the last twenty years, there has been an increasing use of ferrocene derivatives as 
chiral auxiliaries in homogenous asymmetric catalysis, both in research and on an industrial 
scale.  The ferrocene moiety offers many advantages in this respect.  A chiral, redox-active 
ligand is, in theory, capable of acting as a chiral auxiliary in an organic transformation, with 
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subsequent decomplexation of the ligand upon electrochemical oxidation, thus facilitating the 
catalytic cycle.  Due to its bulkiness, a ferrocene nucleus adjacent to a stereogenic centre can 
improve stereoselectivity via steric hindrance, and nucleophilic substitution reactions at 
positions vicinal to the ferrocene group are highly favoured, and take place with retention of 
configuration [16].  To this end, a number of interesting ferrocene containing ligands have 
been prepared. 
 
N
O
S
CH3
n
 
Fe
6  n = 1
7   n = 2  
 
  Two such ligands (6, 7), have been synthesised by Chesney et al. (derived from L-(S-methyl)-
cysteine and L-methionine respectively), and were shown to be particularly effective in 
palladium-catalysed substitution reactions of allylic acetate with diethyl malonate [17]. The 
ligand derived from L-methionine proved to be more effective in transferring chirality than that 
derived from S-methyl-L-cysteine, probably due to the extra methylene group between the donor 
atoms which co-ordinate to the palladium atom.  The effect of this is to bring the asymmetric 
environment closer to the allyl species, as shown in the transition states (Figs. 3 and 4). 
 
Ph Ph
Pd
SCH3
N
Fc
O
Ph Ph
Pd
SCH3
N
Fc
O
Fig. 3: Transition state of
methionine oxazoline ligand
Fig. 4: Transition state of
S-methyl cysteine oxazoline ligand
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Depending on the solvent used, enantiomeric excesses of > 93% were obtained with the 
methionine-derived ligand. 
  Recently, Gonzales reported the synthesis of palladium complexes with chiral ferrocenyl-
thiazolidines, again utilizing S-donor atoms derived from L-cysteine.  The arrangements of 
the ligands (8) in the complex is similar to those described for other palladium (II) complexes 
of the type [Pd(η3-C3 H5)(Br)(L)] which have catalytic activity [18]. 
  The Schiff-base derivatives prepared by Lopez (4, section 1.4), have also proved to be 
effective donors in palladium and platinum complexes, and the group synthesized a di-μ-
chloro-bridged cyclopalladated complex (9) [14]. 
 
N S
MeO2C
Pd
Cl
N
OH
Pd
Cl
Fe
Fe
2
8 9
 
 
  Orthometallation is a common feature of heterobimetallic systems incorporating a ferrocene 
moiety.  This process involves the chelation-controlled, regioselective C-H activation with a 
metallation reagent, resulting in the formation of a new metal-carbon bond [19].  The 
cyclometallation of ferrocene results in the formation of planar, cyclometallated derivatives, 
which have great potential in the area of asymmetric catalysis [20]. 
  Finally, optically pure cyclopalladated ferrocenylimines have been found to be particularly 
effective in the resolution of racemic mixtures of α-amino acids.  When the cyclopalladated 
dimeric complex (scheme 3) was employed as a resolving agent, the resolution of several 
mixtures of racemic amino acids was successfully performed via chromatography (the reverse 
process was also carried out, with enantiomerically pure amino acids being used to resolve 
racemic mixtures of cyclopalladated ferrocene-containing compounds) [21]. 
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Scheme 3: Optical resolution of amino acids with cyclopalladated complex
DL-racemate
AcOH, LiCl
 
 
1.5.2: Anionic Sensors Incorporating Ferrocene Units 
  The design of ferrocene-based anion receptors is another area of current intense research 
[22, 23].  In biological processes, the majority of enzyme substrates are negatively charged 
[24].  Therefore, an understanding of the interactions which bind the guest and host molecule 
together, has potential application in the design of drugs capable of mimicking those 
interactions.  Alzheimer’s disease has been linked to anion-binding enzymes, and cystic 
fibrosis is known to be caused by a misregulation of chloride channels.  From an 
environmental point of view, pollutants such as phosphate and nitrate anions need to be 
continually monitored [25]. 
  The first metallocene-based anion receptors reported in the literature were based on the 
cobaltocenium cation, which were capable of binding anions such as halides, via favourable 
electrostatic interactions.  Electrochemically, the Cp2Co/Cp2Co+ redox couple showed 
significant cathodic shifts upon anion complexation, with the complexed anion stabilizing the 
positively charged cobalt centre, thus making it harder to reduce [26]. 
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  Neutral, ferrocene containing secondary amides have no inherent electrostatic interaction 
with guest anionic species, and their complexed forms have lower stability than their 
cobaltocenium analogues.  However, the anion-receptor interactions can be modulated via 
oxidation to the ferricenium cation, at which point electrostatic interactions can be ‘switched 
on’ [27].  The oxidation of ferrocene in the vicinity of the amide group increases the acidity 
of the amide proton, making hydrogen-bonding stronger, and thus there is a synergy between 
ion-paring and H-bonding interactions [28].  Thermodynamic studies have shown ΔH0 for the 
complexation is favourable, as the formation of H-bonds is energy releasing, while ΔS0 is 
unfavourable, due to the association of two species in solution, and a loss of conformational 
freedom.  Favourable ΔH0 and unfavourable ΔS0 is a common feature of anion recognition in 
biological processes [29]. 
 
 
                 
O
N NH2
HFe
10      
O
N NH2
HFe
11  
 
  Ferrocene containing molecules which have the ability to bind and electrochemically sense 
anionic substrates range from the relatively simple ones first designed by Beer and co-
workers [30] (10, 11), to larger, more complex molecules, such as ferrocene-metalloporphyrin 
receptors, which bind anions via a Lewis acidic zinc centre [31].  Dendrimers containing up to 
eighteen ferrocene units have been prepared [32], as have lower-rim polysubstituted 
ferrocene-containing calixarenes [33], with the aim of increasing ion selectivity. 
  The amide receptor (10) was found to selectively bind dihydrogen phosphate, even in the 
presence of a ten fold excess of hydrogen sulphate and chloride ions, while the amide 
receptor (11), with its more basic amine functionality, was found to selectively bind the more 
acidic HSO4- anion.  Cathodic shifts of over 200mV were observed upon complexation with 
anionic guests. 
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  Finally, the binding of guests by a ferrocene containing molecule has also found application 
in the area of chirality sensing.  Tsukube and co-workers prepared a ferrocene carboxylic 
acid-crown ether conjugate (12) [34], which is capable of binding the protonated form of 
certain unprotected α-amino acids.  The protonated amine is bound by the crown ether ring, 
while the carboxylic acid group can form two-point hydrogen bonding with the carboxyl 
group of the guest.  Via CD spectroscopy, the chirality of the guest could be determined. 
O
O
O
O
O
OH
Fe
O
N O
O
H
12  
 
1.5.3: Ferrocene Containing Molecules for Second Order Non-Linear 
Optics 
  The interest in materials with large second-order optical non-linearities stems from their 
potential application in telecommunications, optical computing, and optical information 
processing.  In such materials, there is no linear relationship between the induced dipole 
moment, and the applied electric field, providing the field is of high enough intensity (as is 
the case with lasers).  The induced dipole moment is given by the equation: 
 
μ* = αε + 1/2βε2 
 
- where μ* is the induced dipole moment, α is the polarizability of the molecule, ε is the 
electric field strength, and β is the first hyperpolarizability [35].  Large hyperpolarizabilities 
are associated with molecules that have large differences between the ground state and 
excited state dipole moments, and a small energy gap between the ground and excited state 
[36].  Organic chromophores which fulfil these criteria, the so-called ‘push-pull’ systems, 
have donor-acceptor moieties separated by conjugated bridges, for example (E)-4-(methoxy)-
4’-nitrostilbene [37]. 
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  In the last ten years, there has been a substantial amount of work devoted to molecules 
incorporating a ferrocene group with potential NLO responses.  Ferrocene derivatives are 
particularly suitable to function as a donor in these materials, owing to the presence of metal 
to ligand charge transfer bands (MLCT) in the visible region, the relatively low redox 
potential, and the enhanced electron delocalisation in π-substituted systems.   
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  Among the first ferrocene derivatives to exhibit large hyperpolarizabilities were those 
prepared by Calabrese and co-workers at DuPont, trans-1-ferrocenyl-2-(4-nitrophenyl) 
ethylene (13) and  trans-1-ferrocenyl-2-(N-methylpyridinum) ethylene iodide (14), which 
displayed second-harmonic generation (SHG) 62 and 220 times greater than that of urea [8].  
It should be noted that these results were obtained using dc electric field induced second 
harmonic generation (EFISH).  The alternative method, the Kurtz second harmonic powder 
generation test gives zero SHG if the material crystallizes in a centrosymmetric space group 
[37].  In no other area of metallocene chemistry do electronic structure and quantum chemical 
calculations take on such importance as in the area of non-linear optics.  Extended Huckel 
molecular orbital calculations assign the HOMO of these ferrocene derivatives as being the 
iron-based a’1g (3dz2) orbital [38]. The LUMO of these conjugated systems is largely located 
around the nitrogen atom.  Hence, electron density is significantly redistributed in the excited 
state relative to the ground state, illustrating the suitability of ferrocene as a donor moiety in 
NLO materials [39].  Conjugation also has the effect of lowering the HOMO-LUMO energy 
gap, with the band observed circa. 440 nm for simple ferrocene (in acetonitrile) being 
bathochromically shifted to 550 nm for the nitrophenyl derivative 13 [40]. 
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1.5.4: Liquid Crystals Incorporating Ferrocene 
  The liquid crystal (mesogenic) state represents a discrete state of matter (the mesophase) 
lying between the solid and liquid states.  A crystal has a defined shape, and its physical 
properties are anisotropic because the molecules (or ions) are ordered in terms of their 
position and orientation.  The molecules of a liquid lack this positional and orientational 
order, and hence its physical properties are isotropic.  Liquid crystals have the fluid 
characteristics of liquids, but also a degree of positional and translational order, reminiscent 
of solids [41].   
  Liquid crystals can be divided into two broad categories, thermotropic and lyotropic.  
Thermotropic mesogens change phase upon heating or cooling, with the solid phase melting 
to the mesophase (the melting point), and, at a higher temperature, forming the isotropic 
liquid (the clearing point).  Some mesogens exhibit polymorphism – they have more than one 
mesophase, depending on temperature.  Lyotropic phases are formed by molecules in a 
solvent (generally water), and the appearance of the mesophase is concentration dependent.   
  Thermotropic mesogens can be classed as calamitic (rod-like) or discotic (disk-like).  Rod-
like thermotropic mesogens can themselves be sub-divided into nematics (where the 
molecules align themselves in a roughly parallel fashion), and smectic (where the mesogens 
form layers), which is a more ordered arrangement than the nematic phase [42].   
  The study of the incorporation of metals into liquid crystals (resulting in what are known as 
metallomesogens) is now a well established area of materials chemistry, with many potential 
applications resulting from the polarizable electron density around a metal atom (such as 
molecular electronics, magnetic/electrical switches, conductors and optical devices) [43].  
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 Other important advantages include stereochemistry not found in organic mesogens, and the 
possibility of paramagnetic materials.  The main disadvantage of metallomesogens is their 
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tendency to decompose upon heating, and hence the chemically robust ferrocene moiety is a 
suitable candidate for incorporation into these materials.    The first ferrocene-containing 
mesogen to appear in the literature were the ferrocenyl imines, prepared by Malthete et al. 
(15), which formed a stable nematic liquid crystal phase upon heating [43].  
  Deschenaux et al. have investigated the thermotropic liquid crystal properties of both 1, 1’ 
and 1, 3- disubstituted ferrocenyl systems, examples of which are 16 and 17 [44, 45].   
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  Interestingly, none of the 1, 1’ disubstituted ferrocenyl systems exhibited any mesogenic 
behaviour upon heating, instead melting into an isotropic liquid.  However, the 1, 3- 
disubstituted systems gave rise to wide nematic phases of over 600C in some cases.  The 
same research group have used the well-defined redox behaviour of ferrocene to induce 
mesomorphism via chemical oxidation.  Prior to treatment with silver tosyolate, the ferrocene 
derivative (18) displayed no mesogenic behaviour. 
  Ferrocene containing polymers are attractive materials, as they combine the unique 
chemical properties of ferrocene with the low thermal expansion and processibility.  Thus, 
polymeric materials incorporating ferrocene units into both the backbone and side chain have 
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been prepared.  Liu et al. have synthesized functionalised liquid crystalline polymers from 
silicon-bridged ferrocenophane monomer units (19).  The introduction of the ferrocene 
moiety has also been shown to induce mesomorphism into an otherwise non-mesogenic 
polymer (20) [46]. 
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  Finally, Galyamaldinov et al. reported the first example of a heterobimetallic liquid 
crystalline material [47], the ferrocene/copper salicylaldimine complex (21). 
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1.5.5: Bioorganometallic Chemistry of Ferrocene Derivatives 
  Bioorganometallic chemistry is currently of interest to many research groups, and 
incorporates areas ranging from inorganic to medicinal chemistry [48].  It takes advantage of 
the unique chemical and spectroscopic properties of organometallic compounds, for the 
incorporation into, or detection of, biomolecules.  Organometallic carbonyl compounds, for 
example, when covalently bound to a biologically active substrate, can be detected via 
infrared spectroscopy, providing a safer alternative to conventional radioactive markers.  
Thus, ferrocene has been incorporated into a number of biomolecules, such as amino acids 
and peptides, steroid derivatives, and sugar molecules (ferrocene derivatives of amino acids 
and peptides will be discussed in section 1.7). 
  The difficulty in controlling pathogenic organisms with antibiotics has risen dramatically in 
the last few decades.  Mycobacterial resistance to anti-tuberculosis agents is particularly 
worrying, as tuberculosis results in three million deaths worldwide annually.  Therefore, there 
is an urgent need for the design of new drugs with new modes of action.  The ferrocene 
moiety is particularly suited to this task, owing to its low toxicity and chemical stability [49].   
  The steroidal (N-ferrocenylmethyl) amine derivative (22) synthesised by Krieg et al. was 
tested in vitro for antimicrobial activity against a broad spectrum of test organisms (fungi, 
mycobacteria, etc.), and shown to be extremely effective against each microorganism. 
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  The three standards used in these experiments, rifampicin, isoniazid and ciproflaxacin, were 
observed to have a different pattern of activity, and did not cover the range of organisms as 
did the 16-(ferrocenylmethyl) amino estratrienes.  The authors attribute these observations to 
a different mode of action to that of known drugs.  The penicillin-ferrocene derivative (23) 
prepared by Edwards et al., is another compound that displays significant antibacterial 
activity [50]. 
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  The ferrocenoyl derivative (24) is one of the few ferrocene-containing compounds to have 
been used in pharmaceutical treatment of illnesses, having been patented in the USSR, and 
marketed under the trade name ferrocenone.  It has been employed in the treatment of various 
conditions, including iron deficiency anemia, and infection of the nasopharynx [51].    
  Ferrocenyl amines have also been shown to have antiproliferative properties against a variety 
of carcinomas and tumours [52].  Cisplatin analogues with ferrocenylamine ligands of the type 
25, have been prepared by Duffy and co-workers [53].  This study highlighted the relationship 
between the toxicology of ferrocenyl amines and their basicity.  N-alkyl ferrocenyl amines were 
observed to protonate and oxidise to their ferricenium analogues more readily than N-aryl 
ferrocenyl amines.  Protonation competes with complexation to the Pt(II) center, and the 
reduced biological activity of the N-alkyl species in vitro is attributed to their propensity to 
protonate [54]. 
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  Ferrocenoyl saccharide derivatives (26) have been prepared by Itoh and co-workers [55], as 
glucosides are known to be effective in the area of antimalarial action and DNA binding 
ability in cancer cells [56]. 
  Ferrocene has also served as a redox active moiety in the determination of blood glucose 
levels in diabetes patients [57], in the selective recognition of nucleotides [58], and in the 
redox modification of enzymatic co-factors [59]. 
 
1.6: Amino Acids and Peptides   
  All proteins can be considered as being polymers of α-amino acids.  These molecules are 
centred around a tetrahedral (α) carbon atom (Fig. 5), to which is attached a carboxyl group, 
an amine functionality, and a hydrogen atom.  The fourth substituent is unique to each 
individual amino acid, and serves a variety of structural and/or functional roles when 
incorporated into a protein.  Of the twenty commonly occurring amino acids, all have an 
asymmetric α-carbon (with the exception of the achiral glycine), and are found in the L-form.  
Threonine and isoleucine also possess additional chiral centres. 
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Fig. 5: general structure 
        of L-amino acids
Amide plane
Fig. 6: Planarity of amide group(s)
 
  Other less common amino acids are also found in minor amounts in proteins, and usually 
result from modification of the R-group after incorporation into the peptide chain (e.g. 
hydroxyproline) [60].   
  Free amino acids are ionic compounds in the solid state, with a protonated amine group, and 
a deprotonated carboxyl group, which accounts for their high melting points, large dipole 
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moments, and water solubility [61].  In addition to the ionisable amine and carboxyl groups, 
five amino acids (lysine, arginine, histidine, aspartic and glutamic acid), have charged R-
groups at physiological pH, and tend to be located on the surface of globular proteins, thus 
aiding in their solubility.  In the early 1950s, Pauling and Corey formulated two rules 
concerning the structure of proteins, from their crystallographic studies of low molecular 
weight peptides.  The first of these was that the amide groups always prefer planarity, i.e. the 
C-N peptide bond, and the four atoms to which they are directly attached, lie in the same 
plane (Fig. 6).  The planarity of the amide group is due to the fact that resonance stabilization 
is maximized when the p-orbitals of the amide C, N, and O atoms lie in the same plane (fig. 
7). 
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Fig. 7: Resonance forms of the peptide bond
 
 
  The second rule was that the partially deshielded amide protons and the carbonyl oxygen 
atoms always form the maximum number of hydrogen bonds.  Thus, regular, repeating 
patterns of hydrogen bonding, such as the α-helix and the β-pleated sheet, are formed.  These 
two rules mean that the conformational freedom of peptide backbones is greatly reduced.  
The higher orders of structure (tertiary and quaternary) imposed by individual amino acid 
side chains, serve to bring an ordered structure to physiologically active proteins, providing 
specific sites for molecular recognition, electron transfer, etc. 
 
1.6.1: The Synthesis of Peptides  
  In living systems, the synthesis of peptide chains is an intricate, enzymatically controlled 
process, the order of amino acids being determined by the order of nucleotides in the 
corresponding messenger RNA template.  In the absence of such a highly ordered, chemically 
selective environment, the formation of a peptide chain of predetermined sequence requires 
multi-step synthetic procedures, namely protection, activation, and coupling. 
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  Modern peptide synthesis employs one of two principal methods: solution and solid phase 
synthesis.  Merrifield's method for the synthesis of peptides on an insoluble polymeric support 
(for which he was awarded the 1984 Nobel prize) has proved so successful that most peptides 
are now prepared in this manner.  Briefly, the C-terminal of an N-protected amino acid is 
anchored to the polymeric resin, usually via the formation of an ester or an amide bond.  
Repetitive cycles of deprotection, followed by coupling then affords the peptide, with 
subsequent cleavage from the resin [62].  This is the reverse of the ribosomal process in 
nature, where chain elongation takes place from the N-terminal. 
  Solid phase peptide synthesis offers several advantages over solution phase synthesis, 
namely speed of preparation, the possibility of automation, and near quantitative yields.  
Solution phase synthesis is still the preferred method, however, for large-scale synthesis, and 
enables isolation of intermediates, as well as the synthesis of cyclic peptides [63]. 
 
1.6.1.1: Activation 
  An amine and a carboxyl group can only react to form an amide bond at elevated 
temperatures, which would inevitably induce side reactions in complex peptides [64].  
Therefore, one of these functional groups must be activated for peptide synthesis.  Increasing 
the nucleophilicity of the amine with an electron-donating substituent (such as a t-Butyl 
group) has the disadvantage of decreasing the rate of N-acylation, due to steric hindrance.  
Therefore, activation in peptide synthesis has been confined to increasing the electrophilicity 
of the carboxyl carbon atom with an electron-withdrawing group.  One of the earliest 
examples of such activation is the azide method of Curtis, still widely used in peptide 
chemistry today.   
  Conversion of the carboxyl group to the acid chloride results in what is known as over 
activation – acid chlorides are powerful acylating agents, and can react with nucleophiles 
other than amines, e.g. hydroxy groups.  Therefore, an activating group must make the 
carboxyl group sufficiently reactive towards amines, while remaining inert towards less 
reactive nucleophiles found in amino acid side chains.  Many examples of carboxyl-activating 
groups have appeared in the literature over the years, with conversion to the azide, acid 
anhydride, and active ester being among the most widely used methods.  
 
1.6.1.2: Protection 
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  In order for peptide synthesis to occur, there should be only one nucleophile available for 
acylation, and therefore one of the amino groups must be blocked.  Similarly, the carboxyl 
group of the other amino acid must be protected from activation.  In addition to these α-
functional groups, several amino acid side chains have functional groups that can potentially 
interfere with peptide bond formation.  Therefore, protecting groups must be carefully chosen 
for all reactive groups not directly involved in coupling, which renders them inert under 
coupling conditions, and can be cleaved without affecting the newly formed peptide bond. 
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  An amine group cannot be protected via acylation, as removal of the protecting group via 
acid/base hydrolysis would result in cleavage of the peptide bonds as well.  Formation of a 
urethane-type bond (27), however, allows for facile removal of the protecting group under 
mild conditions, leaving the amide bond(s) intact.  In 1932, Bergman and Zervas introduced 
the benzyloxycarbonyl (or ‘Z’ group) [65], which is easily removed via catalytic 
hydrogenation and/or acidolysis, and is still widely used in peptide synthesis today.  The most 
popular urethane-type protecting group in peptide chemistry today is probably the 
tertbutyloxycarbonyl (or ‘t-Boc’) group.   
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Scheme 4: Removal of the Fmoc group  
  Other N-blocking groups currently employed in peptide synthesis include the p-toluene 
sulfonylurea (Tonsil, Toss) group (which can be removed by reduction with sodium in liquid 
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ammonia), and the 9-fluorenylmethoxy carbonyl (Fmoc), which is cleaved by a process of β-
proton abstraction in the presence of weak bases (scheme 4). 
  The most widely used procedure in the protection of the α-carboxyl group is conversion to 
the ester.  Thus, methyl, ethyl, t-butyl and aryl esters have all been employed in peptide 
synthesis.  Alkyl esters, while relatively straightforward to prepare, must be removed by 
saponifiation, which can lead to unwanted side reactions, particularly in larger peptides.  The 
most worrying of these is the possibility of racemisation, which is particularly common in 
peptides with S-benzyl cysteine residues.  Benzyl esters have an advantage in this respect, 
being easily cleaved by catalytic hydrogenation.  Ethyl esters, substituted on their β-carbon 
atom with an electron-withdrawing group, can be easily cleaved in base by β-proton 
abstraction.  Phenyl esters are readily removed in dilute base, but they do have some weak 
active ester character, and are liable to nucleophilic attack by a free amine group. 
  The need for protection of side chain functional groups varies with each individual amino 
acid, and with the conditions employed in peptide synthesis.  For instance, the sulfhydryl 
group of cysteine must be protected, irrespective of the coupling conditions, as it is an 
excellent nucleophile, and can compete with amines for acylation, or else be oxidized by air 
to form disulfides.  S-alkylation with benzyl or trityl groups is the most widely used methods 
of sulfhydryl protection.  The ε-amino group of lysine, or the δ-amino group of the less 
common ornithine, are similar in reactivity to their α-amino groups, and are therefore readily 
acylated under normal coupling conditions.  Selective acylation of the side chain amino group 
can be achieved via the formation of a Cu(II) complex of the amino acid (which effectively 
blocks the amino group), followed by introduction of a tosyl group (scheme 5).  
  The side chain carboxyl groups of aspartic and glutamic acid are sometimes left unprotected 
in coupling reactions, although this can lead to undesirable side reactions, such as the 
formation of anhydrides, leading to branching of the peptide chain.  Most often, the diester of 
these amino acids is prepared, followed by selective saponification of one of the ester groups 
[65] (scheme 6).  Protection of the hydroxy groups of serine, threonine and tyrosine is 
optional, and depends on the coupling conditions.  In the presence of bases, deprotonation of 
the hydroxy group can occur, generating nucleophiles which can react in the presence of 
activated species such as anhydrides.   
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Scheme 5:  Selective protection of the lysine ε-amino group 
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Scheme 6: The selective deprotection of the 
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 26
Of the three, serine can most effectively compete with amines for acylation, while the 
sterically hindered secondary alcohol of threonine is the least reactive.  Protection is also 
optional in the case of the indole and imidazole rings of tryptophan and histidine respectively, 
the carboxamide groups of glutamine and asparagine, and the thioether of methionine. 
 
1.6.1.3: Coupling 
  Formation of a peptide bond is a bimolecular dehydration reaction between a free amine and 
a free carboxyl group.  Carbodiimides are powerful dehydrating agents, and have become the 
most widely used coupling reagent in peptide chemistry, the most popular being 
dicyclohexylcarbodiimide (DCC).  In such reactions, activation of the carboxyl group occurs 
through nucleophilic addition to the cumulated double bond of the diimide.  Nucleophilic 
attack by amines is generally too slow to compete.  Addition results in the formation of the O-
acylisourea intermediate, which is prone to nucleophilic attack from a free amino group to 
give the coupled product (scheme 7), from another carboxy group, which affords the reactive 
anhydride, or from an auxiliary nucleophile, which results in the formation of an active ester.  
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  The problem of side reactions, particularly racemisation of the carboxy terminal residue, can 
be overcome by the use of these auxiliary nucleophiles.  The first of these was N-
hydroxysuccimide, which, although still used occasionally in peptide synthesis today, has 
largely been replaced by 1-hydroxybenzotriazole (HOBt).    Although several mechanistic 
studies have been performed on the DCC/HOBt system, it is still not clear how much each 
pathway contributes to the overall coupling reaction.  Two other such additives, 3-hydroxy-4-
oxo-3, 4-dihydro-1, 2, 3- benzotriazine (HODhbt, 28) and 1-hydroxy-7-azabenzotriazole 
(HOAt, 29) have also found widespread use as auxiliaries due to their effectiveness at 
reducing racemisation. 
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Although acylphosphonium salts have been used in coupling reactions since the late sixties,   it 
was not until several years later that their use became widespread, with the introduction of 
Castro's 1-H-benzotriazol-1-yloxy-tris (dimethylamino) phosphonium hexafluorophospate 
(BOP) reagent [66].  A disadvantage of using this reagent is the formation of the toxic by-
product, hexamethylphosphorotriamide.  Thus, other acylphosphonium salts, such as PyBOP, 
have been developed, which form less toxic by-products.  The mechanism for the action of the 
BOP reagent is outlined in scheme 8.  
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Scheme 8:  Formation of the active ester with BOP  
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  Uronium salts were introduced a decade after phosphonium salts, the most popular of which 
are O- (1H-benzotriazol-1-yl)-N, N, N’, N’ -tetramethlyuronium tetrafluoroborate (TBTU, 
30), and HATU, (31), which is based upon the HOAt additive. 
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  The biggest drawback in employing these reagents is their tendency to react with free amine 
groups, unlike carbodiimides or phosphonium salts, which is why the N-protected amino acid 
must be pre-activated with the uronium salt before the addition of the free amine, and the use 
of excess uronium salt must be avoided [67]. 
  Mixed anhydrides have long been used in peptide synthesis.  The most obvious problem 
they present is that of regioselectivity, as nucleophilic attack of the free amine group must 
occur at the correct carbonyl carbon atom.  This problem can be addressed by treatment of 
the N-protected amino acid with carboxylic acids that are severely sterically hindered.  Thus, 
mixed anhydrides prepared with isovaleroyl chloride or pivaloyl chloride can ensure that 
nucleophilic attack occurs at the correct site [68] (scheme 9). 
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Scheme 9: Regiospecificity using mixed anhydrides
 
 
  Mixed carbonic anhydrides are another popular choice of coupling reagent, and their 
regioselectivity is due to electronic rather than steric effects.  The carbonyl carbon atom, 
which is not from the N-protected amino acid, is flanked by two electron-releasing oxygen 
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atoms, thus decreasing its electrophilicity.  Isobutyl chloroformate is probably the most 
popular choice of reagent for this kind of chemistry [69] (Scheme 10). 
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Scheme 10: Regiospecificity using carbonic anhydrides
 
 
  Mixed carbonic anhydrides can also be generated in situ with coupling reagents such as 1-
ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDq) [70], (scheme 11).    Reagents of this 
type are very slow to react with amines, but react readily with carboxylic acids, and the 
anhydride undergoes subsequent aminolysis rapidly. 
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Scheme 11: In situ generation of mixed carbonic anhydrides
 
 
1.6.2: Amino Acids as Ligands 
  Transition metals frequently function as co-factors in enzyme catalysed reactions, and 
known metalloproteins such as ferredoxins, cytochromes, and blue copper proteins number 
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several hundred.  The metal cation can be held in an enforced stereochemistry, which can help 
bind or activate substrates in enzymatically catalysed reactions (see p. 21).  Amino acid 
residues can coordinate to a metal cation via donor atoms from the peptide backbone or side 
chain heteroatoms.  The N-terminal amine, deprotonated amide, and carbonyl oxygen atoms 
from the peptide backbone can all function as donor atoms, while side chain donors include 
the imidazolic nitrogen of histidine, the carboxylate groups of glutamic and aspartic acid, and 
the sulphur atoms of methionine and cysteine. 
  Sulphur donor atoms are among the most common binding sites of proteins [71].  In iron-
sulphur proteins, iron atoms are coordinated tetrahedrally by the thiol groups of cysteine 
residues and inorganic sulfide atoms.  Such iron-sulphur clusters are common in redox 
enzymes (32).  In the blue copper proteins, both cysteine sulphur atoms, and the thioether 
group of methionine are used to coordinate a Cu2+ ion.  Being a ‘soft’ donor atom, sulphur 
shows a great affinity towards the late transition elements, with the thioethers of methionine 
and S-methyl cysteine being particularly selective towards Pd (II) and Pt (II) ions [72]. 
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  Methionine has been used as an inhibitor of the nephrotoxicity of the anti-cancer drug 
cisplatin, and indeed one of the metabolites of the drug is the complex [Pt(L-Met)2] [73].  The 
use of cisplatin has, however, been limited by the toxic side effects.  These side effects result 
from the coordination of the Pt (II) ion to cysteine sulfhydryl residues in the kidney, and the 
formation of the Pt-S bonded species is thought to have a significant role in the toxicity and 
transport of the drug [74]. Cisplatin is also ineffective against gastrointestinal tumours, owing 
to the excess of chloride ions in this region, which are able to bind to the platinum centre [75].  
Hence, many methionine and S- methyl cysteine-Pt (II) and Pd (II) cisplatin analogues have 
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been synthesised, and their anti tumour properties investigated.  These ligands may not be 
replaced so easily by chlorides, thus increasing the effectiveness of the drug. 
  Calaf and co workers synthesised complexes of the type [M(Cl)2(L-MetOMe)], (M = Pt, Pd) 
[76] (33).  The platinum complex was shown in vitro to bind to consecutive DNA bases, the 
two chloride ions being substituted by two molecules of nucleotide, coordinated via the N(7) 
atom of guanine, and the N(3) atom of cytosine. 
  The palladium complex (34) incorporating L-methionine methyl ester and the 
immunoregulatory agent levamisole (LMS) of the formula [(LMS)2Pd(L-Met)] was prepared 
by Nijasure and co-workers, and this was also shown to have antitumour activity [77]. 
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  Finally, an interesting study was carried out by Sheldrick and co workers, in which several 
di-peptides of aromatic amino acids (H-Tyr-Trp-OH, H-Trp-Tyr-OH, H-Trp-Phe-OH, H-
Phe-Tyr-OH) were reacted with [(η6-cymene)Ru(acetone)3], producing compounds of the 
type 35 and 36 [78].   In order to ensure η6-co-ordination of the ruthenium atom to the 
aromatic side chains of these amino acids, these compounds were prepared under strongly 
acidic conditions (neat trifluoroacetic acid) to prevent competitive η6-co-ordination from the 
amine and carboxylate groups.  Under these conditions, it was found that co-ordination of the 
ruthenium atom occurred in a chemospecific manner, in order of electron-donating ability, 
with the indole ring of the tryptophan side chain being the most favoured, followed by the 
phenol group of tyrosine, and finally the phenyl group of phenylalanine.  This was found to 
be the case irrespective of whether the amino acids were found at the C- or N-terminal of the 
dipeptides. 
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  However, when an analogous series of compounds was prepared from the reaction of the 
same dipeptides with [(η5-Cp*)Ir(acetone)3], kinetic studies showed an initial preference for 
co-ordination at the C-terminal of the dipeptide, and a mixture of products of the type 37 and 
38 were obtained. 
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1.7: Ferrocene Derivatives of Amino Acids   
  The first example of an amino acid modified with a ferrocene group was reported as far back 
as 1957, in an attempted synthesis of DL-alanine [79]. In 1987, Degani and Heller employed 
the ferrocene moiety as a redox relay, by modifying the protein glucose oxidase, with several 
ferrocene units. Thus, the enzyme could interact with metal electrodes [59].  In the previous 
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year, Eckert and co-workers had used the lipophilic ferrocene moiety to increase the solubility 
of peptides in organic solvents, and to facilitate their chromatographic purification [80].  
Since then, an increasing number of amino acid derivatives of ferrocene have been reported in 
the literature, taking advantage of the self-assembling properties of peptides, and the well 
defined electrochemical and spectroscopic properties of ferrocene, in areas such as the study 
of electron transfer processes in proteins [81], the development of supramolecular ‘smart’ 
materials [82], asymmetric catalysis [83], and in bioorganometallic chemistry, which is the 
main focus of this section. 
  Following on from the work of Degani and Heller, Shinohara et al. modified several 
proteins, including bovine serum albumin (BSA) and the biotin-binding protein avidin, with 
ferrocene units [84].  The modified proteins were then adsorbed on an SnO2 electrode, 
together with fructose dehydrogenase (FDH), and the sensor response of the electrode for 
fructose was investigated via chronoamperometry.  The co-adsorption of Fc-BSA enhanced 
the response current significantly.  This suggests that the Fc-BSA functioned as an electron-
transferring interface.  Direct modification of FDH with ferrocene units had the effect of 
denaturing the protein. 
  The use of chemically modified metalloproteins to investigate electron transfer within 
peptides has been the focus of much attention in recent years.  The variable redox potential of 
the ferrocene moiety makes it ideally suited to this task.  It has been determined by Kraatz et 
al. that the redox behaviour of the ferrocenoyl group is sensitive not only to individual amino 
acid side chains, but also to the number of residues attached [85].  The electrochemistry of a 
series of oligoprolines, Fc-Pron-oBz (n = 1-4) (39) was investigated, and it was found that 
elongation of the peptide chain resulted in a cathodic shift in the redox potential of the 
ferrocenoyl group. 
Fe
N
O O
OBzn
 Fe
O
BzO
N
N
O
O
N
O
H
39                                                                      40  
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When n = 3, one full turn of the polyproline – II helix was complete, and elongation of the 
chain to n = 4 caused no further shift in redox potential. When n > 3, all the carbonyl groups 
point towards the ester carbonyl of the peptide chain, thereby creating a permanent dipole 
within the molecule.  Such alignments are thought to play a major role in influencing electron 
transfer rates within peptides [86], yet since the Fc group is at the positive end of the dipole, 
the cathodic shift with increasing chain length is counterintuitive.  The authors tentatively 
attribute this effect to the directional character of a carbonyl oxygen p-orbital perpendicular to 
the Cp-amide plane. 
  Interestingly, when the third proline residue was replaced by phenylalanine, a β- turn was 
induced in the peptide, owing to the presence of the amide proton on the third residue, which 
formed a hydrogen bond with the ferrocenoyl oxygen (40).  An anodic shift of ca. 30mV of 
the ferrocenoyl group was observed, illustrating the ability of ferrocene to distinguish 
between different structural motifs present in small peptide chains.   
  The electron transfer between the enzyme ribonuclease reductase (RNR) and modified, 
water-soluble ferrocenes (41, 42) has been investigated by Liu et al. [87].  The enzyme R-2 
sub-unit consists of a μ-oxo-bridged binuclear Fe (III) site, and a tyrosyl radical.  Electron 
transfer is believed to occur in the following manner: 
 
Fe2III, Tyr
. +e- → FeIIIFeII, Tyr. + H+→ Fe2III, Tyr- 
Fe
NH2.HCl
Fe
CO2Hn
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n = 6, 8, 10
 
 
  It was found that the ferrocene derivatives were strong enough oxidizing agents to reduce the 
tyrsoyl radical, but not the FeIII atom, unlike organic radical substrates.  The authors attribute 
this to the difficulty of ferrocene in transferring electrons from its orbitals to the FeIII atom. 
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  Kraatz et al. have also investigated the change in the redox potential of ferrocene-containing 
peptides, via H-bonding with substrates. The ferocenoyl derivative Fc-LF-OMe showed a 
30mV shift in redox potential upon binding 3-aminopyrazole, due to the β-sheet conformation 
induced in the molecule (43) [88]. 
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Kenny et al. investigated the anion-binding properties of three N-ferrocenoyl glycine ester 
derivatives (benzyl, ethyl, and methyl).  While the choice of ester was shown not to be 
crucial, all three were shown to bind H2PO4- strongly [89].                                                                           
  The same group subsequently prepared six novel N-ferrocenoyl dipeptide ester derivatives, 
with the least sterically hindered Fc-GG-OMe (44) producing the most sensitive 
electrochemical response in anion binding studies [90].  Bulky R groups are thought to hinder 
close interaction of the substrate and the amide proton [91]. The group is currently developing 
these compounds by altering the stereochemical environment vicinal to the amide proton, by 
incorporating a phenyl spacer between the ferrocene moiety and the amide group (45) [92]. 
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  The fields of supramolecular science and crystal engineering are concerned with the 
development of advanced materials, capable of performing complicated tasks on the 
molecular level [93].  Due to their potential application as molecular conducting devices, 
superconductors, and molecular memory devices, several groups have taken advantage of the 
self-organizing properties of ferrocene containing peptides, to construct multi-centred charge 
transfer compounds.  The peptide backbone is employed to control the spatial arrangement of 
the ferrocene redox centres. 
    The group of Hirao has investigated the self-assembling properties of ferrocene bearing 
podand dipeptide chains, e.g. (L-Ala-L-Pro-OMe) (46).  They found that, due to two intra-
molecular hydrogen bonds, and hydrophobic interactions of the proline residues, the 
molecules adopted a helical arrangement in the solid state, with one turn of the helix per 
14.91Å [94].  There was a stacking effect observed, with the proline residues forming 
hydrophobic columns, and the ferrocene groups forming redox-active columns. 
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  The mono substituted derivative, in the absence of these intramolecular H-bonds, formed 
intermolecular, H-bonded seven-membered rings.  Because of the intra-molecular H-bonding, 
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the di-substituted derivative was found to crystallize in the 1, 1’-configuration of the 
substituents.  In the absence of an amide proton, as in the di-substituted oligoprolines 
prepared by Kraatz et al. (see p. 34), no intra-molecular H-bonding is possible, and the 
molecule adopts a 1, 3’ conformation in the solid state, to minimize steric interactions of the 
substituents. 
   A novel 21 amino acid peptide with the sequence (Leu-Lys-Leu-Leu-Leu-Lys-Leu)3, 
incorporating six ferrocenoyl groups attached to the lysine side chains, was recently 
synthesized by Wieckowska and co-workers (47).  The peptide was found to preserve the α-
helix, with the ferrocene groups being aligned one on top of the other.  There was also 
evidence from electrochemical studies of communication between the individual redox 
centres [95]. 
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   In their work on linking organometallic moieties to biomolecules, Nolte et al. have 
prepared  several ferrocene containing alkynyl peptides (48), thus providing a synthetic 
method for the selective labelling of the C-terminal of peptides.  The same group also 
produced the heterobimetallic compound (49), using benzoic acid chromium tricarbonyl, 
under mild peptide coupling conditions, thus allowing labelled biomolecules to be detected 
via infra-red spectroscopy [96]. 
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  Xu et al. have recently prepared the asymmetrically di-substituted ferrocenoyl peptide (50) 
as a potential biosensor – one ring is substituted with an oligoproline chain, the other with a 
pentapeptide, containing the uncommon amino acid statine. This pentapeptide is known to be 
a potent inhibitor of aspartic proteases, such as HIV-1 protease.  The electrochemical 
response of this molecule towards aspartic proteases is under investigation [97]. 
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  Ferrocene has an inter-cyclopentadienyl ring separation of circa 3.3Å, which is close to the 
N-O separation for the hydrogen bond in a β-sheet (an important secondary structural feature 
of peptides), and this fact has been exploited by Herrick and co-workers, who prepared the 
proline and valine derivatives of 1, 1’-ferrocene carboxylic acid (51 and 52 respectively) 
[98]. 
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  The spectroscopic data from this work showed that the ferrocene skeletal unit could indeed 
be used to induce an ordered, β-sheet-like conformation in 53, with symmetrical hydrogen 
bonding occurring in an anti-parallel fashion, between the amide proton and the oxygen atom 
of the ester group.  Use of the ferrocene moiety also proved successful in overcoming the 
problem of aggregation in solution associated with other β-sheet mimetics [99].  
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  This observation was further investigated by Weyhermuller et al., who investigated the 
influence of a positive charge on the β-sheet conformation by preparing a series of ferrocene-
peptide derivatives, along with their cobaltocenium analogues (53 and 54 respectively) [100].  
By preparing the positively charged cobaltocenium compounds, the difficulty in isolating the 
one-electron oxidized ferricenium derivative could be overcome. 
  The authors concluded that the proximity of the positively charged cobalt atom had minimal 
effect on intra-molecular hydrogen bonding which is responsible for the stability of the β-
sheet, while recognizing that the symmetrical nature of the organometallic peptides prepared, 
coupled with their exclusive use of non-polar, uncharged amino acids, may have influenced 
their findings. 
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  The ferrocene moiety has also been incorporated into amino acids at non-terminal positions.  
Kira and co-workers prepared the novel ferrocenyl amino acid (55) [101].  The amino acid is 
free to undergo peptide chemistry at both the N and C termini.  In polypeptides containing 
this residue, e.g. (Ferala)2-(Glu(OBz))4, a right-handed helix was still adopted, despite the 
bulky ferrocenyl group. 
  Okamura and co-workers prepared the novel peptide containing skeletal ferrocenoyl groups 
(56), in which the three amide planes were found to stack one over another in the solid state.  
This is indicative of the conformational freedom afforded by the two rotary cyclopentadiene 
rings of ferrocene [102]. 
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  Finally, the group of Frejd et al. used the ferrocene moiety to prepare an analogue of the 
opioid pentapeptide Leu-(5)-enkaphalin, in a multi-step synthetic procedure, in which the 
tetrapeptide subunit Tyr-(Gly)2-Phe was replaced with a cyclic ferrocenyl-containing subunit, 
to afford the pentapeptide (57).  The study of the interaction of biomolecules with membrane-
bound receptors is a difficult process to replicate in vitro, particularly when the parent 
pentapeptide has such a high degree of conformational freedom [103]. The receptor 
selectivity towards enkephalins is, however, thought to be dependent on the relative 
orientation of the aromatic residues of tyrosine and phenylalanine.  The two cyclopentadiene 
rings of the ferrocenyl group effectively replaces these two phenyl rings, and thus functions 
as a ‘constraining’ unit, while still allowing a certain degree of conformational freedom of the 
peptide backbone.  Hence, the peptide is still able to adopt a conformation similar to that 
adopted in vivo.   
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Chapter II 
 
The Synthesis and Characterisation 
of N-Ferrocenoyl Amino Acids 
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2.1:  Introduction 
  Following the discovery of ferrocene more than fifty years ago, a vast array of derivatives have 
been prepared and characterized.   Among the first reactions carried out on ferrocene were 
lithiation using n-butyl lithium, arylation using diazonium salts, and Friedel-Crafts acylation 
with acid halides and aluminium trichloride.  The last of these reactions was instrumental in 
confirming the aromaticity of the compound.  Thus, the well-established organic chemistry of 
ferrocene has allowed its incorporation into many organic compounds [1], among them 
biomolecules such as amino acids and peptides.   
  The work undertaken in this project is a continuation of the research performed by Michael J. 
Sheehy under the supervision of Dr. Peter Kenny.  In this work, it was found that N-ferrocenoyl 
glycine mono and di-peptide derivatives had anion-binding properties, with particular selectivity 
being displayed towards H2PO4- (fig. 1) [2].  Altering the molecular geometry by incorporating 
extra methylene spacers into both the peptide backbone, and/or the side chain can not only 
increase the lipophilicity of the molecule, but also may induce selectivity towards other anionic 
substrates.   
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Fig. 1:  Anion binding mode of N-Ferrocenoyl glycine ester (58);  
 
  Anion binding may be dependant on the steric accessibility of the amide proton, as amino acid 
derivatives with bulkier side chains, such as N-ferrocenoyl phenylalanine, exhibited only small 
perturbations in their N-H chemical shifts during 1H-NMR anion titration studies [2, 3].  
Therefore, tailoring of the chemical environment vicinal to the amide proton is envisaged to alter 
the anion-binding abilities of these molecules. 
  The electrochemical and spectroscopic behaviour and chemical stability of ferrocene has 
resulted in its many different areas of research other than anion sensing, such as asymmetric 
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catalysis, bioorganometallic chemistry, supramolecular chemistry, in liquid crystalline materials, 
and in materials for non-linear optics, with the incorporation of a ferrocene moiety into 
biomolecules currently an area of intense research activity [4].  Modifying a biologically active 
substrate with one or more ferrocene units allows for the possibility of studying these labelled 
compounds, given the previously mentioned electrochemical and spectroscopic properties of 
ferrocene.  Amino acids are logical candidates for such modification, given that they fulfil such 
diverse roles in biological systems. 
  The chirality of amino acids would make the area of asymmetric catalysis an obvious choice for 
application of ferrocene peptide derivatives, while their self-assembling properties opens up 
possibilities in the field of supramolecular chemistry.  Ferrocene-peptide derivatives have also 
been shown to be effective in selective anion recognition.   
  While there have been an increasing number of ferrocene derivatives of amino acids and 
peptides since Degani and Heller employed the ferrocene moiety as a redox relay in the enzyme 
glucose oxidase, few have exploited the presence of potential donor atoms in the amino acid side 
chain.  This is surprising, as side chain donor atoms play an important role in the co ordination of 
metal ions in biological systems [5].   N-Ferrocenoyl derivatives of amino acids such as L-
methionine and L-histidine can provide a possible route towards heterobimetallic systems, given 
the co-ordinating properties of the hetero-atoms in the side chains of these amino acids.  Previous 
work in the area of N-ferrocenoyl peptides has suggested that the ferrocene moiety is 
electrochemically sensitive not only to the number of residues attached, but also to the individual 
side chains [6].  With this in mind, novel N-ferrocenoyl peptides have been prepared with 
potential application in several diverse areas of current research.    
 
 
2.2: The Synthesis of Amino Acid Esters 
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O
R
OH NH2
O
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Scheme 1:  The esterification of amino acids using a solution of thionyl chloride in the 
appropriate alcohol. 
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  Esterification of amino acids was accomplished using the long established thionyl chloride 
procedure, which afforded the amino acid esters as white solids in quantitative yields (scheme 1).     
  The reaction of L-glutamine and L-asparagine under these conditions resulted in esterification 
of the carboxamide groups in the side chain, yielding L-glutamic acid diethyl ester and L-
aspartic acid dimethyl ester respectively (scheme 2).   
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Scheme 2:  The attempted esterification of L-glutamine, using the thionyl chloride protocol.  The 
carboxamide functionality, also proved susceptible to esterification under these conditions. 
 
2.3:  Synthesis of Ferrocene Carboxylic Acid  
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Scheme 3:  Synthesis of ferrocene carboxylic acid (59) 
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  Ferrocene carboxylic acid was prepared using the method of Reeves et al. [7], affording the 
acid as a fine yellow/brown powder in very good yield (70-80%).  However, instead of drying 
the product under vacuum, removal of residual water was accomplished by drying the acid for 6 
hours at 80°C. 
 
2.4:  Synthesis of N-Ferrocenoyl Amino Acid Derivatives 
  Several routes were employed during the preparation of the N-ferrocenoyl amino acid 
derivatives, in order to optimize the conditions best suited to their synthesis.  As the project 
evolved, consistent yields of over 80% were achieved using synthetic route 1.  Several of these 
compounds were selected to undergo subsequent peptide chain elongation to afford N-
ferrocenoyl dipeptide derivatives, which are discussed in chapter 3.   
 
2.4.1:  Synthetic Route 1 
  Synthetic route 1 is a modification of the procedure used by Kraatz et al. [8, 9], which employs 
dicyclohexylcarbodiimide (DCC) as the coupling reagent, as well as the auxiliary nucleophile 1-
hydroxybenzotriazole (HOBt), which forms an air-stable active ester intermediate with ferrocene 
carboxylic acid.  The reactions were followed by TLC analysis at all times.  The synthesis of 70 
is typical of this synthetic route, and is shown in scheme 4.  Column chromatography, using a 2:1 
hexane/ethyl acetate mobile phase proved the only satisfactory method of purification, affording 
complete separation of the target molecules from intermediate 60. 
  As can be seen from table 1, 24 hours was found to be the optimum time at which to quench the 
reaction.  Given the reduced stability of ferrocene compounds in chlorinated solvents [10], it is 
likely that longer reaction times would result in product decomposition. 
 
Reaction Time (Hrs) 12 18 24 36 48 60
Yield 70 26 40 72 66 57 32
Yield 60 41 23 11 12 8 n/d
 
Table 1:  The %  yields of 60 and 70 isolated after varying reaction times during the preparation 
of 70 using synthetic route 1. 
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Scheme 4:  The preparation of N-ferrocenoyl methionine ethyl ester (70), using the DCC/HOBt 
protocol. 
 
 
2.4.2:   Synthetic Route 2 
  Carbonyldiimidazole (CDI), like DCC, is another coupling reagent that has long been employed 
in peptide synthesis [11].  Indeed, the imidazolic adduct of ferrocene, 61, first prepared by Imrie 
et al. [12], is a synthetic intermediate that has recently been used to prepare a large array of 
ferrocene compounds.  It is, however, less stable than the Fc-OBt intermediate, and required 
storage at temperatures < 5 ºC.  Compounds 62, 65, 68, 70 and 73, having previously been 
prepared according to route 1, were also synthesised using the CDI protocol, and on a similar 
scale.     
  As was the case when the DCC/HOBt protocol was employed, the only satisfactory method of 
work-up was column chromatography, again using 2:1 hexane/ethyl acetate mobile phase, 
allowing complete separation from the ferrocene-imidazole intermediate.  Purification by 
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recrystallizations from various solvent combinations did not completely remove traces of 61, and 
had a negative impact upon yields.   
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Scheme 5:  The preparation of 70 using CDI as a coupling reagent.  Ferrocenoyl imidazolide, 
61, was also isolated during work up.   
 
 
2.4.3:  Synthetic Route 3 
    Tetramethyluronium tetrafluoroborate (TBTU) is the most popular of the newer uronium salt 
coupling reagents [13], although considerably more expensive than either DCC or CDI.  
Compounds 65, 68, 70, 73, and 78 were prepared using this protocol.  The synthesis of 70 is 
shown in scheme 6. 
  Mechanistically, the TBTU reagent is thought to function via the formation of an O-
benzotriazole adduct with the free acid [14], as is the case when the DCC/HOBt protocol is 
employed.  This proved to be the case when 65, 68, 70, 73, and 78 were prepared in this manner, 
as varying quantities of the ferrocenoyl-O-benzotriazole adduct were isolated during 
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Purification.  This in turn necessitated the use of column chromatography during the purification 
of the target compounds.  For comparative purposes, table 2 is included, and summarizes the 
yields of several compounds using the various coupling reagents. 
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Scheme 6:  Synthesis of 70 using TBTU as the coupling reagent. 
 
Compound DCC (DCM) CDI (THF) TBTU (DMF) 
62 69 67 N/A 
65 72 65 69 
68 82 79 77 
70 70 60 72 
73 69 55 75 
78 68 N/D 60 
 
Table 2:  The %  yields of selected compounds using the various coupling reagents and solvents. 
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2.4.4:  Synthetic Route 4 
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                  Et3N
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Scheme 7:  Preparation of 87 using the Fc-OBt active ester. 
 
  Compounds 62-89, whether prepared by route 1 or 3, were all found to contain varying amounts 
of the Fc-OBt intermediate 60 during column chromatography.  It was deemed prudent to retain 
all samples of this active ester, as it could be subsequently employed in the preparation of both 
mono- and di- N-ferrocenoyl peptides.  The preparation of 87 with Fc-OBt is shown in scheme 7.  
  From table 2, it can be seen that the more expensive TBTU coupling reagent offers very little 
advantage over the well-established DCC/HOBt protocol.  The yields recorded for compounds 
62, 65, 68, 70, and 73 were all lower when CDI was employed, although this could be because of 
the solvent used (THF).  Synthetic route 1 afforded the N-ferrocenoyl amino acid derivatives in 
varying yields (43% in the cases of 80 to 82% in the case of 68), and are summarised in table 3.  
These yields would appear to depend on several factors, including the solubility of the individual 
amino acid ester (largely dependant on the polarity of the amino acid’s side chain) in DCM, and 
the stoichiometry of the coupling reaction (the dihydrochloride salts of the amino acid esters of 
L-lysine, L-ornithine and L-histidine, were observed to react more slowly).  
    In all cases, work up of the desired compounds was most effectively achieved by silica gel 
column chromatography using a mobile phase of 2:1 hexane/ethyl acetate.  Not only did this 
method tend to avoid the losses incurred during multiple recrystallizations, but it also afforded 
complete separation of the N-ferrocenoyl amino acid ester from the active intermediates N-
ferrocenoyl-O-benzotriazole active ester 60, (which itself could then be employed in synthetic 
route 4), and 61. 
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Compound Name M.P. (ºC) Yield (%)
62 N-ferrocenoyl-L-2-aminobutyric acid ethyl ester 116-118 69 
63 N-ferrocenoyl-L-norvaline ethyl ester 124-126 63 
64 N-ferrocenoyl-L-norleucine ethyl ester 142-144 72 
65 N-ferrocenoyl-L-phenylglycine methyl ester 118-120 72 
66 N-ferrocenoyl-L-valine methyl ester 124-125 61 
67 N-ferrocenoyl-L-glutamic acid diethyl ester 128-129 67 
68 N-ferrocenoyl -L-aspartic acid dimethyl ester 123-125 82 
69 N-ferrocenoyl -(S-benzyl)-L-cysteine ethyl ester 126-128 65 
70 N-ferrocenoyl-L-methionine ethyl ester 122-124 70 
71 N-ferrocenoyl -L-threonine ethyl ester 113-115 71 
72 N-ferrocenoyl-L-serine methyl ester 128-130 74 
73 N-ferrocenoyl-L-tyrosine methyl ester 140-143 69 
74 N-ferrocenoyl-L-histidine methyl ester 162-164 49 
75 N-ferrocenoyl-L-tryptophan methyl ester 111-113 67 
76 N-ferrocenoyl-α-isoaminobutyric acid ethyl ester 139-140 64 
77 N-ferrocenoyl-(1S, 2R)-(+)-norephedrine 153-155 71 
78 N-Ferrocenoyl -D-methionine-ethyl ester 123-125 66 
79 N-ferrocenoyl-( Nε-Fc)-L-lysine methyl ester 228-230 49 
80 N-ferrocenoyl -(Nim-Fc)-L-histidine methyl ester 181-183 43 
81 N-ferrocenoyl -β-alanine methyl ester 128-130 70 
82 N-ferrocenoyl-γ-aminobutyric acid-ethyl ester 110-111 70 
83 N-ferrocenoyl-(1S, 2R)-(+)-ephedrine 138-139 71 
84 N-ferrocenoyl-(1S, 2S)-(+)-pseudoephedrine 131-132 72 
85 N-ferrocenoyl–sarcosine ethyl ester 63-65 59 
86 N-ferrocenoyl-L-thyroxine methyl ester 134-137 69 
87 N-ferrocenoyl-(S-methyl)-L-cysteine methyl ester 119-122 74 
88 N-ferrocenoyl-valeric acid methyl ester 130-131 68 
89 N-ferrocenoyl-(Nδ-Fc)-L-ornithine methyl ester 201-204 60 
 
Table 3:  % Yields and melting points of N-ferrocenoyl amino acid derivatives. 
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  Even after column chromatography, some of those compounds prepared by route 1 were 
observed to contain residual amounts of N, N’ dicyclohexylurea, the presence of which could be 
confirmed by the presence of a doublet in the 1H-NMR spectrum in d6 DMSOcirca 5.5 ppm.  
However it could readily be removed by recrystallization from acetone.   
    All compounds were characterized using 1H, 13C, 135DEPT and HMQC NMR, I.R., and UV-
Vis spectroscopy, as well as mass spectrometry and optical rotary analysis, and melting point 
determination.  In all cases, the half-wave potentials were also recorded, and these will be 
discussed both in this chapter and at length in chapter VI.   
 
2.5:  1H-NMR Spectra of N-Ferrocenoyl Amino Acids 
  Molecular conformation of any peptide is critical in determining its biological activity, and this 
in turn is largely dependant on the number and strength of hydrogen bonds formed in solution.  
Both α-helices and β-sheets, two important features of the secondary structure of proteins, are 
formed as a result of hydrogen bonding between amide protons and the oxygen atom of another 
amide group.  1H-NMR spectroscopy is an invaluable method of determining the solution state 
conformation adopted by compounds such as these.  Specifically, amide protons which form 
hydrogen bonds generally show resonances at 7.5 ppm or greater when recorded in a polar 
solvent [16, 17].  All spectra were recorded in the H-bonding solvent DMSO-d6, and, where 
deemed necessary, CDCl3.   
 
2.5.1:  1H-NMR Spectra of 62 
  The 1H-NMR spectrum of 62, N-ferrocenoyl-L-2-aminobutyric acid ethyl ester, is shown in fig. 
2, and is a typical example of those N-ferrocenoyl amino acid derivatives possessing a chiral α-
carbon atom.  The methyl groups of the side chain and ethyl ester group appear in the spectrum 
as triplets at 0.95 and 1.21 ppm, respectively, with the two protons of the methylene group of the 
side chain being observed as a multiplet ca. 1.8 ppm, and the complexity of this signal is 
enhanced by geminal coupling of these protons, as their proximity to the chiral centre results in 
them being magnetically non-equivalent. 
 The presence of this chiral centre is responsible for many of the distinctive features of the 
spectrum, as it renders otherwise similar protons in magnetically non-equivalent environments.  
For example, the two ortho-hydrogen atoms on the substituted Cp ring appear as two sharp 
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singlets at 4.85 and 4.93 ppm, presumably as a result of their proximity to different substituents 
on the α-carbon atom. 
  The meta-protons are observed as a slightly broadened singlet at 4.36 ppm, and the 
unsubstituted Cp ring is observed as a singlet at 4.21 ppm.  The hydrogen located on the α-
carbon, being adjacent to both the amide hydrogen and a methylene group, is observed as a 
multiplet in the 4.24-4.30 region.   
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Fig. 2:  The 1H-NMR spectrum of compound 62 in d6 DMSO. 
 
  The amide hydrogen is observed as a doublet (J = 7.6 Hz), due to coupling with the α-
hydrogen, and its position in the spectrum at ca. 7.9 ppm is indicative of a hydrogen-bonding 
interaction with the solvent.  Non-hydrogen-bonded amide protons generally show resonances 
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between 5.5 and 7.0 ppm, and this is observed to be the case when the 1H-NMR spectrum of 62 
is recorded in CDCl3, where the amide hydrogen is observed as a doublet at ca. 6.3 ppm (J = 7.0 
Hz).   
 
2.5.2:  1H-NMR Spectra of 79 and 89 
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Fig. 3:  Compounds 79 (left) and 89, N-ferrocenoyl-( Nε-Fc)-L-lysine methyl ester and N-
ferrocenoyl-(Nδ-Fc)-L-ornithine methyl ester respectively.  Each has two amide protons which 
appear in the 1H-NMR spectrum as doublets (d), or triplets (t.) 
 
  Compounds 79 and 89, N-ferrocenoyl-( Nε-Fc)-L-lysine methyl ester and N-ferrocenoyl-(Nδ-
Fc)-L-ornithine methyl ester respectively, are unusual in that they both have additional 
ferrocenoyl groups attached to their side chains.   The 1H-NMR spectrum of 79 in d6 DMSO (fig. 
4) shows the presence of two unsubstituted Cp rings, at 4.14 and 4.23 ppm, each signal 
integrating for five protons.  In addition, two different amide proton resonances are observed, a 
doublet (J = 7.6 Hz) for the amide group adjacent to the chiral centre at 7.98 ppm, and a triplet (J 
= 5.4 Hz) for the side chain amide proton at 7.83 ppm.  The substituted Cp ring adjacent to the 
chiral carbon atom shows two sharp singlets for the ortho- protons.  The ortho-protons of the 
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substituted Cp ring on the side chain, which are in magnetically equivalent environments, appear 
as a singlet integrating for two protons at 4.80 ppm.   
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Fig. 4:  The 1H-NMR spectrum of compound 79 in d6 DMSO. 
 
 
  The 1H-NMR spectrum of 79 (fig. 5), recorded in CDCl3, is quite revealing in terms of the 
conformation adopted by this compound in non-polar solution.  The doublet observed for the 
amide proton adjacent to the chiral centre appears at 6.50 ppm, whereas the triplet observed for 
the amide proton on the side chain appears at 7.62 ppm, indicating that the latter proton forms a 
hydrogen bond with either the oxygen atom of the other amide group, or else the oxygen atom of 
the ester group.  Certainly, from a spatial point of view, either conformation would appear 
possible.  The 1H-NMR spectrum of 89 in CDCl3 shows amide hydrogen resonances at 6.42 ppm 
(doublet), and 7.01 ppm (triplet).  This would suggest that compound 89 does not form an intra-
molecular hydrogen bond in CDCl3, perhaps due to the fact that it’s side chain is a methylene 
group shorter than that of 79. 
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Fig. 5:  The amide protons in the 1H-NMR spectrum of 79 recorded in d6 DMSO (left) and 
CDCl3. 
 
2.5.3:  1H-NMR Spectra of 81, 82 and 88 
  The achiral compounds 81, 82, and 88 all have an extended peptide backbone due to the 
presence of extra methylene groups between their amide and ester functionalities (fig. 6).  These 
compounds have amide protons which appear as triplets in their 1H-NMR spectrum, due to 
coupling to the neighboring methylene protons, with chemical shifts similar to the amide protons 
of the other N-ferrocenoyl amino acid derivatives.  Another noticeable feature of their spectra is 
that the ortho-protons of the substituted Cp ring no longer appear as two sharply defined singlets, 
as, in the absence of a chiral centre, they are magnetically equivalent.  The 1H-NMR spectrum of 
81 is shown in fig. 7.    
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Fig. 6:  The structures of compounds 81, 82, and 88. 
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Fig. 7:  The 1H-NMR spectrum of compound 81 in d6 DMSO. 
 
  The presence of these extra methylene groups naturally affords a greater degree of 
conformational freedom to the peptide backbone.  This effect becomes noticeable when the 1H-
NMR spectrum of 81, 82, and 88 are recorded in the non-hydrogen bonding solvent, CDCl3.  
The amide protons of both 81 and 82 both appear as broadened singlets, with chemical shifts of 
6.26 and 6.29 ppm respectively.  A dramatic contrast is observed in the spectrum of 88, where a 
resonance for the amide proton is observed at 7.71ppm (fig. 8). 
 
 
Fig. 8:  Amide proton signals in the 1H-NMR spectrum of 81 (left), 82 (centre), and 88, recorded 
in CDCl3.. 
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  The four methylene groups between the amide and ester moieties allow the molecule to adopt a 
stable conformation in CDCl3, where a hydrogen bonding interaction between the amide 
hydrogen and the oxygen atom of the ester group is established. 
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Fig. 9: Compound 65, N-ferrocenoyl-L-phenylglycine methyl ester. 
 
  Compound 65 (fig. 9), the N-ferrocenoyl derivative of the uncommon amino acid L-
phenylglycine, has a side chain which consists of a phenyl group.  Therefore, the hydrogen 
located on the α-carbon is effectively in the benzylic position, and is observed as a doublet at 
5.62 ppm, which is a downfield shift of over 1 ppm when compared to similar compounds with 
alkyl side chains.  The amide proton experiences a greater downfield shift in d6 DMSO than any 
of the other N-ferrocenoyl amino acid derivatives, being observed at 8.47 ppm.  A summary of 
these 1H-NMR results is given in table 4. 
 
Compound N-H Cpunsub. Hortho Hmeta Hα 
62 7.95(d) 4.21 4.85, 4.93 4.36 4.24-4.30 
63 7.97(d) 4.02 4.84, 4.92 4.36 4.32-4.36 
64 7.97(d) 4.2 4.85, 4.92 4.36 4.32-4.36 
65 8.47(d) 4.19 4.80, 4.91 4.37 5.62 (d) 
66 7.84(d) 4.19 4.91, 4.96 4.37 4.22-4.26 
67 8.03(d) 4.26 4.83, 4.89 4.38 4.37-4.42 
68 8.25(d) 4.2 4.80, 4.81 4.38 4.73-4.80 
69 8.16(d) 4.23 4.85, 4.87 4.38 4.57-4.63 
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Compound N-H Cpunsub. Hortho Hmeta Hα 
70 8.03(d) 4.22 4.84, 4.90 4.38 4.49-4.55 
71 7.46(d) 4.23 4.84, 4.92 4.38-4.44 4.38-4.44 
72 7.84(d) 4.23 4.81, 4.89 4.38 4.45-4.50 
73 8.02(d) 4.03 4.78, 4.81 4.33 4.55-4.61 
74 8.13(d) 4.65 4.78 4.35 4.63-4.67 
75 7.99(d) 3.98 4.78 4.32 4.72 
76 7.83(s) 4.21 4.58 4.34 4.11-4.16 
77 7.49(d) 3.98 4.74, 4.75 4.28 4.11-4.16 
78 8.03(d) 4.27 4.87, 4.90 4.37 4.49-4.84 
79 7.98(d) 4.23 4.86, 4.96 4.34 4.39-4.42 
 7.83(t) 4.15 4.80 4.34  
80 8.13(d) 4.07 4.84 4.39 4.77-4.84 
  4.25 4.96 4.73  
81 7.90(t) 4.17 4.77 4.33 - 
82 7.82(t) 4.13 4.77 4.31 - 
83 - 4.02 4.68 4.28 4.26  
84 - 4.02 4.68 4.28 4.37  
85 - 4.26 4.69 4.42 - 
86 8.15(d) 3.99 4.71, 4.88 4.35 4.64-4.69 
87 8.16(d) 4.23 4.84, 4.86 4.38 4.57-4.62 
88 7.96(t) 4.15 4.78 4.33 - 
89 8.13(d) 4.15 4.85, 4.92 4.33 4.37-4.41 
  4.21 4.79 4.37  
 
Table 4: 1H-NMR Chemical shifts (ppm), of N-ferrocenoyl amino acid derivatives in d6 DMSO 
 
2.6:  13C-NMR Spectra of N-Ferrocenoyl Amino Acid Derivatives 
  The 13C-NMR spectrum of the N-ferrocenoyl amino acid derivatives, recorded in d6 DMSO, 
show a large degree of consistency in terms of their ferrocenoyl resonances, with the ortho, meta, 
and unsubstituted Cp ring carbon atoms occurring within a narrowly defined region (68-71 ppm).  
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Similarly, the ipso-carbon of the substituted Cp ring appears consistently in the 75-77 ppm 
region.  The amide carbonyl carbons are observed ca. 169 ppm, while the ester carbonyl carbons 
appear ca. 172 ppm.  A signal in the 50-60 ppm region is also observed for those compounds 
which possess a chiral α-carbon atom, its chemical shift being largely a function of the side chain 
of the individual amino acid used.  Those compounds which have an α-methylene group instead 
of a tertiary chiral carbon show resonances in the 30-40 ppm region. 
  An important distinction can be drawn between these chiral compounds and achiral compounds 
76, 81, 82, 86 and 88 in terms of their pattern of ferrocenoyl resonances.  All chiral compounds 
show two signals for the ortho-carbons of the substituted Cp ring, and most also show two 
signals for the meta-carbons, while the achiral compounds show only one signal for these 
carbons.  Also, the ipso-carbon of the substituted Cp ring of the achiral compounds tends to 
appear at a slightly more downfield position in the spectrum. 
 
 2.6.1:  13C-NMR Spectrum of 62 
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Fig. 10:  The 13C-NMR spectrum of compound 62 
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  The 13C-NMR spectrum of 62 recorded in d6 DMSO, (fig. 10), is typical of those N-ferrocenoyl 
amino acid derivatives possessing a chiral α-carbon atom.  Two signals for the methyl groups of 
both the side chain and ester group appear at 11.2 and 14.5 ppm, with another two signals for the 
adjacent methylene groups appear at 24.2 and 60.7 ppm, while a signal for the α-carbon is 
present at 54 ppm.  Two narrowly separated signals are observed for the ortho-carbon atoms on 
the substituted Cp ring in the 68.5-69 ppm region.  This feature of the spectrum is presumably as 
a consequence of the chiral centre, which caused the ortho-protons to appear as two individual 
signals in the 1H-NMR spectrum.  A single signal for the unsubstituted Cp ring in the 69.5–70 
ppm region, and two signals for the meta-carbon atoms in the 70–71 ppm region (these signals 
were unambiguously assigned by the 2-D HMQC spectrum).   
  The resonance for the ipso-carbon on the substituted Cp ring is consistently observed in the 75–
76 ppm region, the amide carbon atom signal is observed at 169.7 ppm, and the ester carbon at 
173 ppm.  These quaternary carbons are, as expected, absent from the 135DEPT spectrum (fig. 
11), while the two methylene carbons appear as negative peaks.  
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Fig. 11:  The 135DEPT spectrum of compound 62 
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2.6.2:  13C-NMR Spectrum of 81   
  The 13C-NMR spectrum of 81 recorded in d6 DMSO is shown in fig. 12, and is typical of the 
achiral N-ferrocenoyl amino acid derivatives, in that only one signal is observed for each of the 
ortho- and meta-carbons of the substituted Cp ring.  The two methylene groups appear at 34.3 
and 35.5 ppm, and are observed as negative peaks in the 135DEPT spectrum (fig. 13).  The 
chemical shifts of the unsubstituted ring (69.7 ppm), amide carbonyl (169.4 ppm), and ester 
carbonyl carbons (172.3 ppm) are typical of all the N-ferrocenoyl amino acid derivatives 
discussed in this chapter, and are independent of any chirality within the molecule.  The ipso-
carbon on the substituted Cp ring is observed at 76.7 ppm, which is a downfield shift of 
approximately 1 ppm compared to compounds with a chiral α-carbon atom.  A summary of the 
13C-NMR data for compounds 62-89 is given in table 5.   
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Fig. 12:  The 13C-NMR spectrum of compound 81 
 67
  
 
 
 
 
 
 
 
 
 
 
2030405060708090 ppm
 
Fig. 13:  The 135DEPT spectrum of compound 81 
 
Compound C=Oamide C=Oester Cpunsub.Cortho Cmeta Cipso 
62 169.74 172.78 69.71 68.61, 68.81 70.43, 70.50 75.97 
63 169.76 173.00 69.71 68.62, 68.81 70.44, 70.51 75.92 
64 169.63 172.96 69.70 68.64, 69.70 70.43, 70.50 75.99 
65 169.61 171.63 69.73 68.89, 68.94 70.59, 70.66 75.51 
66 169.86 172.84 69.68 68.75, 68.93 70.49, 70.59 75.85 
67 169.85 172.34, 172.64 69.73 68.62, 68.75 70.50, 70.57 75.76 
68 169.51 171.10, 171.81 69.80 68.03, 68.60 70.65 75.14 
69 169.67 171.35 69.33 68.83, 68.73 70.59, 71.05 75.78 
70 169.87 172.60 69.74 68.64, 68.77 70.57 75.90 
71 169.96 171.23 69.78 68.67, 68.70 70.55, 70.60 75.95 
72 169.72 171.65 69.81 68.50, 68.86 70.52, 70.75 75.83 
73 169.57 172.99 69.69 68.35, 68.80 70.40, 70.44 75.81 
74 169.58 172.71 69.74 68.47, 68.60 70.49, 70.73 75.85 
75 169.57 173.17 69.61 68.43, 68.71 70.38, 70.42 75.83 
76 168.78 174.32 69.68 68.76 70.38 76.11 
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Compound C=Oamide C=Oester Cpunsub.Cortho Cmeta Cipso 
77 168.55 - 69.93 68.04, 68.82 70.11, 70.15 76.94 
78 169.81 172.58 69.73 68.64, 68.78 70.49, 70.55 75.85 
79 169.19 173.40 69.63 68.64, 68.63 70.16, 70.45 75.90 
 169.76  69.72 68.84  70.51 77.17 
80 168.83 172.70 69.70 68.50, 68.93 70.60, 71.90  75.63 
 169.69  70.73   71.54 
81 169.42 172.29 69.69 68.47 70.27 76.69 
82 169.25 173.06 69.62 68.45 70.19 77.06 
83 169.39 - 69.79 70.17 71.38 78.67 
84 169.39  - 69.79 70.17 71.38 78.65 
85 169.79 170.64 69.78 70.45 71.29 76.12 
86 169.81 172.46 69.77 68.34, 68.94 70.35, 70.83 75.68 
87 169.74 171.96 69.82 68.69  70.58, 70.61 75.73 
88 169.06 173.67 69.62 70.13 68.43 77.23 
89 169.55 173.28 69.66 68.45, 68.49 70.23, 70.51 75.79 
 170.01  69.75 68.72 70.58 76.99 
 
Table 5:  13C-NMR Chemical shifts (ppm), of N-ferrocenoyl amino acid derivatives in d6 DMSO 
 
2.7:  Infra-Red Spectra of N-Ferrocenoyl Amino Acid Derivatives 
Infrared spectra can provide valuable information regarding both the inter- and intra-molecular 
hydrogen bonding interactions of these compounds.  The C=O ester and C=O amide bands, when 
recorded as KBr discs, are consistently observed in the 1740 and 1620 cm-1 region in the solid 
state respectively.  When the spectra are recorded as thin film CH2Cl2 solutions, these values are 
generally increased by ca. 25 cm-1.   For compounds with tertiary amide groups (83, 84, 85), the 
amide band is observed at slightly lower wavenumbers.   
  The contrast between the N-H stretch vibrations recorded in the solid state and in solution can 
be quite revealing in terms of the molecular conformations adopted by these compounds. 
Wavenumbers lower than 3400 cm-1 are diagnostic of hydrogen bonded amide protons, and the 
solid-state spectra (KBr) of these compounds show N-H stretches in the 3250 – 3350 cm-1 region.  
 69
This is to be expected, as hydrogen bonds would be largely responsible for the coherence of 
these compounds in the solid state.  Infrared spectra of compounds 79 and 88, recorded in 
CH2Cl2, show N-H stretching vibrations below 3400 cm-1, indicating that these compounds form 
intra-molecular hydrogen bonds in non polar solution [16].  This observation is in agreement 
with the 1H-NMR data recorded for these compounds, where 79 and 88 showed amide proton 
resonances above 7.5 ppm when recorded in CDCl3. 
  The infrared spectrum of 88, recorded as a thin film methylene chloride solution, shows an N-H 
stretch at 3361 cm-1, which is indicative of a hydrogen-bonded amide proton, with the carbonyl 
oxygen of the ester group acting as a donor.  As mentioned in section 2.5.3, this conformation 
would appear to be inaccessible to compounds 81 and 82, due to their shorter peptide backbone 
(these compounds show υN-H stretches at 3422 and 3404 cm-1 respectively).  These results have 
further implications when these compounds are employed in anion binding studies, and are 
discussed at length in chapter VI.   
  As was mentioned in section 2.5.2, compound 79 showed an amide proton resonance at 7.62 
ppm (triplet) when recorded in CDCl3, and also shows an N-H stretch at 3361 cm-1 when 
recorded as a thin film methylene chloride solution.  Both these observations are indicative of a 
hydrogen-bonded amide proton.  A summary of the infra-red data for compounds 62-89 is given 
in table 6. 
Compound υN-H(KBr) υCOOR(KBr) υCONR(KBr) υN-H (CH2Cl2) 
62 3274 1746 1629 3418 
63 3276 1751 1626 3417 
64 3274 1748 1625 3414 
65 3394 1735 1642 3421 
66 3332 1742 1629 3409 
67 3290 1735 1638 3402 
68 3304 1735 1628 3409 
69 3238 1748 1626 3412 
70 3268 1752 1628 3414 
71 3317 1723 1609 3402 
72 3341 1738 1610 3408 
Compound υN-H(KBr) υCOOR(KBr) υCONR(KBr) υN-H (CH2Cl2) 
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73 3355 1724 1609 3410 
74 3387 1750 1639 3422 
75 3324 1747 1628 3409 
76 3333 1736 1635 3411 
77 3364 - 1607 - 
78 3267 1751 1628 3413 
79 3287 1743 1626 3401, 3361 
80 3298 1758 1645 3407 
81 3303 1735 1624 3422 
82 3289 1734 1625 3404 
83 - - 1607 - 
84 - - 1578 - 
85  1744 1603 - 
86 3350 1739 1613 3411 
87 3294 1753 1631 3407 
88 3303 1738 1621 3373 
89 3292 1745 1626 3414 
 
Table 6: Infrared bands of N-ferrocenoyl amino acid derivatives (cm-1) (KBr).  The N – H 
stretch, recorded in CH2Cl2, is also included. 
 
2.8:  UV-Vis Spectra of N-Ferrocenoyl Amino Acid Derivatives 
  The UV-Vis spectra of the compounds discussed in this chapter are largely invariant, with two 
low energy bands being observed in the 440 and 300 nm range, indicating that the nature of the 
amino acid substituent has negligible impact on the electronic properties of the ferrocenoyl 
moiety.  Similarly consistent results were obtained when the extinction coefficients of these 
compounds were calculated, with results being in the 200 A.U. range, which is typical of values 
for these types of compounds.  
  An unexpected compound was isolated during the preparation of 74, N-ferrocenoyl-L-histidine 
methyl ester, whereby a second ferrocenoyl derivative of L-histidine methyl ester, 80 (N-
ferrocenoyl-(Nim-Fc)-L-histidine methyl ester), was isolated (fig. 14).  80 is the only N-
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ferrocenoyl amino acid derivative whose UV-Vis spectrum differs substantially from the others, 
where the low energy bands are bathochromically shifted to 345 and 460 nm respectively.  This 
would suggest that there is some degree of conjugation between the imidazolic and 
cyclopentadienyl aromatic systems via the sp2 amide carbon atom. 
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Fig 14:  Compounds 74 (left) and 80 (right), L- histidine methyl ester derivatives. 
 
2.9:  Cyclic Voltammograms of N-Ferrocenoyl Amino Acid Derivatives 
  Cyclic voltammograms of all compounds were recorded in acetonitrile, using the 
ferrocene/ferricenium couple as an internal redox standard.  Each exhibited a reversible, one-
electron peak, due to the oxidation of the ferrocenoyl group to the ferricenium cation.  Half-wave 
potentials of the compounds bearing an amide proton ranged from 170 mV in the case of 77, to 
202 mV in the case of 68.  However, in compounds where the amide proton is replaced by a 
methyl group (83, 84, 85), significant cathodic shifts are observed. For the N-ferrocenoyl 
sarcosine (81) derivative, the half wave potential recorded was 156 mV, while the N-ferrocenoyl 
derivatives of ephedrine (83) and pseudoephedrine (84) displayed redox potentials of 117 and 
108 mV respectively.  It has been previously noted that sterically constrained ferrocene-amide 
derivatives have lower redox potentials than unconstrained analogues.  This cathodic shift is 
illustrated in fig. 15, where the structure of the two ferrocenoyl derivatives differs only by 
substitution of the amide proton in 77 with a methyl group in 83. 
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Fig 15:  Cyclic voltammograms of compounds 77 and 83 recorded in CH3CN.  
 
  This can be explained by the fact that the bulky amide substituents, such as a methyl group, can 
cause deviations from co-planarity between the amide group and the substituted Cp ring, and 
hence the overlap between these two π-systems is decreased.  This decreased overlap has the 
effect of lessening the electron-withdrawing capability of the amide group.  Thus, the energy of 
the ferrocene HOMO orbital is not lowered as much, making oxidation to the ferricenium cation 
easier [15].   
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O
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Fig. 16:  Compounds 77 and 83. 
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Fig. 17:  Cyclic voltammogram of 79, displaying only one oxidation/reduction peak, despite the 
presence of two ferrocenoyl groups. 
 
  A summary of both the electrochemical and UV-Vis data for compounds 62-89 is given in table 
7. 
Compound λmax (nm) ε (M-1 cm-1)[α]D20 E1/2(mV) 
62 443, 306 200 -42 186 
63 441, 303 220 -37 187 
64 440, 304 191 -39 176 
65 445, 305 202 -52 199 
66 444, 306 201 -50 189 
67 443, 306 204 -44 190 
68 443, 306 202 -39 202 
69 443, 304 214 -77 196 
70 446, 306 200 -58 182 
71 439, 306 199 -50 190 
72 440, 306 193 -40 190 
73 445, 305 204 -9 192 
74 445, 305 195 -39 190 
75 440 222 -47 187 
76 442, 305 196 - 179 
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Compound λmax (nm) ε (M-1 cm-1)[α]D20 E1/2(mV) 
77 442, 304 209 34 170 
78 445, 305 212 59 188 
79 440, 305 199 -43 177 
80 460, 345 440 -47 184 
81 439, 304 179 - 175 
82 446, 301 181 - 169 
83 445 180 34 117 
84 440 189 36 108 
85 445, 305 209 - 156 
86 443, 305  -21 170 
87 442, 304  - 169 
88 442, 302 212 - 160 
89 441, 307 161 -22 188 
 
Table 7:  Electrochemical, UV-Vis and optical rotation data of compounds 62-89.  All ε values 
refer to lowest energy band. 
 
  The cyclic voltammograms of 79, 80 and 89, surprisingly, do not differ substantially from those 
observed for compounds of the other N-ferrocenoyl amino acid derivatives, in that only one 
distinct oxidation and reduction peak is observed for each compound, despite the presence of two 
ferrocenoyl groups, as illustrated in fig. 17.   Even when a slower scan rate was employed 
(0.02V/sec), neither oxidation nor reduction waves could be resolved into two discernable peaks. 
 
2.10:  Conclusions 
   Coupling of ferrocene carboxylic acid to the hydrochloride salts of various amino acid esters 
(and β-amino alcohols in the case of 77, 83, and 84) was effected using various well established 
coupling reagents (dicyclohexylcarbodiimide, carbonyldiimidazole, O- (1H-benzotriazol-1-yl) - 
N, N, N’, N’, -tetramethyluronium tetrafluoroborate).  Compounds 65, 68, 70 and 73 were 
prepared using all three routes, and while all proved effective, it was found that CDI resulted in 
slightly lower yields than the other two reagents.  This may be partially explained by the 
suggestion that the active ester formed when employing CDI, 61, is more prone to decomposition 
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than the active ester 60, which is formed when DCC and TBTU is employed.  From an economic 
standpoint, DCC would appear the more attractive option.  The optimum reaction time was 
determined to be 24 hours for the purpose of maximizing yields when DCC was employed, 
although longer reaction times have been reported in the literature [18]. 
  Compounds 79 and 89 were formed in a 2:1 stoichiometric reaction of ferrocene carboxylic 
acid with L-lysine methyl ester and L-ornithine methyl ester respectively, the amine groups on 
their side chains proving just as reactive as their α-amino groups when using the DCC/HOBt 
coupling protocol.  No mono-N-acylated product was isolated during the work-up of either of 
these compounds.  Compound 80 was formed in a similar manner, and resulted from reaction of 
ferrocene carboxylic acid with both the α-amino group and the imidazolic ring of L-histidine 
methyl ester.  
  All N-ferrocenoyl amino acid derivatives possessing an α-chiral carbon showed the same basic 
pattern of resonances in their 1H-NMR spectra, with two sharply defined, one-proton singlets 
being observed for the ortho-protons of the substituted Cp ring, a two-proton singlet for the 
meta-protons, and a five-proton singlet for unsubstituted Cp ring.  In the absence of a chiral 
centre, these ortho-protons appear either as slightly broadened singlets (82, 88), or doublets with 
weak coupling to the meta-protons (76, 81).  The amide protons, when recorded in the hydrogen-
bonding solvent d6 DMSO, appear in the 7.5-8.5 ppm range, and in the 6.0-6.5 range when 
recorded in the non-polar solvent CDCl3.  The exceptions to this general trend are 79 and 88, 
which appear to adopt a stable, hydrogen-bonded conformation in non-polar solution.  This is in 
agreement with the υN-H stretch vibrations observed in the IR spectra when recorded in 
dichloromethane, in which only 79 and 88 show bands below 3400 cm-1. 
  All compounds show a reversible, one-electron peak in their cyclic voltammograms, due to the 
oxidation of the ferrocenoyl group to the ferricenium cation.  This proved to be the case even 
with 79, 80, and 89, all of which incorporate two ferrocenoyl groups in different chemical 
environments.  Slowing of the scan rate from 0.1V/sec to 0.02V/sec did not result in resolution 
of the voltammogram into two separate oxidation or reduction peaks.  Compounds with tertiary 
amide groups (83, 84 and 85) showed cathodic shifts relative to those compounds with secondary 
amide groups.   
  .      
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2.11:  Experimental 
Ferrocene carboxylic acid (59) 
  7.0g (0.05mol) anhydrous aluminium chloride was added to a solution of ferrocene (9.3g, 
0.05mol) and 2-chlorobenzoyl chloride (8.8g, 0.1mol) in dry dichloromethane under nitrogen at 
0ºC.  After 30mins, the reaction was raised to room temperature, and allowed to proceed for two 
hours.  The reaction was once again cooled to 0ºC, and 100mls water was added.  After stirring 
for a further 30mins, the layers were allowed to separate, and the aqueous layer extracted with 
10mls water.  The organic layers were combined, dried over magnesium sulphate, and the 
solvent removed in vacuo, yielding a viscous red oil which solidified after 10mins. 
  The 2-Chlorobenzoyl ferrocene was then added to a solution of potassium tert-butoxide (18.2g, 
0.16mol) and water (0.88mls, 0.5mol) in 1,2-dimethoxyethane.  The reaction was then refluxed 
under nitrogen for 3hrs, cooled, and added to 500mls water.  The solution was then washed with 
diethyl ether, and the organic layer back extracted with 10% sodium hydroxide.  The aqueous 
layers were combined, and acidified to pH 2 using conc. HCl, causing the title product to 
precipitate as a fine yellow/brown powder.  The product was then dried at for 6 hours at 80°C. 
Yield 9.2g, 80%, m.p. 223-225°C (lit 224-225°C) [2]. 
1H-NMR (400MHz) δ (CDCl3): 4.24 (5H, s, unsub. Cp ring), 4.44 (2H, br. s, Hmeta Cp ring), 
4.84 (2H, br. s, Hortho Cp ring), 12.04 (1H, br. s, FcCOOH). 
 
N-ferrocenoyl-OBt (60). 
  All coupling reactions between ferrocene carboxylic acid and amino acid esters, using the 
DCC/HOBt protocol yielded varying amounts of the title product during column 
chromatography on silica gel, using a mobile phase of 2:1 hexane/ethyl acetate.  It was isolated 
as an air-stable, dark red crystalline solid. 
m.p. 135-137°C. 
1H-NMR (400MHz) δ (CDCl3):  4.47 (5H, s, unsub. Cp ring), 4.70 (2H, br. s, Hmeta Cp ring), 
5.11 (2H, br. s, Hortho Cp ring), 7.45-7.59 (3H, m, ArH), 8.11-8.14 (1H, m, ArH). 
 
N-ferrocenoyl-imidazole (61) 
  Coupling reactions between ferrocene carboxylic acid and amino acid esters, using CDI as the 
coupling reagent, yielded varying amounts of the title product during column chromatography on 
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silica gel, using a mobile phase of 2:1 hexane/ethyl acetate.  It was invariably eluted before the 
N-ferrocenoyl amino acid derivatives, and isolated as a dark red solid (typically 10 – 20%).   
m.p. 118-119°C, (lit 121-122°C) [12]. 
1H-NMR (400MHz) δ (CDCl3):  4.28 (5H, s, unsub. Cp ring), 4.52 (2H, br. s, Hmeta Cp ring), 
4.90 (2H, br. s, Hortho Cp ring), 7.18 (1H, br. s, Himidazole), 7.73 (1H, br. s, Himidazole), 8.47 (1H, br. 
s, Himidazole).   
 
N-Ferrocenoyl Amino Acid Esters 
 
Route 1, General procedure:   
  0.35g (2.5mmol) of 1-hydroxybenzotriazole, 0.4mls (2.5mmol) of triethylamine, 0.6g 
(3.0mmol) of dicyclohexylcarbodiimine, and 2.5mmol of the corresponding amino acid ester 
hydrochloride salt* were added to a slurry of 0.57g (2.5mmol) of ferrocene carboxylic acid in 
dichloromethane (30mls), at 0°C.  After 30 mins, the mixture was raised to room temperature, 
and stirring was continued for 48 hrs. The precipitated N,  N - dicyclohexylurea was filtered off, 
and the solvent evaporated in vacuo, and the crude product was purified by silica gel column 
chromatography using a mobile phase of 2:1 hexane/ethyl acetate. 
*1.25 mmol was used in the case of 79, 80 and 89. 
 
Route 2, General procedure: 
  0.4mls (2.5mmol) of triethylamine, 0.49g (3.0mmol) of carbonyldiimidazole, and 2.5mmol of 
the corresponding amino acid ester hydrochloride salt were added to a slurry of 0.57g (2.5mmol) 
of ferrocene carboxylic acid in dry tetrahydrofuran (30mls) at 0°C.  After 30 mins, the mixture 
was raised to room temperature, and stirring was continued for 24 hrs.  The solvent evaporated in 
vacuo, and the crude product was purified by silica gel column chromatography using a mobile 
phase of 2:1 hexane/ethyl acetate. 
 
Route 3, General procedure: 
  0.4mls (2.5mmol) of triethylamine, and 0.83g of O- (1H-benzotriazol-1-yl) - N, N, N’, N’, -
tetramethyluronium tetrafluoroborate (2.5mmol) was added to a slurry of 0.57g (2.5mmol) of 
ferrocene carboxylic acid in dimethylformamide (30mls) at ambient temperature.  After 30 mins, 
 78
2.5mmol of the corresponding amino acid ester hydrochloride salt was added, and stirring was 
continued for 24 hrs.  The solvent evaporated in vacuo, and the crude product was purified by 
silica gel column chromatography using a mobile phase of 2:1 hexane/ethyl acetate. 
 
Route 4, General procedure: 
  0.4mls (1.2mmol) of triethylamine and 2.5mmol of the corresponding amino acid ester 
hydrochloride salt were added to a solution of 60 (0.87g, 2.5mmol), in dichloromethane (30mls).  
Stirring was continued for 24 hrs, and the solvent evaporated in vacuo.  The crude product was 
purified by silica gel column chromatography using a mobile phase of 2:1 hexane/ethyl acetate. 
 
N-ferrocenoyl-L-2-aminobutyric acid ethyl ester (62) 
 0.42g of L-2-aminobutyric acid ethyl ester hydrochloride was used in the syntheses. 
Yields:  Route 1, 0.26g, (69%).  Route 2, 0.25g, (67%), orange microcrystalline solid. m.p. 116-
118°C  
E1/2 = 0.186V (Vs. Fc/Fc+), [α]D20 =  – 42° (EtOH), UV-Vis (λmax) (EtOH): 266, 306, 443 nm (ε 
= 200 M-1 cm-1), I.R. υmax (KBr): 3274, 3090, 2976, 1746, 1629, 1543, 1299, 1187, 1025, 820 
cm-1. 
1H-NMR (400MHz) δ (d6 DMSO): 0.95 (3H, t, J = 7.2 Hz, NHCH(CH2CH3)), 1.21 (3H, t, J = 
7.2 Hz, OCH2CH3), 1.72-1.87 (2H, m, NHCH(CH2CH3), 4.10 (2H, q, J = 7.2 Hz, -OCH2CH3), 
4.21 (5H, s, unsub. Cp ring), 4.24-4.30 (1H, m, NHCH-), 4.36 (2H, s, Hmeta Cp ring), 4.85 (1H, s, 
Hortho Cp ring), 4.93 (1H, s, Hortho Cp ring), 7.95 (1H, d, J = 7.6 Hz, NHCH-).  
13C-NMR (100 MHz) δ (d6 DMSO): 11.21, 14.49, 24.22, (-ve DEPT), 54.01, 60.71 (-ve DEPT), 
68.61, 68.81, 69.71, 70.43, 70.50, 75.97, 169.74, 172.78  
 
N-ferrocenoyl-L-norvaline ethyl ester (63) 
  0.45g of L-norvaline ethyl ester hydrochloride was used in the synthesis. 
Yield 0.56g, (63%), orange micro-crystalline solid. m.p. 124-126°C.  
E1/2 =   0.187V (Vs. Fc/Fc+), [α]D20 =  -37° (EtOH), UV-Vis (λmax) (EtOH): 264, 303, 441 nm (ε 
= 220 M-1 cm-1), I.R. υmax (KBr): 3276, 1751, 1626, 1536, 1380, 1190, 1028, 819 cm-1. 
1H-NMR (400MHz) δ (d6 DMSO): 0.91 (3H, t, J = 7.2 Hz, -CH2CH2CH3), 1.21 (3H, t, J = 7.2 
Hz, -OCH2CH3), 1.39-1.48 (2H, m, -CH2CH2CH3), 1.72-1.77 (2H, m, -CH2CH2CH3), 4.02 
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(5H, s, unsub. Cp ring), 4.12 (2H, q, J = 7.2 Hz, -OCH2CH3), 4.32-4.36 (1H, m, NHCH-), 4.36 
(2H, s, Hmeta Cp ring), 4.84 (1H, s, Hortho Cp ring), 4.92 (1H, s, Hortho Cp ring), 7.97 (1H, d, J = 
7.6 Hz, NHCH-).   
.  
13C-NMR (100 MHz) δ (d6 DMSO): 13.78, 14.48, 19.27 (-ve DEPT), 32.78 (-ve DEPT), 52.06, 
60.74 (-ve DEPT), 68.62, 68.81, 69.71, 70.44, 70.51, 75.92, 169.76, 173.00.  
 
N-ferrocenoyl-L-norleucine ethyl ester (64) 
   0.49g of L-norleucine ethyl ester hydrochloride was used in the synthesis. 
Yield 0.66g, (72%), orange microcrystalline solid. m.p. 142-144°C.  
E1/2 = 0.176V (Vs. Fc/Fc+), [α]D20  = –39° (EtOH), UV-Vis (λmax) (EtOH): 260, 304, 444 nm (ε 
= 191 M-1 cm-1), I.R. υmax (KBr): 3274, 3089, 2956, 2362, 2341, 1748, 1625, 1540, 1187 cm-1
1H-NMR (400MHz) δ (d6 DMSO): 0.88 (3H, t, J = 7.2 Hz, CH2CH2CH2CH3), 1.21 (3H, t, -
OCH2CH3, J = 7.2 Hz), 1.30-1.42 (4H, m, -CH2CH2CH2CH3), 1.73-1.79 (2H, m, -
CH2CH2CH2CH3), 4.14 (2H, q, J = 7.2 Hz,-OCH2CH3), 4.20 (5H, s, unsub. Cp ring), 4.32-4.36 
(3H, m, NHCH- + 2Hmeta Cp ring), 4.85 (1H, s, Hortho Cp ring), 4.96 (1H, s, Hortho Cp ring), 7.96 
(1H, d, J = 7.6 Hz, NHCH-,).   
13C-NMR (100 MHz) δ (d6 DMSO): 14.20, 14.49 , 22.02 (-ve DEPT), 28.25 (-ve DEPT), 30.25 
(-ve DEPT), 52.28, 60.73 (-ve DEPT), 68.64, 68.79, 69.70, 70.43, 70.50, 75.99, 169.63, 172.96.  
 
N-ferrocenoyl-L-phenylglycine methyl ester (65) 
  0.51g of L-phenylglycine methyl ester hydrochloride was used in the syntheses. 
Yields:  Route 1, 0.68g, (72%).  Route 2, 0.61g, (65%).  Route 3, 0.6g, (69%), orange-red 
crystalline solid. m.p. 118-120°C. 
E1/2 = 0.199V (Vs. Fc/Fc+), [α]D20  =  – 52° (EtOH), UV-Vis (λmax) (EtOH): 265, 305, 445 nm (ε 
= 202 M-1 cm-1), I.R. υmax (KBr): 3394, 3125, 2947, 1735, 1642, 1509, 1325, 1268,1176, 105, 
817 cm-1.  
1H-NMR (400MHz) δ (d6 DMSO): 3.68 (3H, s, -OCH3), 4.19 (5H, s, unsub. Cp ring), 4.37 (2H, 
s, Hmeta Cp ring), 4.91 (1H, s, Hortho Cp ring), 5.00 (1H, s, Hortho Cp ring), 5.62 (1H, d, J = 7.0 
Hz, NHCH-), 7.35-7.48 (5H, m, ArH), 8.47 (1H, d, J = 7.0 Hz, NHCH-).   
13C-NMR (100 MHz) δ (d6 DMSO): 52.57, 56.70, 68.89, 68.94, 69.73, 70.59, 70.66, 75.51, 
128.45, 128.60, 128.87, 131.89, 169.61, 171.63.   
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 N-ferrocenoyl-L-valine methyl ester (66) 
  0.42g of L-valine methyl ester hydrochloride was used in the synthesis. 
Yield 0.5g, (61%), orange microcrystalline solid. m.p. 124-125°C.  
E1/2 = 0.189V (Vs. Fc/Fc+), [α]D20  =   –50° (EtOH), UV-Vis (λmax) (EtOH): 260, 306, 444 nm (ε 
= 201 M-1 cm-1), I.R. υmax (KBr): 3332, 2963, 1742, 1629, 1377, 1306, 1200, 993 cm-1.  
1H-NMR (400MHz) δ (d6 DMSO): 0.93 (3H, d, (CH(CH3)2), J = 6.8 Hz) ), 0.98 (3H, d, J = 6.8 
Hz,-CH(CH3)2), 2.13-2.20 (1H, m, NHCH(CH(CH3)2), 3.66 (3H, s, -OCH3), 4.19 (5H, s, unsub. 
Cp ring), 4.22-4.26 (1H, m, NHCH-), 4.37 (2H, s, Hmeta Cp ring), 4.91 (1H, s, Hortho Cp ring) 
4.96 (1H, s, Hortho Cp ring), 7.84 (1H, d, NHCH-, J = 7.6 Hz).   
13C-NMR (100 MHz) δ (d6 DMSO): 19.45, 19.60, 29.60, 51.98, 58.35, 68.75, 68.93, 69.68, 
70.49, 70.59, 75.85, 169.86, 172.84.  
 
N-ferrocenoyl-L-glutamic acid diethyl ester (67) 
  0.60 g of L-glutamic acid diethyl ester hydrochloride was used in the synthesis. 
Yield 0.69g, (67%), orange microcrystalline solid. m.p. 128-129°C.  
E1/2 = 0.190V (Vs. Fc/Fc+), [α]D20 =  -44° (EtOH), UV-Vis (λmax) (EtOH): 268, 306, 443 nm (ε = 
204 M-1 cm-1), I.R. υmax (KBr): 3290, 3097, 2930, 1735, 1638, 1561, 1381, 1213, 1191, 1106 cm-
1. 
1H-NMR (400MHz) δ (d6 DMSO): 1.14-1.30 (6H, m, OCH2CH3), 1.89-2.01 (1H, m, 
NHCH(CH2CH2-)), 2.08-2.15 (1H, m, NHCH(CH2CH2-)), 2.44 (2H, t, J = 7.4 Hz, 
NHCH(CH2CH2-)), 4.03-4.06 (4H, m, -OCH2CH3), 4.26 (5H, s, unsub. Cp ring), 4.37-4.42 (3H, 
m, 2Hmeta CP ring + NHCH-), 4.83 (1H, s, Hortho Cp ring), 4.80 (1H, s, Hortho Cp ring), 8.03 (1H, 
d, J = 7.6 Hz, NHCH-).   
13C-NMR (100 MHz) δ (d6 DMSO): 14.42, 26.02 (-ve DEPT), 33.70 (-ve DEPT), 51.63, 60.13 (-
ve DEPT), 60.92 (-ve DEPT), 68.62, 68.75, 69.73, 70.50, 70.57, 75.76, 169.85, 172.34, 172.64.   
 
N-ferrocenoyl-L-aspartic acid dimethyl ester (68) 
  0.49g of L-aspartic acid dimethyl ester hydrochloride was used in the syntheses. 
Yields:  Route 1, 0.76g, (82%).  Route 2, 0.73g, (79%).  Route 3, 0.71g, (77%), orange 
microcrystalline solid. m.p. 123-125°C.  
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E1/2 = 0.202V (Vs. Fc/Fc+), [α]D20 = -43° (EtOH), UV-Vis (λmax) (EtOH): 265, 306, 443 nm (ε = 
204 M-1 cm-1), I.R. υmax (KBr): 3304, 1735, 1628, 1537, 1309, 1230, 818 cm-1. 
1H-NMR (400MHz) δ (d6 DMSO): 2.81 (1H, dd, Ja = 8.8 Hz, Jb = 8.0 Hz,   NHCH(CH2-), 2.94-
2.99 (1H, m, NHCH(CH2-), 3.63 (3H, s, -OCH3), 3.66 (3H, s, -OCH3), 4.20 (5H, s, unsub. Cp 
ring), 4.38 (2H, s, Cmeta Cp ring), 4.73-4.80 (1H, m, NHCH-), 4.80(1H, s, Hortho Cp ring), 4.81 
(1H, s, Hortho Cp ring), 8.25 (1H, d, J = 8.0 Hz, NHCH-).   
13C-NMR (100 MHz) δ (d6 DMSO): 33.69 (-ve DEPT), 49.11, 52.04, 52.27, 68.03, 68.60, 69.80, 
70.65, 75.14, 169.51, 171.10, 171.81. 
 
N-ferrocenoyl -(S-benzyl)-L-cysteine ethyl ester (69) 
  0.50g of  (S-benzyl)-L-cysteine ethyl ester hydrochloride was used in the synthesis. 
Yield 0.73g, (65%), orange microcrystalline solid. m.p. 126-128°C.  
E1/2 = 0.196V (Vs. Fc/Fc+), [α]D20 = –77° (EtOH), UV-Vis (λmax) (EtOH): 269, 304, 443 nm (ε = 
214 M-1 cm-1), I.R. υmax (KBr): 3238, 1748, 1626, 1536, 1219, 1183, 1105, 817, 703 cm-1.   
1H-NMR (400MHz) δ (d6 DMSO): 1.21 (3H, t, J = 7.2 Hz, (-OCH2CH3), 2.51-2.90 (2H, m, 
NHCH(CH2SCH2Ph), 3.80 (2H, s, -SCH2Ph), 4.12 (2H, q, J = 7.2 Hz, -OCH2CH3), 4.23 (5H, s, 
unsub. Cp ring), 4.38 (2H, s, Hmeta Cp ring), 4.57-4.63 (1H, m, NHCH-), 4.85 (2H, s, Hortho Cp 
ring), 7.25-7.34 (5H, m, ArH), 8.16 (1H, d, J = 8.0 Hz, NHCH-).   
13C-NMR (100 MHz) δ (d6 DMSO): 14.32, 32.00 (-ve DEPT), 35.36 (-ve DEPT), 51.92, 61.16 (-
ve DEPT), 68.83, 68.73, 69.33, 70.59, 71.05, 75.78, 127.26, 128.75, 129.30, 138.49, 169.67, 
171.35.   
 
N-ferrocenoyl-L-methionine ethyl ester (70) 
  0.53g of L-methionine ethyl ester hydrochloride was used in the syntheses. 
Yields:  Route 1, 0.68g, (70%).  Route 2, 0.58g, (60%). Route 3, 0.70g, (72%), orange 
microcrystalline solid. m.p. 122-124°C.  
E1/2 = 0.179V (Vs. Fc/Fc+), [α]D20  = -58° (EtOH), UV-Vis (λmax) (EtOH): 266, 306, 446 nm (ε = 
200 M-1 cm-1), I.R. υmax (KBr): 3268, 2917, 1752, 1628, 1541, 1221, 1182, 1024, 821 cm-1. 
1H-NMR (400MHz) δ (d6 DMSO): 1.22 (3H, t, J = 7.2 Hz, -OCH2CH3), 2.01-2.07 (5H, m, -
CH2SCH3), 2.51-2.63 (2H, m, -CH2CH2SCH3), 4.13 (2H, q, J = 7.2 Hz, -OCH2CH3), 4.22 (5H, 
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s, unsub. Cp ring), 4.38 (2H, s, Cmeta Cp ring), 4.49-4.55 (1H, m, NHCH-), 4.84 (1H, s, Hortho Cp 
ring), 4.90 (1H, s, Hortho Cp ring), 8.03 (1H, d, J = 7.6 Hz, NHCH-).   
13C-NMR (100 MHz) δ (d6 DMSO): 14.47, 14.93, 30.29 (-ve DEPT), 51.32, 60.95 (-ve DEPT), 
68.64, 68.77, 69.74, 70.57, 75.90, 169.87, 172.60.   
 
N-ferrocenoyl -L-threonine ethyl ester (71) 
  0.46g of L-threonine ethyl ester hydrochloride was used in the synthesis.              
Yield 0.64g, (71%), orange-red crystalline solid. m.p. 113-115°C.  
E1/2 = 0.190V (Vs. Fc/Fc+), [α]D20 = – 50° (EtOH), UV-Vis (λmax) (EtOH): 264, 306, 439 nm (ε 
= 199 M-1 cm-1), I.R. υmax (KBr): 3103, 3317, 2976, 2933, 1723, 1609, 1546, 1380, 1104, 1027, 
824 cm-1.   
1H-NMR (400MHz) δ (d6 DMSO): 1.14 (3H, d, J = 6.2 Hz, -CH(OH)CH3), 1.22 (3H, t, J = 7.2 
Hz, -OCH2CH3), 4.11-4.22 (3H, m, -OCH2CH3, + NHCH(CH(OH)CH3)), 4.23 (5H, s, unsub. 
Cp ring), 4.38-4.44 (3H, m, Hmeta Cp ring + NHCH(CH(OH)-), 4.84 (1H, s, Hortho on Cp ring), 
4.92 (1H, s, Hortho Cp ring), 4.99 (1H, d, J = 7.6 Hz, -CH(OH)CH3), 7.46 (1H, d, J = 8.8 Hz, 
NHCH-).   
13C-NMR (100 MHz) δ (d6 DMSO): 14.48, 20.71, 58.56, 60.28 (-ve DEPT), 66.74, 68.67, 68.70, 
9.78, 70.55, 70.60, 75.95, 169.96, 171.23.   
esis. 
93 M-1 cm-1), I.R. υmax (KBr): 3426, 3341, 2932, 2362, 2343, 1738, 1610, 1542, 1177, 1074 
6
 
N-ferrocenoyl-L-serine methyl ester (72) 
  0.39g of L-serine methyl ester hydrochloride was used in the synth
Yield 0.61g, (74%), orange-red crystalline solid. m.p. 128-130°C.  
E1/2 = 0.190V (Vs. Fc/Fc+), [α]D20 = – 43° (EtOH), UV-Vis (λmax) (EtOH): 268, 305, 440 nm (ε 
= 1
cm-1. 
1H-NMR (400MHz) δ (d6 DMSO): 3.67 (3H, s, -OCH3), 3.73-3.78 (2H, m, -CH(CH2OH)), 4.23 
(5H, s, unsub. Cp ring), 4.38 (2H, s, Hmeta Cp ring), 4.45-4.50 (1H, m, NHCH(CH2OH)), 4.81 
(1H, s, Hortho Cp ring), 4.89 (1H, s, Hortho Cp ring), 5.08 (1H, t, J = 6.0 Hz, -CH2OH), 7.84 (1H, 
d, J = 7.2 Hz, NHCH-).   
13C-NMR (100 MHz) δ (d6 DMSO): 52.19, 55.34, 61.43 (–ve DEPT), 68.50, 68.86, 69.81, 70.52, 
0.75, 75.83, 169.72, 171.65.   7
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 N-ferrocenoyl-L-tyrosine methyl ester (73) 
  0.64g of L-tyrosine methyl ester hydrochloride was used in the syntheses. 
Yields:  Route 1, 0.67g, (69%).  Route 2, 0.53g, (55%).  Route 3, 0.73g, (75%), orange-red 
ε = 
crystalline solid. m.p. 140-143°C.  
E1/2 = 0.192V (Vs. Fc/Fc+), [α]D20 = -9° (EtOH), UV-Vis (λmax) (EtOH): 265, 305, 445 nm (
204 M-1 cm-1), I.R. υmax (KBr): 3355, 1724, 1609, 1551, 1520, 1436, 1315, 1225, 1109 cm-1. 
1H-NMR (400MHz) δ (d6 DMSO): 2.89-2.96 (1H, m, NHCH(CH2PhOH), 3.02-3.06 (1H, m, 
NHCH(CH2PhOH), 3.65 (3H, s, -OCH3), 4.03 (5H, s, unsub. Cp ring), 4.33 (2H, s, Hmeta Cp 
ring), 4.55-4.61 (1H, m, NHCH-), 4.78 (1H, s, Hortho Cp ring), 4.81 (1H, s, Hortho Cp ring), 6.68 
(2H, d, J = 8.8 Hz, ArH), 7.12  (2H, d, J = 8.8 Hz, ArH), 8.02 (1H, d, J = 8.0 Hz, NHCH-), 9.22 
4.20, 68.35, 68.80, 69.69, 70.40, 
0.44, 75.81, 115.37, 128.19, 130.32, 156.27, 169.57, 172.99.   
ynthesis. 
 (ε 
(1H, s, phenolic OH).   
13C-NMR (100 MHz) δ (d6 DMSO): 35.73 (-ve DEPT), 52.24, 5
7
 
N-ferrocenoyl-L-histidine methyl ester (74) 
  0.61g of L-histidine methyl ester dihydrochloride was used in the s
Yield 0.47g, (49%), orange-red crystalline solid. m.p. 162-164°C.  
E1/2 = 0.190mV (Vs. Fc/Fc+), [α]D20 = -58° (EtOH), UV-Vis (λmax) (EtOH): 260, 305, 445 nm
= 195 M-1 cm-1), I.R. υmax (KBr): 3387, 2954, 1750, 1639, 1561, 1511, 1381, 819, 763 cm-1.   
1H-NMR (400MHz) δ (d6 DMSO): 3.03 (2H, s, NHCH(CH2-)), 3.64 (3H, s, -OCH3), 4.11 (5H, 
s, unsub. Cp ring), 4.35 (2H, s, Hmeta Cp ring), 4.63-4.67 (1H, m, NHCH-), 4.78 (2H, s, Hortho Cp 
ring), 6.92 (1H, s, Himidazole ), 7.62 (1H, s, Himidazole), 8.15 (1H, d, J = 7.6 Hz, NHCH-), 11.20 
(1H, s, NHimidazole).   
13C-NMR (100 MHz) δ (d6 DMSO): 29.52 (-ve DEPT), 51.84, 52.21, 68.47, 68.60, 69.74, 70.49, 
0.73, 75.85, 115.55, 127.40, 130.07, 135.45, 169.58, 172.71.   
synthesis.   
Yield 0.72g, (67%), orange-red crystalline solid. m.p. 111-113°C.  
7
 
N-ferrocenoyl-L-tryptophan methyl ester (75) 
  0.64g of L-tryptophan methyl ester hydrochloride was used in the 
 84
E1/2 = 0.187V (Vs. Fc/Fc+), [α]D20 = -47° (EtOH), UV-Vis (λmax) (EtOH): 270, 444 nm (ε = 222 
M-1 cm-1), I.R. υmax (KBr): 3324, 3260, 2932, 1747, 1628, 1542, 1440, 1274, 1218, 1176, 1107, 
1044 cm-1. 
1H-NMR (400MHz) δ (d6 DMSO): 3.20-3.28 (2H, m, NHCH(CH2-), 3.67 (3H, s, -OCH3), 3.98 
(5H, s, unsub. Cp ring), 4.32 (2H, s, Hmeta Cp ring), 4.72 (1H, m, NHCH-), 4.79 (2H, s, Hortho Cp 
ring), 7.01-7.07 (2H, m, Hindole), 7.26 (1H, s, Hindole), 7.33 (1H, d, J = 7.6 Hz, Hindole), 7.60 (1H, 
d, J = 7.6 Hz, Hindole), 7.99 (1H, d, J = 8.0 Hz, NHCH-), 10.09  (1H, s, N-Hindole).   
13C-NMR (100 MHz) δ (d6 DMSO): 26.93 (-ve DEPT), 52.66, 53.28, 68.43, 68.71, 69.61, 70.38, 
70.42, 75.83, 110.40, 111.84, 118.38, 118.79, 121.32, 124.09, 127.37, 136.50, 169.57, 173.17.   
 
N-ferrocenoyl-α-isoaminobutyric acid ethyl ester (76) 
  0.42g of α-isoaminobutyric acid ethyl ester hydrochloride was used in the synthesis.   
Yield 0.57g, (64%), orange solid. m.p. 139-140°C.  
E1/2 = 0.179V (Vs. Fc/Fc+), UV-Vis (λmax) (EtOH): 267, 305, 440 nm (ε = 196 M-1 cm-1), I.R. 
υmax (KBr): 3333, 2989, 2937, 1737, 1636, 1523, 1301, 1149 cm-1. 
1H-NMR (400MHz) δ (d6 DMSO): 1.17 (3H, t, J = 6.8 Hz, -OCH2CH3), 1.43 (6H, s, 
NHC(CH3)2-), 4.06 (2H, q, J = 6.8 Hz, -OCH2CH3), 4.21 (5H, s, unsub. Cp ring), 4.34 (2H, d, J 
= 1.6 Hz, Hmeta Cp ring), 4.85 (2H, d, J = 1.6 Hz, Hortho Cp ring), 7.83 (1H, s, NHC(CH3)2-).   
13C-NMR (100 MHz) δ (d6 DMSO): 14.42, 25.47, 25.70, 55.47, 60.48 (-ve DEPT), 68.76, 69.68, 
70.38, 76.11, 168.78, 174.32.   
 
N-ferrocenoyl-(1S, 2R)-(+)-norephedrine (77) 
  0.47g of (1S, 2R)-(+)-norephedrine hydrochloride was used in the synthesis. 
Yield 0.64g, (71%), orange-red crystalline solid. m.p. 153-155°C.  
E1/2 = 0.170V (Vs. Fc/Fc+), [α]D20 = +34° (EtOH), UV-Vis (λmax) (EtOH): 268, 304, 442 nm (ε = 
209 M-1 cm-1), I.R. υmax (KBr): 3364, 3288, 3042, 2980, 1607, 1552, 1444, 1327, 1199, 1002, 
821, 701 cm-1.   
1H-NMR (400MHz) δ (d6 DMSO): 1.11 (3H, d, J = 6.4 Hz, NHCH(CH3)-, 3.98 (5H, s, unsub. 
Cp ring), 4.11-4.16 (1H, m, NHCH(CH3)-, 4.28 (2H, s, Hmeta Cp ring), 4.61-4.64 (1H, m, 
NHCH(CH3),CHOH), 4.72 (1H, s, Hortho Cp ring), 4.75 (1H, s, Hortho Cp ring), 5.51 (1H, d, J = 
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4.0 Hz, -CHOHPh), 7.20 (1H, d, J = 7.2 Hz, ArH), 7.33 (2H, m, ArH), 7.42 (2H, d, J = 7.6 Hz, 
ArH), 7.49 (1H, d, J = 8.8 Hz, NHCH-).   
13C-NMR (100 MHz) δ (d6 DMSO): 16.35, 50.67 (NHCH(CH3), 68.04, 68.82, 69.93, 70.11, 
70.15, 75.22, 76.94, 126.88, 127.16, 128.15, 144.29,  168.55.    
 
N-ferrocenoyl -D-methionine-ethyl ester (78) 
  0.53g of D-methionine ethyl ester hydrochloride was used in the synthesis. 
Yield 0.64g, (66%), orange microcrystalline solid. m.p. 123-125°C.  
E1/2 = 0.188V (Vs. Fc/Fc+), [α]D20 = +74° (EtOH), UV-Vis (λmax) (EtOH): 260, 305, 445 nm (ε = 
212 M-1 cm-1) nm, I.R. υmax (KBr): 3267, 2917, 2362, 1751, 1628, 1538, 1219, 1182, 1024, 821 
cm-1. 
1H-NMR (400MHz) δ (d6 DMSO): 1.22 (3H, t, J = 6.8 Hz, -OCH2CH3), 2.03 (2H, t, J = 6.8 Hz, 
-CH2SCH3), 2.07 (3H, s, -CH2SCH3), 2.50-2.64 (2H, m, -CH2CH2SCH3), 4.13 (2H, q, J = 6.8 
Hz, -OCH2CH3), 4.27 (5H, s, unsub. Cp ring), 4.37 (2H, s, Hmeta Cp ring), 4.49-4.84 (1H, m, 
NHCH-), 4.87 (1H, s, Hortho Cp ring), 4.90 (1H, s, Hortho Cp ring), 8.03 (1H, d, J = 8.0 Hz, 
NHCH-).  
 13C-NMR (100 MHz) δ (d6 DMSO): 14.47, 14.93, 30.31 (-ve DEPT), 30.34 (-ve DEPT), 51.33, 
0.93 (-ve DEPT), 68.64, 68.78, 69.73, 70.49, 70.55, 75.85, 169.81, 172.58.   
hesis. 
-1), I.R. υmax (KBr): 3287, 3081, 2867, 2365, 1743, 1626, 1560, 1542, 1376, 1297, 
6
 
N-ferrocenoyl-( Nε-Fc)-L-lysine methyl ester (79) 
  0.29g of L-lysine methyl ester dihydrochloride was used in the synt
Yield 0.36g, (49%) orange microcrystalline solid. m.p. 228-230°C.  
E1/2 = 0.177V (Vs. Fc/Fc+), [α]D20 = – 43° (EtOH), UV-Vis (λmax) (EtOH): 265, 305, 440 nm (ε 
= 199 M-1 cm
1107 cm-1.   
1H-NMR (400MHz) δ (d6 DMSO): 1.30-1.55 (4H, m, CH2CH2CH2CH2NH-Fc), 1.84-1.86 (2H, 
m, NHCH(CH2CH2CH2-), 3.19-3.22 (2H, m, CH2CH2NH-Fc,), 3.67 (3H, s, -OCH3), 4.15 (5H, 
s, unsub. Cp ring), 4.23 (5H, s, unsub. Cp ring), 4.34 (2H, s, Hmeta Cp ring), 4.39-4.42 (3H, m, 
2Hmeta Cp ring + NHCH(CH2CH2CH2-)), 4.80 (2H, s, Hortho Cp ring), 4.86 (1H, s, Hortho Cp 
ring), 4.96 (1H, s, Hortho Cp ring), 7.82 (1H, t, J = 5.4 Hz, CH2CH2NH-Fc), 7.98 (1H, d, J = 7.6 
Hz, NHCH-).   
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13C-NMR (100 MHz) δ (d6 DMSO): 23.42 (-ve DEPT), 29.38 (-ve DEPT), 30.37 (-ve DEPT), 
38.59 (-ve DEPT), 52.16, 52.40, 68.64, 68.63, 68.84, 69.63, 69.72, 70.16, 70.45, 70.51, 75.90, 
77.17, 169.19, 169.76, 173.40.   
 
N-ferrocenoyl -(Nim-Fc)-L-histidine methyl ester (80) 
  0.31g of L-histidine methyl ester dihydrochloride was used in the synthesis. 
Yield 0.32g, (43%), orange-red crystalline solid. m.p. 181-183°C.  
E1/2 = 0.184mV (Vs. Fc/Fc+), [α]D20 = -50° (EtOH), UV-Vis (λmax) (EtOH): 270, 345, 460 nm (ε 
= 440 M-1 cm-1), I.R. υmax (KBr): 3298, 3168, 2952, 2368, 1758, 1688, 1645, 1526, 1440, 1382, 
1250, 824, 756 cm-1.   
1H-NMR (400MHz) δ (d6 DMSO): 3.10 (2H, d, J = 7.2 Hz, NHCH(CH2-)), 3.36 (3H, s, -OCH3), 
4.07 (5H, s, unsub. Cp ring), 4.36 (2H, s, Hmeta Cp ring), 4.25 (5H, s, unsub. Cp ring), 4.73 (2H, 
s, Hmeta Cp ring), 4.77-4.84 (3H, m, 2Hortho Cp ring + NHCH-), 4.96 (2H, s, Hortho Cp ring), 7.71 
(1H, s, Himidazole), 8.13 (1H, d, J = 8.0 Hz, NHCH-), 8.44 (1H, s, Himidazole).   
13C-NMR (100 MHz) δ (d6 DMSO): 29.52 (-ve DEPT), 51.84, 52.41, 68.50, 68.93, 69.70, 70.60, 
70.73, 71.54, 71.73, 71.90, 73.43, 75.63, 115.55, 135.35, 137.35, 168.83, 169.69, 172.70.   
 
N-ferrocenoyl -β-alanine methyl ester (81) 
  0.35g of β-alanine methyl ester hydrochloride was used in the synthesis. 
Yield 0.55g, (70%), orange solid. m.p. 128-130°C.  
E1/2 = 0.175V (Vs. Fc/Fc+), UV-Vis (λmax) (EtOH): 304, 439 nm (ε = 179 M-1 cm-1), I.R. υmax 
(KBr): 3303, 2926, 1735, 1624, 1504, 1326, 1206, 1171 cm-1. 
1H-NMR (400MHz) δ (d6 DMSO): 2.60 (2H, t, J = 6.6 Hz, NHCH2CH2-), 3.41-3.44 (2H, m, 
NHCH2CH2-), 3.62 (3H, s, -OCH3), 4.17 (5H, s, unsub. Cp ring), 4.33 (2H, d, J = 2.0 Hz, Hmeta 
Cp ring), 4.77 (2H, d, J = 2.0 Hz, Cortho Cp ring), 7.90 (1H, t, J = 5.6 Hz, NHCH2CH2-).  
 13C-NMR (100 MHz) δ (d6 DMSO): 34.28 (-ve DEPT), 35.51 (-ve DEPT), 51.72, 68.47, 69.69, 
70.27, 76.69, 169.42, 172.29.  
  
N-ferrocenoyl-γ-aminobutyric acid-ethyl ester (82) 
  0.42g of γ-aminobutyric acid ethyl ester hydrochloride was used in the synthesis. 
Yield 0.60g, (70%), orange solid. m.p. 110-111°C.  
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E1/2 = 0.169V (Vs. Fc/Fc+), UV-Vis (λmax) (EtOH): 268, 301, 446 nm (ε = 181 M-1 cm-1), I.R. 
υmax (KBr): 3289, 2932, 2376, 1734, 1625, 1511, 1379, 1306, 1185, 816 cm-1. 
1H-NMR (400MHz) δ (d6 DMSO): 1.16 (3H, t, J = 6.8 Hz, OCH2CH3), 1.74 (2H, m, 
NHCH2CH2-), 2.34 (2H, br s, NHCH2CH2CH2-), 3.18 (2H, s, NHCH2CH2-), 3.59 (s, 3H, -
OCH3), 4.04 (2H, q, J = 6.8 Hz, -OCH2CH3), 4.13 (5H, s, unsub. Cp ring), 4.31 (2H, s, Hmeta Cp 
ring), 4.77 (2H, s, Hortho Cp ring), 7.82 (1H, t, J = 5.6 Hz,, NHCH2CH2-).   
13C-NMR (100 MHz) δ (d6 DMSO): 14.48, 25.17 (-ve DEPT), 31.31 (-ve DEPT), 38.28 (-ve 
DEPT), 60.12 (-ve DEPT), 68.45, 69.62, 70.19, 77.06, 169.25, 173.06.   
 
N-ferrocenoyl-(1S, 2R)-(+)-ephedrine (83) 
  0.50g of (1S, 2R)-(+)-ephedrine hydrochloride was used in the synthesis. 
Yield 0.67g, (71%), dark red crystalline solid. m.p. 138-139°C.  
E1/2 = 0.117mV (Vs. Fc/Fc+), [α]D20 = +34° (EtOH), UV-Vis (λmax) (EtOH): 265, 307, 445 nm (ε 
= 180 M-1 cm-1), I.R. υmax (KBr): 3369, 3088, 2982,1607,1495,1457, 1103, 1053, 821 cm-1. 
1H-NMR (400MHz) δ (d6 DMSO): 1.20 (3H, s, N(CH3)CH(CH3)-), 2.78 (1H, s, N(CH3)CH-
),3.03 (2H, s, N(CH3)CH-), 4.02 (5H, s, unsub. Cp ring), 4.26 (1H, s, N(CH3)CH(CH3)-), 4.28 
(2H, s, Hmeta Cp ring), 4.55 (1H, s, -CH(OH)Ph), 4.68 (2H, s, Hortho Cp ring), 5.50 (1H, d, J = 4.0 
Hz, -CH(OH)Ph), 7.09-7.41 (5H, m, ArH).  
 13C-NMR (100 MHz) δ (d6 DMSO): 13.27, 32.68, 55.27, 69.79, 70.17, 71.38, 75.02, 75.67, 
126.83, 127.41, 128.15, 144.26, 169.39.   
 
N-ferrocenoyl-(1S, 2S)-(+)-pseudoephedrine (84) 
  0.50g of (1S, 2S)-(+)-pseudoephedrine hydrochloride was in the synthesis. 
Yield 0.68g, (72%), orange solid. m.p. 131-132°C. 
E1/2 = 0.108mV (Vs. Fc/Fc+), [α]D20 = +36° (EtOH), UV-Vis (λmax) (EtOH): 260, 307, 444 nm (ε 
= 189 M-1 cm-1), I.R. υmax (KBr): 3445, 3090, 2375,1576, 1452,1406, 1036, 818 cm-1.    
1H-NMR (400MHz) δ (d6 DMSO): 1.20 (3H, s, N(CH3)CH(CH3)-), 2.78 (1H, s, N(CH3)CH-), 
3.03 (2H, s, N(CH3)CH-), 4.02 (5H, s, unsub. Cp ring), 4.28 (2H, s, Hmeta Cp ring), 4.37 (1H, s, 
N(CH3)CH(CH3)-), 4.55 (1H, s, -CH(OH)Ph), 4.68 (2H, s, Hortho on Cp ring), 5.50 (1H, d, J = 
4.8 Hz, -CH(OH)Ph), 7.09-7.41 (5H, m, ArH).   
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13C-NMR (100 MHz) δ (d6 DMSO): 13.27, 32.68, 55.27, 69.79, 70.17, 71.38, 75.02, 78.67, 
126.83, 127.41, 128.15, 144.26, 169.39.   
 
N-ferrocenoyl–sarcosine ethyl ester (85) 
  0.38g of sarcosine ethyl ester hydrochloride was used in the synthesis. 
Yield 0.48g, (59%) orange-red solid. m.p. 63-65°C.  
E1/2 = 0.156V (Vs. Fc/Fc+), UV-Vis (λmax) (EtOH): 268, 305, 445 nm (ε = 209 M-1 cm-1), I.R. 
υmax (KBr): 3080, 2920, 1744, 1603, 1499, 1298, 1203, 1098, 763 cm-1.    
1H-NMR (400MHz) δ (d6 DMSO): 1.22 (3H, t, J = 7.0 Hz, -OCH2CH3), 3.33 (3H, s, 
N(CH3)CH2-), 4.10-4.52 (4H, m, N(CH3)CH2- + -OCH2CH3), 4.25 (5H, s, unsub. Cp ring), 
4.42 (2H, s, Hmeta Cp ring), 4.69 (2H, s, Cmeta Cp ring).   
13C-NMR (100 MHz) δ (d6 DMSO): 14.43, 38.17, 50.83 (-ve DEPT), 60.28 (-ve DEPT), 69.78, 
70.45, 71.29, 76.12, 169.79, 170.64.   
 
N-ferrocenoyl-L-thyroxine methyl ester (86) 
  0.82g of L-thyroxine methyl ester hydrochloride was used in the synthesis. 
Yield 0.69g (69%), orange solid, m.p. 140-143°C.  
E1/2 = 0.190V (Vs. Fc/Fc+), [α]D20 = -11° (EtOH), UV-Vis (λmax) (EtOH): 270, 305, 441 nm (ε = 
200 M-1 cm-1), I.R. υmax (KBr): 3350, 1739, 1613, 1526, 1520, 1433, 1400, 1222, 1083, 909, 823 
cm-1. 
1H-NMR (400MHz) δ (d6 DMSO):  2.99-3.05 (1H, m, -NHCH(CH2-)),3.16-3.20 (1H, m, - 
NHCH(CH2-)), 3.66 (3H, s, OCH3), 3.99 (5H, s, unsub. Cp ring), 4.35 (2H, s, Hmeta Cp ring), 
4.64-4.69 (1H, m, -NHCH-), 4.77 (1H, s, Hortho Cp ring), 4.81 (1H, s, Hortho Cp ring), 7.04 (1H, 
s, ArH), 7.19 (1H, s, ArH), 7.93 (1H, s, ArH), 7.97 (1H, s, ArH), 8.15 (1H, d, J = 8.0 Hz, -
NHCH-), 9.23 (1H, s, ArOH). 
13C-NMR (100 MHz) δ (d6 DMSO):  34.52 (-ve DEPT), 52.34, 68.34, 68.94, 69.77, 70.35, 70.83, 
75.68, 125.38, 125.68, 141.01, 141.09, 150.43, 151.36, 169.81, 172.46. 
 
N-ferrocenoyl-(S-methyl)-L-cysteine methyl ester (87) 
0.46g of (S-methyl)-L-cysteine methyl ester hydrochloride was used in the syntheses. 
Yields:  Route 1, 0.67g (74%).  Route 4, 0.81g (90%)*, orange solid, m.p. 136-139°C 
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E1/2 = 0.183mV (Vs. Fc/Fc+), [α]D20  = -48° (EtOH), UV-Vis (λmax) (EtOH): 260, 304, 444 nm (ε 
= 195 M-1 cm-1), I.R. υmax (KBr): 3294, 2925, 2363, 1753, 1631, 1530, 1222, 818 cm-1.    
1H-NMR (400MHz) δ (d6 DMSO):  2.11 (3H, s, -SCH3), 2.89 (1H, dd, Ja = 10.0 Hz, Jb  = 13.6 
Hz, -CH2SCH3), 2.97 (1H, dd, Ja  = 4.8 Hz, Jb  = 13.6 Hz, -CH2SCH3), 3.68 (3H, s, OCH3), 4.23 
(5H, s, unsub. Cp ring), 4.38 (2H, s, Hmeta Cp ring), 4.57-4.62 (1H, m, -NHCH-), 4.84 (1H, s, 
Hortho Cp ring), 4.86 (1H, s, Hortho Cp ring), 8.16 (1H, d, J = 8.0 Hz, -NHCH-). 
13C-NMR (100 MHz) δ (d6 DMSO):  15.33, 33.69 (-ve DEPT), 51.76, 52.45, 68.69, 69.82, 70.58, 
70.61, 75.73, 169.74, 171.96. 
*Based on the input of 56. 
 
N-ferrocenoyl-valeric acid methyl ester (88) 
  0.42g of valeric acid methyl ester hydrochloride was used in the syntheses. 
Yields:  Route 1, 0.58g (68%).  Route 3, 0.51g, (60%).  Route 4, 0.78g, (91%)*, orange solid, 
m.p 121-124°C. 
E1/2 = 0.149V (Vs. Fc/Fc+), UV-Vis (λmax) (EtOH): 262, 304, 440 nm (ε = 191 M-1 cm-1), I.R. 
υmax (KBr): 3303, 2950, 1738, 1621, 1537, 1292, 1170, 817 cm-1. 
1H-NMR (400MHz) δ (d6 DMSO):  1.49-1.61 (4H, m, -NHCH2CH2CH2CH2CO-), 2.36 (2H, t, J 
= 7.2 Hz, -CH2CH2CO-), 3.15-3.20 (2H, m, -NHCH2CH2-), 3.62 (3H, s, -OCH3), 4.15 (5H, s, 
unsub. Cp ring), 4.33 (2H, s, Hmeta Cp ring), 4.78 (2H, s, Hortho Cp ring), 7.96 (1H, t, J = 5.6 Hz, 
-NHCH-). 
13C-NMR (100 MHz) δ (d6 DMSO):  22.30 (-ve DEPT), 29.23 (-ve DEPT), 33.61 (-ve DEPT), 
38.50 (-ve DEPT), 51.55, 68.43, 69.62, 70.13, 77.23, 169.06, 173.67. 
*Based on the input of 56. 
 
N-ferrocenoyl-(Nδ-Fc)-L-ornithine methyl ester (89) 
  0.27g of L-ornithine methyl ester dihydrochloride was used in the synthesis. 
Yield 0.39g (60%), orange crystalline solid, m.p. 201-204°C. 
E1/2 = 0.188V (Vs. Fc/Fc+), [α]D20  = – 22° (EtOH), UV-Vis (λmax) (EtOH): 265, 307, 441 nm (ε 
= 161 M-1 cm-1),  I.R. υmax (KBr): 3292, 2877, 2365, 1745, 1626, 1555, 1370, 1256, 1100 cm-1. 
 1H-NMR (400MHz) δ (d6 DMSO):  1.63-1.74 (2H, m, -CH2CH2CH2NHCO-), 1.69-1.84 (2H, 
m, -CH2CH2CH2NHCO-), 3.20-3.25 (2H, m, -CH2CH2CH2NHCO-), 3.64 (3H, s, OCH3), 4.15 
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(5H, s, unsub. Cp ring), 4.21 (5H, s, unsub. Cp ring), 4.33 (2H, br. s, Hmeta Cp ring), 4.37 (2H, 
br. s, Hmeta Cp ring), 4.37-4.41 (1H, m, -NHCH-), 4.79 (2H, s, Hortho Cp ring), 4.85 (1H, s, Hortho 
Cp ring), 4.92 (1H, s, Hortho Cp ring), 7.91 (1H , t, J = 5.6 Hz, -NHCH2-), 8.13 (1H, d, J = 7.6 
Hz, -NHCH-). 
 13C-NMR (100 MHz) δ (d6 DMSO):  26.74 (-ve DEPT), 28.06 (-ve DEPT), 38.49 (-ve DEPT), 
52.19, 52.45, 68.45, 68.49, 68.72, 69.66, 69.75, 70.23, 70,51, 70.58, 75.79, 76.99, 169.55, 
170.01, 173.28. 
 
2.12:  References 
1) N.J. Long, Metallocenes, Blackwell sciences, (1998)  
2) M. Sheehy, The Design and Synthesis of Novel Peptide Derivatives as Malarial Protease 
Inhibitors and Electrochemical Anion Sensing Receptors, Ph.D. Thesis, DCU, (1999) 
3) D. L. Stone, D. K. Smith, Polyhedron Lett., 22, (2003), 763. 
4) A. Hess, O. Broch, T. Wheymuller, N.M. Nolte, J. Organometallic Chem., 589, (1999), 75. 
5) G. Zubay , Biochemistry, 3rd ed., WCB Publishers, (1993) 
6) H.B. Kraatz, J. Lusztyk, G.D. Enright, Inorg. Chem., 36, (1997), 2400 
7) P.C. Reeves., Org. Syn., 56, (1977), 28. 
8) Y. Xu, H.B. Kraatz., Tetrahedron Lett., 42, (2001), 75. 
9) P. Saweczko, H.B. Kraatz, Co-ord. Chem. Rev., 190-192, (1999), 185. 
10)  A. Tongi, T. Hayashi, Ferrocenes, VCH, Wienhiem, (1993). 
11)  M. Bodansky, A. Bodansky, Principles of Peptide Synthesis, 2nd ed., Springer-Verlay, 
(1993). 
12)  C. Imrie, L. Cook, D. Levendis, J. Organometallic Chem.,637-639, (2001), 266. 
13)  S.C. Story, J.V. Aldrich, Int. J. Pept. Protein. Res., 43, (1994), 29.  
14)  P.L. Williams, Chemical Approaches to the Synthesis of Peptides, CRC press, (1997), 95. 
15)  L. Lin, A. Berces, H.B.Kraatz, J. Organometallic Chem., 556, (1998), 11 
16)  D.H. Williams, I. Fleming, Spectroscopic Methods in Organic Chemistry, 4th ed., McGraw-
Hill, (1989). 
17)  C.N. Kirsten, T.H. Schrader, J. Am. Chem. Soc., 119, (1997), 12061. 
18) J.F. Gallagher, P.T.M. Kenny, M.J. Sheehy, Inorg. Chem. Comm., 2, (1999), 200. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter III 
 
The Synthesis and Characterisation 
of N-Ferrocenoyl Dipeptides 
92 
3.1:  Introduction 
  While there have been a growing number of reports of ferrocene di- and polypeptide derivatives 
in the literature in recent years, few have been prepared by exposing the ferrocene moiety to the 
normal cycles of protection/deprotection encountered in standard peptide synthesis.  In the 
majority of cases, this methodology has been avoided via the addition of the ferrocene group to a 
pre-prepared peptide, i.e. at the final step of peptide chain elongation.  Of those reports of chain 
elongation involving the ferrocene group, low overall yields and problems with purification are 
common [1, 2].  In addition, the ferrocene group has been shown to be entirely unsuitable to 
several standard peptide reactions, for example acidolysis and the Merryfield synthesis [3]. 
  The group of Kraatz et al. were able to prepare the dipeptide ferrocenoyl-(proline)2-OBz by 
hydrogenation of the N-ferrocenoyl-L-proline benzyl ester to give the free acid, followed by 
DCC/HOBt coupling to H-pro-OBz.HCl (scheme 1) [4]. 
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Scheme 1:  Preparation of 90 via catalytic hydrogenation of benzyl ester. 
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  The starting material for this reaction, N-ferrocenoyl-L-proline benzyl ester, was itself prepared 
from ferrocene carboxylic acid and proline benzyl ester, using the DCC/HOBt coupling protocol.    
Although the authors of this publication report a 65% yield for the final coupling step of the 
preparation of 90, the overall yield based on the input of ferrocene carboxylic acid works out at < 
55%, assuming quantitative recovery of the free acid after catalytic hydrogenation of the benzyl 
ester. 
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Scheme 2:  Preparation of 91 via removal of Fmoc protecting group. 
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  Nolte et al. have prepared the dipeptide 91 via removal of the N-protecting Fmoc group in the 
presence of the ferrocene moiety to yield the free amine, which enabled the molecule to undergo 
chain elongation [5].  Interestingly, when the BOC-protecting group was used for this purpose, 
its removal using TFA resulted in the degradation of the ferrocene group (scheme 2).  Based on 
the initial input of ferrocene aldehyde, the authors report an overall yield of ca. 50%.   
   Another approach was adopted by Kenny et al., who used the enzyme α-chymotrypsin to 
hydrolyse the methyl ester of the N-ferrocenoyl phenylalanine derivative, to yield the free acid, 
which could then be coupled to other amino acid esters to yield compounds such as 92  (scheme 
3) [6]. 
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Scheme 3:  Preparation of 92 via α-chymotrypsin catalysed hydrolysis of the methyl ester. 
 
  The obvious drawback with this methodology is that the action of α-chymotrypsin is limited to 
amino acids which have aromatic side chains (phenylalanine, tyrosine, tryptophan). 
95 
 
  With this in mind, several synthetic routes were employed in attempting to synthesize 
compounds 103-111.  In order to compare the suitability of each of these synthetic routes, 
compound 103, N-ferrocenoyl-((S-methyl) L-cysteine)2 methyl ester was prepared by each of 
these methods.   
  
3.2:  Synthesis of Dipeptides 
  Four different dipeptides (93-96) were prepared with a view to synthesizing the N-ferrocenoyl 
monosubstituted dipeptides discussed in this chapter.  All were prepared using the DCC/HOBt 
coupling protocol, i.e. by reacting an N-BOC protected amino acid with an amino acid ester, 
followed by cleavage of the BOC protecting group by TFA (scheme 4).  The dipeptide, ((S-
methyl) L-cysteine)2 methyl ester was also isolated as the hydrobromide salt, and was prepared 
via cleavage of the BOC group by hydrobromic acid in a solution of acetic acid.       
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Scheme 4:  Preparation of the dipeptide 93, using the DCC/HOBt protocol, followed by 
TFA or HBr cleavage of the BOC protecting group. 
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  Almost identical 1H-NMR spectra were obtained for the different salts of the dipeptide 93, 
irrespective of the method of BOC removal. The formation of the dipeptide was confirmed by 
1H-NMR spectroscopy, with the appearance of a signal for the amide proton at ca. 8.1 ppm.  All 
the desired dipeptide esters were recovered in 70-80% yield after deprotection of the N-terminal. 
 
3.3:  Synthesis of N-Ferrocenoyl Monosubstituted Dipeptides 
 
3.3.1:  Synthetic Route 1 
  The first attempt at synthesizing compound 103 involved reaction of the TFA salt of the ((S-
methyl) L-cysteine)2 methyl ester dipeptide with ferrocene carboxylic acid, employing the same 
DCC/HOBt conditions which had been used successfully in the synthesis of the N-ferrocenoyl 
amino acid derivatives.  This methodology gave the desired N-ferrocenoyl dipeptide derivative 
in yields < 20%.  It was thought that this was due to the difficulty in removing residual TFA 
from the reaction mixture following the deprotection step, as it is well know that acidic 
conditions can drastically interfere with coupling reactions.  However, even after strenuous 
attempts at removing any TFA were made (exposure of the reaction mixture to high vacuum for 
prolonged periods, neutralization with excess triethylamine), coupling of the deprotected 
dipeptide with ferrocene carboxylic acid still failed to yield 103 in yields any greater than 20%.  
The synthetic procedure is shown in scheme 5. 
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Scheme 5:  The preparation of 103 via reaction of the TFA dipeptide salt, 93, with ferrocene 
carboxylic acid. 
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3.3.2:  Synthetic Route 2 
  It was subsequently decided to employ a different coupling reagent for the final step of the 
synthesis of 103, in order to determine whether yields could be increased in this fashion.  CDI 
was the reagent chosen, and the coupling reaction was carried out using THF as a solvent.  Both 
these methods failed to increase the yield of 103 to any great extent, again producing the desired 
compound in a yield of 23%.   
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Scheme 6:  The preparation of 103 via use of CDI as the coupling reagent 
 
3.3.3:  Synthetic Route 3 
  It was noted from column chromatography of the reaction mixtures from both of the previous 
two synthetic routes that the activated form of ferrocene carboxylic acid, i.e. ferrocenoyl-OBt, 
60, from route one and N-ferrocenoyl imidazole, 61, from route 2, were not formed in significant 
quantities (5 and 8% respectively recovered from the reaction mixtures).  Inhibition of the 
formation of these intermediates, therefore, may have been a limiting factor in the preparation of 
103.  It was therefore decided to employ a convergent synthetic strategy, by isolation of the 
ferrocenoyl-benzotriazole active ester, and to react this with the triflouroacetate salt of the 
freshly prepared dipeptide, 93.  The ferrocene-imidazole adduct, 61, was deemed unsuitable for 
this purpose, as it is known to be unstable above 5°C [7], and preparation of 103 was not 
attempted using this particular synthon.  The reaction would also be easier to follow by TLC, as 
there would be no further intermediates between the conversion of ferrocenoyl-benzotriazole 
active ester, 60, to the target molecule 103.   
  This strategy was slightly more successful than the previous two routes, affording 103 in a 31% 
yield (based on ferrocene carboxylic acid input).  Changing the solvent from dichloromethane to 
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THF had a slightly deleterious effect on the yield, 103 being recovered after column 
chromatography in ca. 28% yield.     
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Scheme 7:  The preparation of 103 by reaction of 93 with the active ester 60. 
 
  Although this was a definite improvement on the first two strategies, it had become apparent 
that residual TFA was still an issue.  Therefore, it was decided to employ different synthetic 
strategies in which the use of TFA could be avoided. 
 
3.3.4:  Synthetic Route 4 
  In order to avoid usage of TFA for cleavage of the t-BOC protecting group from the N-terminal 
of the dipeptide, a solution of hydrobromic acid in acetic acid was employed for this purpose.  
The N-ferrocenoyl-O-benzotriazole intermediate, 60, was then reacted with the hydrobromide 
salt of the dipeptide 93 in DCM.  
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Scheme 8:  The preparation of 103 by reaction of the 93 with the active ester 60. 
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  This strategy proved to be the most successful to date, and for the first time, yields of over 
40% were recorded for 103.  However, it was clear that there was still significant room for 
improvement.   
  All strategies employed to date had relied upon cleavage of the protecting group from the 
N-terminal of the dipeptide, in acidic solution.  Subsequent coupling to ferrocene carboxylic 
acid, in turn, appeared to be inhibited to a large extent.  The most likely explanation for this 
was the presence of residual acid from the deprotection step.  In order to remove the need for 
this step, several alternative strategies were investigated.   
 
3.3.5:  Synthetic Route 5 
  It was decided to attempt to synthesize the N-ferrocenoyl dipeptide by coupling two amino 
acids sequentially to ferrocene carboxylic acid, thereby removing the need for N-terminal 
protection.   
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Scheme 9:  The preparation of 103 by reaction of the unprotected amino acid with the active ester 
60. 
 
  The first of these synthetic routes involved reaction of the active ester, N-ferrocenoyl-O-
benzotriazole, with the unprotected form of (S-methyl) L-cysteine.  As the carboxyl group on the 
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ferrocene moiety had already been activated, protection of the carboxyl group of L- cysteine was 
rendered unnecessary. 
  When the reaction was carried out in DCM, the N-ferrocenoyl amino acid, 97, was not formed 
in any appreciably quantity.  This could no doubt be attributed to the extremely low solubility of 
the zwitterionic free amino acid in DCM.  This situation was only slightly improved upon by 
changing the solvent to the more polar absolute methanol, which resulted in the formation of 103 
in a 14% yield.  Subsequent coupling of 97 to (S-methyl) L-cysteine methyl ester in DCM led to 
the formation of 103 in an overall yield of 12%.  It was clear that this particular method, 
although circumventing the need for column chromatography, was inferior to the previous 
methods in terms of maximizing yield.  Replacing absolute methanol with DMF, ethanol, or 
ethyl acetate failed to yield 103 in any appreciable quantity.  It became obvious that the 
solubility of the free amino acid was too low in organic solvents to be of use.  It therefore 
became apparent that protection of the C-terminal of the amino acid would be necessary, i.e. 
replacing the carboxylate group with a less polar functional group, in order to increase solubility 
in organic solvents.  This, in turn, would necessitate exposure of the ferrocenoyl moiety to 
reaction conditions appropriate for the removal of the C-terminal protecting group.  To this end, 
several further synthetic routes were investigated.  
 
3.3.6:  Synthetic Route 6 
  As discussed in section 3.1, previous work in this particular area involved synthesis of the N-
ferrocenoyl amino acid ester, followed by conversion of the ester group to the free acid via 
enzyme-catalysed hydrolysis.  The enzyme employed for this purpose was α-chymotrypsin, 
whose action is limited to amino acid residues which have aromatic side chains, i.e. tyrosine, 
tryptophan, and phenylalanine.  Obviously, this method would be of little use in any attempted 
synthesis of 103.  Alkyl esters, while excellent protecting groups for the C-terminal of peptide 
chains, are notoriously difficult to remove, and can result in a host of unwanted side reactions, 
not least of which is racemization [8].  Therefore, it was decided to use the freshly prepared 
benzyl ester form of (S-methyl) L-cysteine to synthesize the N-ferrocenoyl amino acid ester, 
followed by palladium catalysed hydrogenation of the benzyl group to form the free acid, which 
could then undergo further peptide chain elongation.  The synthesis is outlined in scheme 10. 
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Scheme 10:  Preparation of 103 via catalytic hydrogenation of the N-ferrocenoyl benzyl ester. 
 
  This synthetic route proved to be the most successful to date, affording 103 in an overall yield 
of 52%, which is comparable to previous work in this area.  The main drawback with this 
particular route, however, was the difficulty in recovering the N-ferrocenoyl-(S-methyl)-L-
cysteine free acid from the catalytic hydrogenation mixture, which resulted in losses of around 
20%.  The final step of the procedure, i.e. the coupling of (S-methyl)-L-cysteine methyl ester to 
97 was accomplished in a yields > 80% and, more importantly, allowed 103 to be isolated 
without the need for column chromatography.   
   
3.3.7:  Synthetic Route 7 
  Cleavage of alkyl esters from the C-terminal of peptide chains can result in unwanted side 
reactions.  Saponification of the ester group would also necessitate exposure of the ferrocenoyl 
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moiety to basic aqueous conditions, which could potentially lead to decomposition, and the 
formation of iron (III) hydroxide salts.  Previous attempts at saponification of N-ferrocenoyl 
amino acid esters via refluxing in aqueous sodium carbonate had led to the decomposition of the 
ferrocenoyl moiety [6].  Although ferrocene is one of the more chemically robust organometallic 
compounds, it was clear that if the saponification route were to be a viable alternative to the 
previous routes, much milder conditions would have to be employed. 
  The first attempt at hydrolysis involved the addition of N-ferrocenoyl-L-methionine methyl 
ester to a 0.5M solution of sodium hydroxide at room temperature under nitrogen, followed by 
neutralization of the reaction mixture with 0.5M HCl, which led to the precipitation of the N-
ferrocenoyl-L-met free acid in yields ca. 30% after drying. (scheme 11). 
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Scheme 11: Saponification of the ester 87 with 0.5M NaOH. 
   
  Upon examination, the filtrate had the green colour characteristic of iron III hydroxide.  This is 
not surprising, as oxidation of aqueous Fe (II) complexes is known to occur more rapidly in basic 
solution [9].  Obviously, the ferrocene group was proving too sensitive for these reaction 
conditions.  What was encouraging however was the NMR spectrum of the free acid, which 
showed only one signal for the amide proton, suggesting that racemization had not taken place.  
Repetition of the procedure at 0ºC did not result in an increased yield of 97. 
  It had become clear that, as decomposition of the ferrocene group was occurring even at 0 ºC, a 
lower concentration of sodium hydroxide would have to be employed in order to prevent this 
degradation, while at the same time ensuring complete saponification of the ester group. 
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  When the hydrolysis was repeated for a third time, 87 was slurried in a 0.1M solution of sodium 
hydroxide at 0ºC, followed by neutralization by 0.1M HCl.  Although the reaction time was 
considerably longer than was the case when 0.5M sodium hydroxide was used, it was found that 
the free acid could be recovered almost quantitatively after drying.  Again, the NMR spectrum of 
the free acid gave no evidence of racemization having occurred.  Subsequent coupling of the free 
acid to (S-methyl)-L-cysteine under standard coupling conditions yielded 103 in an overall yield 
of 64%.  The full synthesis of 103 is given in scheme 12. 
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Scheme 12:  Preparation of 103 via saponification of 87. 
 
  A summary of the yields of compounds 103-111 is given in table 1, with all compounds being 
prepared via synthetic route 7.  It is important to note that these yields are based on the initial 
inputs of ferrocene carboxylic acid, and not on the final coupling reaction.  All compounds were 
recovered in yields < 50%, which compares very favourably with any literature values recorded 
for compounds of this type [10, 11]. 
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Compound Name M.P. (ºC) Yield (%) 
103 N-ferrocenoyl-((S-methyl) L-cysteine)2 methyl ester 119-120 62 
104 N-ferrocenoyl-(S-methyl)-L-cysteine-L-aspartic acid 
dimethyl ester 
131-133° 59 
105 N-ferrocenoyl-(L-methionine)2 methyl ester 119-120 62 
106 N-ferrocenoyl-L-methionine-L-tyrosine 
methyl ester 
119-120 63 
107 N-ferrocenoyl-L-methionine-L-threonine  
methyl ester 
138-141 60 
108 N-ferrocenoyl-L-tyrosine-(S-methyl)-L-cysteine  
methyl ester 
121-125 57 
109 N-ferrocenoyl -(β-alanine)2 methyl ester 150-151 58 
110 N-ferrocenoyl-(γ-aminobutyric acid)2 methyl ester 150-151 60 
111 N-ferrocenoyl-(valeric acid)2 methyl ester 154-155 52 
 
Table 1:  % Yields and melting points of the N-ferrocenoyl monosubstituted dipeptide 
derivatives. 
 
3.4:  1H-NMR Spectra of N-Ferrocenoyl Monosubstituted Dipeptides 
  In common with the previously discussed N-ferrocenoyl amino acid derivatives, compounds 
103-111 also show a signal for the unsubstituted Cp ring integrating for five protons in the 3.96 - 
4.21 ppm range, and the meta-protons of the substituted Cp ring also appear as a similar 
broadened singlet in the 4.3 – 4.4 ppm range.  However, in all cases where there is a chiral centre 
adjacent to the ferrocenoyl group, the ortho-protons of the substituted Cp ring do not appear as 
sharp singlets, but rather as a broadened singlet integrating for two protons.  This is an 
unexpected result, as there are no further chemical modifications made to the ferrocenoyl moiety 
relative to the N-ferrocenoyl mono peptide derivatives, and one would expect a similar pattern of 
signals to be recorded.  This observation is discussed further in section 3.4.1.  
  Compounds 103-111 also, as expected, show the presence of two individual amide proton 
signals in the 7.7 – 8.7 ppm range, although, as will be discussed in subsequent sections, the 
presence of heteroatoms in the side chains of the individual amino acids have a bearing on the 
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spectra recorded.  Compounds 103-108 also show the presence of two α-protons, which appear 
as multiplets in the 4.3 – 4.8 ppm range, although these signals are convoluted in the case of 108.   
  The amide protons of the achiral compounds 109-111 show an interesting pattern of amide 
proton signals, ranging from two clearly defined triplets in the case of 108, to a convoluted 
multiplet in the case of 111.  These protons also appear at slightly lower ppm compared to their 
chiral counterparts.  These observations will be discussed further in section 3.4.2.  A summary of 
the 1H-NMR data obtained for these compounds is given in table 2. 
 
Compound N-H Cpunsub. Hortho Hmeta Hα 
103 7.85 (d) 
8.56 (d), 8.67 (d) 
4.20 4.72 4.35 4.52 
4.72 
104 7.85 (d) 
8.56 (d), 8.64 (d) 
4.21 4.86 4.37 4.62-4.71 
105 7.76(d), 7.79(d) 
8.41(d), 8.45(d) 
4.18 4.89 4.36 4.41-4.46 
106 7.72 (d), 7.76 (d) 
8.28 (d), 8.36 (d) 
4.17 4.88 4.34-4.44 4.34-4.44 
4.54-4.59 
107 7.86 (d) 
7.92 (d) 
4.14-4.19 4.89 
4.91 
4.36 4.30-4.32 
4.61-4.65 
108 7.76 (d) 
8.56 (d) 
3.96 4.70-4.74 4.30 4.51-4.54 
4.70-4.74 
109 7.79 (t) 
8.05 (t) 
4.15 4.76 4.32 - 
110 7.83 (t) 
7.89 (t) 
4.15 4.77 4.35 - 
111 7.76-7.80 (m) 4.15 4.76 4.33 - 
  
Table 2:  The 1H-NMR chemical shifts (ppm) of the N-ferrocenoyl monosubstituted dipeptide 
derivatives recorded in d6 DMSO. 
 
 
3.4.1:  1H-NMR Spectra of 103 and 104 
  The 1H-NMR spectrum of 103 is shown in fig. 1.  Two closely grouped singlets are observed at 
2.07 and 2.16 ppm, each integrating for three protons, which correspond to the two methyl 
groups of the thioether side chains, with the two multiplets in the 2.72 – 2.82 ppm range 
corresponding to the two methylene groups of the side chains.  A singlet integrating for three 
protons,  corresponding to the methyl ester group appears at 3.6 ppm. 
  A singlet, integrating for five protons, of the unsubstituted Cp ring (4.20 ppm), as well as the 
singlet (2H) of the meta-protons of the substituted Cp ring (4.35 ppm), appear in roughly the 
same region in the spectrum as was observed for the N-ferrocenoyl-(S-methyl)-cysteine amino 
acid derivative, 87.  Two multiplets, each integrating for one proton and corresponding to the 
two α-protons, appear ca. 4.5 and 4.7 ppm. 
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Fig. 1:  The 1H-NMR Spectrum of 103  in d6 DMSO. 
 
  There is, however, an interesting contrast between 87 and 103, in terms of the appearance of the 
ortho-protons of the substituted Cp ring in their respective spectra.  This can be seen in fig. 2, 
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where the ortho-protons of 87 appear as two sharp singlets, whereas these protons appear as a 
slightly broadened singlet in the case of 103.  
 
Fig. 2:  The contrast between the ortho-protons of 87 (left, two sharp singlets), and 103 (right, 
one broadened singlet). 
 
  One possible explanation for this is that the longer dipeptide chain may have a more fluxional 
nature in solution, thus lessening the defined nature of the ortho-proton signals.  Although no 
low temperature studies are possible in d6 DMSO, the idea that more than one conformation may 
be present in solution at ambient temperature can be further investigated via inspection of the 
amide-proton signals. 
  The doublet at 7.85 ppm in the 1H-NMR spectrum of 103, (J = 8.0 Hz), is typical of the amide 
signals observed in the spectra of the N-ferrocenoyl amino acid derivatives.  The other amide 
signal is however observed further downfield as two individual doublets, each with J = 8.0 Hz, 
and between them integrating for one proton.  At first it was feared that the splitting of the amide 
signal was due to racemization of one of the chiral centres, although this signal pattern was seen 
to be the case, irrespective of the synthetic route employed.  In order to determine whether loss 
of chiral purity had taken place, high temperature 1H-NMR spectra of 103 were recorded, and 
can be seen in fig. 3.  The two individual components of the amide signal are seen to converge at 
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80°C, which would strongly suggest the presence of two individual conformers in d6 DMSO 
solution at ambient temperature. 
 
Fig. 3:  The amide protons of 103 recorded at ambient temperature (left), 50°C (centre), and 
80°C (right). 
 
  While the amide protons of the dipeptide do form inter-molecular hydrogen bonds with the 
solvent, they could also form an intra-molecular hydrogen-bonding interaction with the sulphur 
atoms of the cysteine side-chain, providing these bonds were spatially accessible.  It is 
informative to compare the amide signals of 103 with N-ferrocenoyl-(S-methyl)-L-cysteine-L-
aspartic acid dimethyl ester, 104.  These two compounds differ only in terms of the side chain of 
their C-terminal residue. 
 
Fig. 4:  The amide proton signals of 103 (right) and 104 (left). 
109 
 
  The exact same pattern of amide proton resonances is observed for 104, with the more 
downfield signal appearing as doublets of different intensity.  Once again, high temperature 1H-
NMR spectra show these two components converging at 80°C.  As table 2 illustrates, these 
signals appear at almost identical positions in their respective 1H-NMR spectra (7.85 and 
8.56/8.67 for 103, 7.85 and 8.56/8.64 for 104).  These results would suggest that the split amide 
signal is due to a hydrogen-bonding interaction between the C-termini amide proton, and the 
sulphur atom of the N-terminal cysteine residue.  From a conformational perspective, this would 
certainly be possible. 
 
 
Fig. 5:  The amide protons of 103 recorded in CDCl3. 
 
  In order to confirm this, a 1H-NMR spectrum of 103 was recorded in the non-polar solvent 
CDCl3, and shows two amide signals at ca. 6.6 and 8.0 ppm (although these signals were not 
resolved into doublets in deuterated chloroform).  This confirms the idea that only one of the 
amide protons is involved in an intra-molecular hydrogen bonding interaction.  It could therefore 
be concluded that the sulphur atom of the N-terminal cysteine residue acts as a hydrogen-
bonding donor for the C-terminal amide proton in compounds 103 and 104.  Similar results are 
also observed for compounds 105 and 106, which have a methionine residue located at their N-
termini.     
 
 3.4.2:  1H-NMR Spectra of 109-111 
  The 1H-NMR spectrum of 109 is shown in fig. 6.  The methylene protons adjacent to the 
carbonyl groups appear as triplets at 2.4 ppm, while the methylene protons adjacent to the 
nitrogen atoms of the amide groups appear as triplets at 3.3 ppm.  The protons of the 
unsubstituted Cp ring, and the meta- and ortho- protons of the substituted Cp ring all appear as 
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singlets at 4.15, 4.32, and 4.76 ppm respectively.  Compounds 110 and 111 also show a similar 
pattern of signals for their ferrocenoyl protons, as well as for the methylene protons in their 
peptide backbones.  The most striking difference between their respective spectra can be seen in 
the amide proton signals recorded. 
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Fig. 6:  The 1H-NMR spectrum of 109 in d6 DMSO. 
 
  Two clearly defined triplets can be seen for the amide protons of 109 at 7.79 and 8.05 ppm, 
while two much more closely grouped triplets are observed for 110 at 7.83 and 7.89 ppm.  This 
is in contrast to the amide signals of 111, which appear as a convoluted multiplet at 7.8 ppm, as 
illustrated in fig. 7.  As the only structural difference between these compounds is in the number 
of methylene groups in their peptide backbones, between their amide nitrogen atoms and 
carbonyl groups, it appeared likely that the separation of these amide signals was directly related 
to their conformational flexibility in solution.   
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Fig. 7:  The amide protons of 109-111 recorded in d6 DMSO. 
 
  It will be recalled form chapter 2 that among the N-ferrocenoyl amino acid analogues of 
compounds 109-111, (81, 82 and 88 respectively), the number of methylene groups has an 
impact on the flexibility of the peptide backbone of the compounds, and hence their ability to 
form intra-molecular hydrogen bonds.  In order to gain a clearer picture of the conformations 
these compounds were able to adopt in solution, it was necessary to record their 1H-NMR spectra 
in the non-hydrogen bonding solvent, CDCl3. 
 
 
Fig. 8:  The amide protons of 109 (left), 110 (centre) and 111 (right) recorded in CDCl3. 
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  As can be seen from fig. 8, compound 109 shows two amide proton signals (triplets) at ca. 6.4 
ppm and 7.5 ppm in CDCl3, the latter appearing further downfield in the spectrum due to an 
intra-molecular hydrogen-bonding interaction.  A similar situation is observed in the spectrum of 
110, with two amide proton signals being observed at ca. 6.7 ppm and 7.7 ppm.  Compound 111 
shows a multiplet at 7.7 ppm, integrating for two protons, which is almost identical to that which 
was observed when the spectrum was recorded in d6 DMSO. These results would suggest that 
both the amide protons of this compound are involved in an intra-molecular hydrogen-bonding 
interaction in non-polar solution.    
 
3.5:  13C-NMR Spectra of N-Ferrocenoyl Monosubstituted Dipeptides 
  The 13C-NMR spectra of compounds 103-111 show that there are minimal differences between 
the N-ferrocenoyl monosubstituted dipeptides and their amino acid analogues in terms of the 
chemical shifts of the ferrocenoyl carbon resonances in their spectra, with the positions of the 
unsubstituted Cp ring carbons, and the ortho, meta, and ipso carbons of the substituted Cp ring 
consistent with the spectra of compounds 62-89.  Those compounds which incorporate a chiral α-
carbon also show two distinct signals for the ortho-carbons, but unlike compounds 62-89, only 
one signal is observed for the meta-carbons.      
  Elsewhere in the spectra, the most obvious differences between the mono- and di- substituted 
compounds is the appearance of a second amide carbon signal ca. 170 ppm, and, for compounds 
103-108, a second α-carbon resonance at 52 ppm.  A summary of the 13C-NMR data for 
compounds 103-111 is given in table 3. 
 
CompoundC=Oamide C=Oester Cpunsub. Cortho Cmeta Cipso 
103 169.64 
171.38 
172.65 69.84 68.63 
68.82 
70.42 76.43 
104 169.32 
169.58 
170.79 
171.30 
69.85 68.64 70.44 76.19 
105 169.53 
169.61 
172.60 70.40 68.70 
68.77 
70.57 76.17 
106 169.48 
172.18 
172.32 69.72 68.58 
68.87 
70.04 76.21 
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CompoundC=Oamide C=Oester Cpunsub. Cortho Cmeta Cipso 
104 169.64 
171.31 
172.56 69.73 68.65 
68.78 
70.44 76.25 
105 169.30 
171.51 
172.65 69.69 68.20 
68.93 
70.25 76.24 
106 169.28 
170.94 
172.11 69.69 68.44 70.20 76.95 
107 169.16 
172.22 
173.47 69.65 68.44 70.16 77.14 
108 169.00 
172.20 
173.61 69.62 68.42 70.12 77.25 
 
Table 3:  The 13C-NMR chemical shifts ( δ ppm)  of the N-ferrocenoyl monosubstituted dipeptide 
derivatives recorded in d6 DMSO. 
 
3.5.1:  13C-NMR Spectrum of 103 
  The 13C-NMR Spectrum of 103 is shown in fig. 9, and is typical of those N-ferrocenoyl 
monosubstituted dipeptide derivatives which incorporate a chiral centre.  Two closely grouped 
signals for the two methyl groups of the thioether side chains can be seen at 15.5 and 15.6 ppm, 
with the methylene carbons of the side chain appearing at 35.3 and 35.7 ppm.  As expected, these 
latter carbons appear as negative peaks in the 135DEPT 13C-NMR spectrum (fig. 10).  The two 
α-carbon signals are observed at 52 and 52.5 ppm. 
  Two separate, closely grouped signals for the ortho-carbons of the substituted Cp ring are 
observed at 68.6 and 68.8 ppm, which is almost identical to the positions of these carbons in the 
spectrum of 87, the amino acid analogue of 103.  The magnetic non-equivalence of these carbons 
can once again be attributed to the presence of the chiral centre.  The position of the carbons of 
the unsubstituted Cp ring, which appear at 69.8 ppm, is identical to that of compound 87, but 
only one signal for the meta-carbons is observed, at 70.4 ppm.  The ipso-carbon of the 
substituted ring appears at 76.4 ppm, while two amide carbon signals appear at 169.6 and 171.3 
ppm, while the ester carbon is observed at 172.6 ppm.   
 
  
Fe S
N
O
N
O
S
H
OMe
HO
 
220 200 180 160 140 120 100 80 60 40 20 0 ppm
 
 
 
 
 
 
 
 
 
Fig. 9:  The 13C-NMR spectrum of 103 in d6 DMSO. 
 
  
 Fig. 10:  The 135DEPT spectrum of 103 in d6 DMSO. 
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3.5.2:  13C-NMR Spectrum of 109 
  The 13C-NMR spectrum of compound 109 is shown in fig. 11.  The four methylene groups of 
the peptide backbone are observed in the 34–36 ppm region, and appear as negative peaks in the 
DEPT-135 spectrum.  The chiral carbon atoms, which appear in the 50–60 ppm region for 
compounds 103-108, are naturally absent from the spectrum.  In the absence of a chiral centre, 
only one signal is observed for the ortho-carbons of the substituted Cp ring at 68.4 ppm, while 
the ipso-carbon of the substituted ring appears at a slightly more downfield position in the 
spectrum, 77 ppm, than the chiral compounds 103-108.  The position of both the unsubstituted 
Cp ring, 69.7 ppm, and the meta-carbons of the substituted Cp ring are consistent with 
compounds 103-108, as are the carbons of both amide groups, 169.2 and 170.9 ppm, and the 
ester group, 172.1 ppm.  
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Fig. 11: The 13C-NMR spectrum of compound 109 in DMSO. 
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Fig. 12: The 135DEPT Spectrum of 109 in d6 DMSO 
 
 
3.6:  Infrared Spectra of N-Ferrocenoyl Monosubstituted Dipeptides   
  Infrared spectra of compounds 103-111 were recorded both in the solid state (as KBr discs), 
and in solution (as thin-film methylene chloride solutions).  In the solid state, only one broad N-
H stretch vibration is observed in the spectra, despite the presence of two amide groups within 
each of the compounds.  The wavenumbers recorded are, however, consistent with those 
observed for the amino acid analogues 62-89, and indicate that the amide protons of these 
compounds are involved in hydrogen-bonding interactions in the solid state.  The C=O ester 
band (or bands in the case of 104) are observed between 1725 and 1752 cm-1.  Two separate 
C=O amide stretches appear in all spectra recorded, one in the 1625 cm-1 region, and a second in 
the 1655 cm-1 region.  The former is consistent with that observed for compounds 62-89, 
suggesting that this band is due to the amide group adjacent to the ferrocene moiety, while the 
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latter is due to the C-terminal amide group.  A summary of the infrared data recorded for 
compounds 103-111 is given in table 4. 
 
Compound υN-H  υCOOR υCONR υN-H (CH2Cl2) 
103 3280 1749 1656, 1627 3409, 3356  
104 3304 1735, 1725 1655, 1628 3416, 3347  
105 3285 1746 1656, 1626 3351 
106 3277 1744 1655, 1638 3383, 3348  
107 3277 1742 1654, 1638 3401 
108 3277 1752 1657, 1625 3402 
109 3257 1741 1664, 1614 3410, 3367 
110 3248 1735 1661, 1619 3412, 3370 
111 3268 1742 1659, 1628 3366 
 
Table 4: Infrared data for 103-111 (cm-1) (as KBr discs unless stated) 
 
  In order to investigate the conformations adopted by these N-ferrocenoyl monosubstituted 
dipeptides in non-polar solution, thin-film infrared spectra of 103-111 were also recorded.  
Compounds 103 and 104, which showed the presence of one hydrogen-bonded and one non-
hydrogen-bonded amide proton in their 1H-NMR spectra recorded in CDCl3 (section 3.4.1), and 
both these compounds also show two υN-H stretches, one below 3400 cm-1 (hydrogen-bonded), 
the other above 3400 cm-1 (non-hydrogen bonded). 
  A similar situation is observed for the achiral compounds 109 and 110, which also show the 
presence of one hydrogen-bonded and one non-hydrogen bonded amide proton in their 1H-NMR 
spectra recorded in CDCl3, and show two υN-H stretches, one below 3400 cm-1, with the second 
above 3400 cm-1.  Interestingly, the C=O amide bands of these compounds are both shifted to 
higher wavenumbers when their spectra are recorded in CH2Cl2, while the C=O ester bands 
remain largely unaltered compared to those observed in the solid state.  As discussed in section 
3.3, those carbonyl groups, which do not form hydrogen bonds in non-polar solution, tend to 
appear at lower wavenumbers in the solid state.  It is therefore likely that the oxygen atom of the 
ester group functions as a donor atom for the N-terminal amide proton in non-polar solution for 
both compounds 109 and 110.     
 Fe
NH
O
N
H
O
O
OMe
            
Fe
O
N
H
O
NHO
MeO
 
 
Fig. 13:  Likely conformations in non-polar solution of 109 (left) and 110 (right). 
 
  Compound 111 shows only one N-H stretch in thin film methylene chloride solution, at 3366 
cm-1, which would suggest that both amide protons are involved in a hydrogen-bonding 
interaction.  The C=O amide stretch in methylene chloride is not particularly informative, only 
one broad band being observed ca. 1650 cm-1.  The amino acid analogue of this compound, 88, 
also forms an intra-molecular hydrogen bond in non-polar solution, and based on this 
observation, the most likely conformation for 111 is shown in fig. 14. 
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Fig. 14:  Likely conformations in non-polar solution of 111, with intra-molecular hydrogen 
bonds accomplished via the formation of two eight-membered rings. 
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3.7:  UV-Vis Spectra of N-Ferrocenoyl Monosubstituted Dipeptides   
  The UV-Vis spectra of compounds 103-111 show minimal differences from those recorded for 
the N-ferrocenoyl mono peptide derivatives, either in terms of the λmax or the extinction 
coefficients recorded, i.e. it would appear that modification of the ferrocenoyl peptide at the C-
terminal has minimal effect on the electronic properties of the ferrocene moiety.  All compounds 
show two low energy bands in the 440 and 300 nm range, while extinction coefficients are in the 
200 M-1 cm-1 range.   
 
3.8:  Cyclic Voltammograms of N-Ferrocenoyl Monosubstituted Dipeptides   
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Fig. 15:  The cyclic voltammograms of 70 and 105. 
 
  The cyclic voltammograms of compounds 103-111, like the N-ferrocenoyl amino acid 
derivatives, exhibit a reversible, one-electron peak, due to the oxidation of the ferrocenoyl group 
to the ferricenium cation.   What is noticeable is that there does appear to be a cathodic shift of 
the ferrocenoyl dipeptides relative to the amino acid derivatives, i.e. increasing the length of the 
peptide chain makes the molecule easier to oxidize.  This effect has been previously noted in 
ferrocenoyl-proline derivatives, although no satisfactory explaination for this could be 
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elucidated, it was proposed that the alignment of the carbonyl oxygen p-orbitals might be 
partially responsible, possibly facilitating outer sphere electron transfer [12].  The cyclic 
voltammograms of compound 105, N-ferrocenoyl-(L-methionine)2 methyl ester, along with, for 
comparative purposes, its amino acid analogue 70, are shown in fig. 15. 
  A summary of the electrochemical and UV-Vis data for compounds 103-111 is given in table 5. 
 
Compound λmax (nm) ε (M-1 cm-1)[α]D20 E1/2(mV) 
103 306, 441 182 -25 175 
104 305, 443 220 -18 170 
105 306, 444 196 -21 167 
106 305, 443 174 -20 162 
107 306, 440 199 -24 166 
108 302, 441 178 -19 180 
109 304, 442 187 - 160 
110 306, 442 187 - 155 
111 302, 441 187 -  151 
 
Table 5:  The electrochemical, UV-Vis, and optical rotation data for compounds 103-111. All ε 
values refer to lowest energy band. 
 
3.9:  Conclusions 
  Hydrolysis of the N-ferrocenoyl amino acid esters, at 0˚C, using 0.1M NaOH, followed by 
addition of an equimolar amount of 0.1M HCl, led to the quantitative precipitation of the N-
ferrocenoyl free amino acids, which could be then coupled to the free amine of another amino 
acid ester to yield the N-ferrocenoyl dipeptides.  Based on the initial input of ferrocene 
carboxylic acid, molar yields of > 70% were recorded, which compares very favourably to 
literature procedures.  Catalytic hydrogenation of the N-ferrocenoyl amino acid benzyl esters 
also yielded the free acids, although in lower yields.  Both these routes proved more successful 
than the coupling of ferrocene carboxylic acid to the pre-prepared dipeptide, where removal of 
the BOC protecting group from the dipeptide resulted in residual acid adversely affecting peptide 
coupling. 
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  The 1H-NMR spectra of compounds 103-108 in d6 DMSO and in CDCl3, showed the presence 
of intra-molecular hydrogen bonding of one or both of the amide protons to heteroatoms of the 
side chain of the adjacent residue.  Also observed for the chiral compounds 103-108 was the 
appearance of the ortho-protons of the substituted Cp ring as a broadened singlet, as opposed to 
two sharp singlets observed for the chiral N-ferrocenoyl amino acid derivatives.  One possible 
explanation for this is the presence of more than one conformer in solution at ambient 
temperature.  However, several of these compounds, like their amino acid analogues, show two 
distinct signals for the ortho-carbons in their 13C-NMR spectra.  Compounds 109-111 also show 
the presence of intra-molecular hydrogen bonds in solution in their 1H-NMR spectra.  The infra-
red data for compounds 103-111 is in agreement with the 1H-NMR data recorded in terms of the 
presence of intra-molecular hydrogen bonds in non-polar solution. 
  Little difference is observed in the UV-Vis spectra between compounds 103-111 and 
compounds 62-89, suggesting that modification of the N-ferrocenoyl peptide at the C-terminal 
has minimal effect on the electronic properties of the ferrocene moiety.  However, the 
electrochemical properties of the ferrocene group does seem to be impacted by this modification, 
with a noticeable cathodic shift being observed for compounds 103-111 relative to compounds 
62-89, although no definitive explanation for this observation can be given. 
 
3.10:  Experimental 
   
Synthesis of Dipeptides 
General Procedure 
  2.5mmol of the N-t-BOC protected amino acid and 2.5mmol of the amino acid ester 
hydrochloride salt were added a solution of DCC (0.6g, 3.0mmol) and Et3N (0.4mls, 2.5mmol) 
in 25mls dichloromethane at 0˚C.  The reaction was raised to room temperature after 30 mins, 
and allowed to proceed for 24 hrs.  The precipitated N,  N - dicyclohexylurea was removed by 
filtration, and the filtrate washed with 5% citric acid, saturated NaHCO3, and water.  The organic 
phase was then dried over MgSO4, and concentrated to ca. 5mls in vacuo.  Subsequent removal 
of the N-t-BOC group was effected in one of two ways.   
(i) The resulting solution was then cooled to 0˚C, and 5mls TFA were added, and the 
solution stirred at this temperature for 30 mins.  Diethyl ether was then added drop-wise, 
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precipitating the TFA salt as a white solid (only 93 was prepared successfully in this 
way).  
(ii) After cooling to 0˚C, 10mls of a 45% solution of HBr in acetic acid was added drop-
wise, and stirred for 30 mins.   Diethyl ether was then added drop-wise, precipitating the 
HBr salt as a white solid, or, in the case of 94 and 96, the solvent was removed in vacuo, 
to yield the dipeptides as brown oils.  
 
 ((S-methyl) L-cysteine)2 methyl ester (93) 
0.52g of N-t-BOC-(S-methyl)-L-cysteine and 0.46g of (S-methyl)-L-cysteine methyl ester 
hydrochloride were used in the synthesis. 
Yields: (i) After TFA de-protection 0.73g (77%), (ii) After HBr de-protection, 0.65g (69%), 
white waxy solid. 
1H-NMR (400MHz) δ (d6 DMSO):  2.01 (3H, s, -SCH3), 2.10 (3H, s, -SCH3), 2.72-2.80 (2H, m, 
-CH2SCH3), 2.81-2.89 (2H, m, -CH2SCH3), 3.68 (3H, s, OCH3), 4.40-4.42 (1H, m, NH2CH-), 
4.70-4.71 (1H, m, -NHCH-), 7.79 (2H, br. s, NH2CH-), 8.10 (1H, br. s, -NHCH-). 
 
(β-alanine)2 methyl ester (94) 
0.47g of N-t-BOC-β-alanine and 0.34g of β-alanine methyl ester hydrochloride were used in the 
synthesis. 
Yield 0.50g (80%), brown oil. 
1H-NMR (400MHz) δ (d6 DMSO): 2.33 (2H, t, J = 6.8 Hz, NHCH2CH2CO-), 2.51 (2H, t, J = 
6.8 Hz, NHCH2CH2CO-), 3.20-3.30 (4H, m, NHCH2CH2CO X 2), 3.55 (3H, s, -OCH3), 7.69 
(2H, br. s, (NH2CH2CH2-), 8.00 (1H, t, J = 6.4 Hz, NHCH2CH2-). 
 
(L-methionine)2 methyl ester (95) 
0.62g of N-t-BOC-L-methionine and 0.49g of L-methionine methyl ester hydrochloride were 
used in the synthesis.   
Yield 0.66g (71%), white waxy solid. 
1H-NMR (400MHz) δ (d6 DMSO): 1.73-1.99 (10H, m, -CH2SCH3 x 2), 2.46-2.59 (4H, m, -
CH2CH2SCH3 x 2), 3.60 (3H, s, -OCH3), 4.30-4.31 (1H, m, NH2CH-), 4.62-4.64 (1H, m, -
NHCH-), 7.65 (2H, br. s, NH2CH-), 8.22 (1H, br. s, -NHCH-).   
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(γ-aminobutyric acid)2 methyl ester (96) 
0.51g of N-t-BOC-γ-aminobutyric acid and 0.39g of γ-aminobutyric acid methyl ester were used 
in the synthesis. 
Yield 0.49g (69%), white waxy solid. 
1H-NMR (400MHz) δ (d6 DMSO): 1.69-1.82 (4H, m, NHCH2CH2CH2CO X 2), 2.17 (2H, t, J = 
7.6 Hz, NHCH2CH2CH2-), 2.40 (2H, t, J = 7.6 Hz, NHCH2CH2CH2-), 3.03-3.21 (4H, m, 
NHCH2CH2- X 2), 3.61 (3H, s, -OCH3), 7.83 (2H, br. s, NH2CH2CH2-), 7.99 (1H, t, J = 6.4 Hz, 
NHCH2CH2-). 
 
N-Ferrocenoyl Amino Acids 
Route 1, General Procedure 
  2.5mmol of the appropriate N-ferrocenoyl amino acid ester was slurried in 38mls 0.1M NaOH 
and 12mls methanol at 0˚C, and the mixture was stirred under N2 until a deep orange solution 
was obtained (ca. 2 hrs for methyl esters, 4 hrs for ethyl esters).  38mls of 0.1M HCl was then 
added drop-wise, (a pH of 7 was confirmed with pH paper), precipitating the free acids as orange 
solids, which were then dried for ca. 12 hrs at ca. 60˚C.  Complete hydrolysis was confirmed by 
the absence of the ester group protons in the 1H-NMR spectrum, and the appearance of a singlet 
at 12 ppm.  A KBr disc IR spectrum also showed a C=O band at 1715 cm-1, indicative of a 
carboxyl carbonyl group, and the disappearance of the C=O ester band at 1740 cm-1.  
 
Route 2 
  2.5mmol (1.1g) of N-ferrocenoyl-(S-methyl)-L-cysteine benzyl ester was dissolved in a slurry 
of 2g of Pd/C in 50mls methanol.  A vigorous stream of H2 was then bubbled through the 
mixture for 30mins, and the Pd/C was removed by filtration.  The solvent was then removed in 
vacuo, and again formation of the free acid was confirmed by the appearance of a singlet at 12 
ppm, and the appearance of a C=O band at 1715 cm-1 in the KBr disc IR spectrum.  Only 97 was 
prepared by this method. 
 
N-ferrocenoyl-(S-methyl)-L-cysteine (97) 
0.72g of -ferrocenoyl-(S-methyl)-L-cysteine benzyl ester was used in the synthesis. 
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Yields:  Route 1, 0.70g (97%).  Route 2, 0.88g (80%), orange microcrystalline solid. 
1H-NMR (400MHz) δ (d6 DMSO):  2.10 (3H, s, -SCH3), 2.87 (1H, dd, Ja = 9.6 Hz, Jb  = 13.6 
Hz, -CH2SCH3), 2.97 (1H, dd, Ja  = 4.8 Hz, Jb  = 13.6 Hz, -CH2SCH3), 4.20 (5H, s, unsub. Cp 
ring), 4.36 (2H, s, Hmeta Cp ring), 4.57-4.62 (1H, m, -NHCH-), 4.82 (1H, s, Hortho Cp ring), 4.85 
(1H, s, Hortho Cp ring), 8.16 (1H, d, J = 8.0 Hz, -NHCH-), 11.84 (1H, s, -COOH). 
 
N-ferrocenoyl-L-methionine (98) 
0.78g of 70 was used in the synthesis. 
Yield 0.73g (94%), orange microcrystalline solid. 
1H-NMR (400MHz) δ (d6 DMSO): 2.02-2.06 (5H, m, -CH2SCH3), 2.54-2.64 (2H, m, -
CH2CH2SCH3), 4.20 (5H, s, unsub. Cp ring), 4.41 (2H, s, Cmeta Cp ring), 4.50-4.54 (1H, m, 
NHCH-), 4.87 (1H, s, Hortho Cp ring), 4.91 (1H, s, Hortho Cp ring), 8.00 (1H, d, J = 7.6 Hz, 
NHCH-), 11.91 (1H, s, -COOH). 
 
N-ferrocenoyl-L-tyrosine (99) 
0.81g of 73 was used in the synthesis. 
Yield 0.78g (96%), orange-red crystalline solid. 
1H-NMR (400MHz) δ (d6 DMSO): 2.86-2.95 (1H, m, -NHCH(CH2PhOH), 3.02-3.05 (1H, m, 
NHCH(CH2PhOH), 4.09 (5H, s, unsub. Cp ring), 4.37 (2H, s, Hmeta Cp ring), 4.57-4.62 (1H, m, 
NHCH-), 4.80 (1H, s, Hortho Cp ring), 4.86 (1H, s, Hortho Cp ring), 6.68 (2H, d, J = 8.8 Hz, ArH), 
7.12  (2H, d, J = 8.8 Hz, ArH), 8.09 (1H, d, J = 8.0 Hz, NHCH-), 9.29 (1H, s, phenolic OH), 
11.79 (1H, s, -COOH).  
 
N-ferrocenoyl -β-alanine (100) 
0.63g of 81 was used in the synthesis. 
Yield 0.62g (98%), orange microcrystalline solid. 
1H-NMR (400MHz) δ (d6 DMSO): 2.61 (2H, t, J = 6.6 Hz, NHCH2CH2-), 3.40-3.44 (2H, m, 
NHCH2CH2-), 4.13 (5H, s, unsub. Cp ring), 4.33 (2H, d, J = 2.0 Hz, Hmeta Cp ring), 4.79 (2H, d, 
J = 2.0 Hz, Cortho Cp ring), 7.96 (1H, t, J = 6.0 Hz, NHCH2CH2-), 12.01 (1H, s, -COOH).  
 
N-ferrocenoyl-γ-aminobutyric acid (101)  
0.69g of 82 was used in the synthesis. 
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Yield 0.64g (94%), orange microcrystalline solid. 
1H-NMR (400MHz) δ (d6 DMSO):  1.81-1.83 (2H, m, NHCH2CH2-), 2.34 (2H, t, J = 5.6 Hz, 
NHCH2CH2CH2-), 3.17-3.18 (2H, m, NHCH2CH2-), 4.17 (5H, s, unsub. Cp ring), 4.33 (2H, d, J 
= 2.0 Hz, Hmeta Cp ring), 4.77 (2H, d, J = 2.0 Hz, Cortho Cp ring), 7.87 (1H, t, J = 5.6 Hz, 
NHCH2CH2-, 11.98 (1H, s, -COOH). 
 
N-ferrocenoyl-valeric acid (102) 
0.85g of 88 was used in the synthesis. 
1H-NMR (400MHz) δ (d6 DMSO):  1.50-1.60 (4H, m, -NHCH2CH2CH2CH2CO-), 2.40 (2H, t, J 
= 7.2 Hz, -CH2CH2CO-), 3.16-3.20 (2H, m, -NHCH2CH2-), 4.11 (5H, s, unsub. Cp ring), 4.37 
(2H, s, Hmeta Cp ring), 4.78 (2H, s, Hortho Cp ring), 7.99 (1H, t, J = 5.6 Hz, -NHCH-), 11.91 (1H, 
s, -COOH). 
 
N-Ferrocenoyl Monosubstituted Dipeptides 
  All yields reported are based on the input of ferrocene carboxylic acid.  For example, 
compound 103 was prepared via route 3, the reaction of the O-benzotriazole active ester of 
ferrocene carboxylic acid, 60, with the TFA salt of the dipeptide 93.  The yield for the 
preparation of 60 was 87% (Ch. 2 section 3.7), and the yield for the subsequent coupling to 93 
yielded the target molecule in 32% yield, giving an overall yield of 28%.  Similarly, preparation 
of 103 by route 7 was accomplished via the preparation (82%) and subsequent hydrolysis (97%) 
of 87, followed by coupling to (S-methyl)-L-cysteine methyl ester (81%), giving an overall yield 
of 64%.  Unless stated, all N-ferrocenoyl monosubstituted dipeptides were prepared by synthetic 
route 7. 
  
Route 1, General Procedure 
  1mmol of the appropriate dipeptide ester TFA salt and 0.23 (1mmol) of ferrocene carboxylic 
acid were added to a solution of 0.14g (1mmol) of 1-hydroxybenzotriazole, 0.19mls (1.2mmol) 
Et3N, and 0.24g (1.2mmol) of DCC in 10mls dichloromethane at 0˚C.  The reaction was raised 
to room temperature after 30mins, and allowed to proceed for 24 hrs.  The precipitated N,  N - 
dicyclohexylurea  was removed by filtration, and the solvent evaporated in vacuo.  The crude 
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product was purified by silica gel column chromatography, using a mobile phase of 2:1 
hexane/ethyl acetate. 
 
Route 2, General Procedure 
  1mmol of the appropriate dipeptide ester TFA salt and 0.23 (1mmol) of ferrocene carboxylic 
acid were added to a solution of 0.20g (1.2mmol) carbonyldiimidazole and 0.19mls (1.2mmol) 
Et3N, in dry tetrahydrofuran at 0˚C.  The reaction was raised to room temperature after 30mins, 
and allowed to proceed for 24 hrs.  The solvent evaporated in vacuo, and the crude product was 
eluted from a column of silica gel, using a mobile phase of 2:1 hexane/ethyl acetate. 
 
Route 3, General Procedure 
 1mmol of the appropriate dipeptide ester TFA salt was added to a solution of 60 (0.35g, 1mmol) 
and 0.19mls (1.2mmol) Et3N, in dichloromethane.  The reaction was allowed to proceed for 
24hrs, and the solvent evaporated in vacuo.  The crude product was purified by silica gel column 
chromatography, using a mobile phase of 2:1 hexane/ethyl acetate.       
 
Route 4, General Procedure 
   1mmol of the appropriate dipeptide ester HBr salt was added to a solution of 60 (0.35g, 
1mmol) and 0.19mls (1.2mmol) Et3N, in dichloromethane.  The reaction was allowed to proceed 
for 24hrs, and the solvent evaporated in vacuo.  The crude product was purified by silica gel 
column chromatography, using a mobile phase of 2:1 hexane/ethyl acetate.    
 
Route 5, General Procedure 
  3mmol of the appropriate amino acid and 0.69g (3mmol) of 60 was added to a solution of 0.42g 
(3mmol) of 1-hydroxybenzotriazole, 0.57mls (3.6mmol) Et3N, and 0.72g (3.6mmol) of DCC in 
30mls absolute methanol at 0˚C.  The reaction was raised to room temperature after 30mins, and 
allowed to proceed for 24 hrs.  The precipitated N,  N - dicyclohexylurea  was removed by 
filtration, and the N-ferrocenoyl amino acid was precipitated via the drop-wise addition of 0.5M 
HCl.   
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Route 6, General Procedure 
    1mmol of the appropriate N-ferrocenoyl amino acid (prepared via hydrogenation of the 
appropriate N-ferrocenoyl amino acid benzyl ester) and 1mmol of the appropriate amino acid 
ester hydrochloride salt were added to a solution of 0.14g (1 mmol) of 1-hydroxybenzotriazole, 
0.19mls (1.2mmol) Et3N, and 0.24g (1.2mmol) of DCC in 10mls dichloromethane at 0˚C.  The 
reaction was raised to room temperature after 30mins, and allowed to proceed for 24 hrs.  The 
precipitated N,  N - dicyclohexylurea  was removed by filtration, and the filtrate washed with 5% 
citric acid, saturated NaHCO3, and water.  The organic phase was then dried over MgSO4, and 
evaporated to dryness in vacuo, to afford the N-ferrocenoyl monosubstituted dipeptides as 
orange solids. 
 
Route 7, General Procedure 
  1mmol of the appropriate N-ferrocenoyl amino acid (prepared via hydrolysis of the appropriate 
N-ferrocenoyl amino acid alkyl ester) and 1mmol of the appropriate amino acid ester 
hydrochloride salt were added to a solution of 0.14g (1 mmol) of 1-hydroxybenzotriazole and 
0.24g (1.2mmol) of DCC in 10mls dichloromethane at 0˚C.  The reaction was raised to room 
temperature after 30mins, and allowed to proceed for 24 hrs.  The precipitated N,  N - 
dicyclohexylurea  was removed by filtration, and the filtrate washed with 5% citric acid, 
saturated NaHCO3, and water.  The organic phase was then dried over MgSO4, and evaporated 
to dryness in vacuo, to afford the N-ferrocenoyl monosubstituted dipeptides as orange solids.   
  
 
N-ferrocenoyl-((S-methyl) L-cysteine)2 methyl ester (103) 
0.35g of N-ferrocenoyl-(S-methyl)-L-cysteine and 0.19g of (S-methyl)-L-cysteine methyl ester 
hydrochloride were used in the synthesis.. 
Yields:  Route 1, 0.09g, (19%).  Route 2, 0.11g, (23%).  Route 3, 0.15g, (28%).  Route 4, 0.22g 
(41%).  Route 5, 0.13g  (9%).  Route 6, 0.25g (52%).  Route 7, 0.30 g (64%), orange solid, m.p. 
119-120°C.  
E1/2 0.175mV (Vs. Fc/Fc+), [α]D20 -25° (EtOH), UV-Vis (λmax) (EtOH): 306, 441 nm (ε = 182 M-
1 cm-1), I.R. υmax (KBr): 3280, 2917, 1749, 1656, 1627,1531, 1383, 1215, 819 cm-1. 
1H-NMR (400MHz) δ (d6 DMSO):  2.07 (3H, s, -SCH3), 2.16 (3H, s, -SCH3), 2.72-2.82 (2H, m, 
-CH2SCH3), 2.84-2.92 (2H, m, -CH2SCH3), 3.63 (3H, s, OCH3), 4.20 (5H, s, unsub. Cp ring), 
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4.35 (2H, s, Hmeta Cp ring), 4.50-4.55 (1H, m, -NHCH-), 4.68-4.73 (1H, m, -NHCH-), 4.86 (2H, 
s, Hortho Cp ring), 7.85 (1H, d, J = 8.0 Hz, -NHCH-), 8.56, 8.67 (1H, two doublets, J = 8.0 Hz, -
NHCH-). 
13C-NMR (100 MHz) δ (d6 DMSO):  15.53, 15.60, 35.31 (-ve DEPT), 35.73 (-ve DEPT), 51.99, 
52.22, 52.48, 68.63, 68.82, 69.84, 70.42, 76.43, 169.64, 171.38, 172.65. 
 
N-ferrocenoyl-(S-methyl)-L-cysteine-L-aspartic acid dimethyl ester (104) 
  0.35g of N-ferrocenoyl-(S-methyl)-L-cysteine and 0.20g of L-aspartic acid dimethyl ester 
hydrochloride were used in the synthesis. 
Yield 0.29g (59%), orange solid. m.p. 131-133°C.  
E1/2 = 0.170mV (Vs. Fc/Fc+), [α]D20 = - 18° (EtOH), (UV-Vis (λmax) (EtOH): 305, 443 nm (ε = 
220 M-1 cm-1), I.R. υmax (KBr):  3304, 1735, 1725, 1655, 1628, 1537, 1309, 1230, 818 cm-1.    
1H-NMR (400MHz) δ (d6 DMSO):  2.12 (1H, s, -SCH3), 2.51-2.91 (4H, m, -CH2SCH3 + -
CH2COOCH3), 3.60 (3H, s, OCH3), 3.62 (3H, s, OCH3), 4.21 (5H, s, unsub. Cp ring), 4.37 (2H, 
br. s, Hmeta Cp ring), 4.62-4.71 (2H, m, -NHCH- x 2) 4.86 (2H, s, 2Hortho Cp ring) 7.85 (1H, d, J 
= 8.8 Hz, NHCH-) 8.56, 8.64 (1H, two doublets, J = 8.0 Hz, NHCH-). 
13C-NMR (100 MHz) δ (d6 DMSO):  15.34, 35.63 (-ve DEPT), 35.76(-ve DEPT), 49.00, 51.82, 
51.92, 52.09, 52.61, 68.64, 69.85, 70.44, 76.19, 169.32, 169.58, 170.79, 171.30.   
 
N-ferrocenoyl-(L-methionine)2 methyl ester (105) 
   0.36 g of N-ferrocenoyl-L-methionine and 0.20g of L-methionine methyl ester hydrochloride 
were used in the synthesis. 
Yields:  Route 4, 0.20g (40%).  Route 7, 0.31 g, (62%), orange solid. m.p. 119-120°C.  
E1/2 0.167mV (Vs. Fc/Fc+), [α]D20 -21° (EtOH), UV-Vis (λmax) (EtOH): 260, 306, 444 nm (ε = 
196 M-1 cm-1), I.R. υmax (KBr): 3285, 2917, 1746, 1656, 1626,1538, 1214, 1107, 820 cm-1.   
1H-NMR (400MHz) δ (d6 DMSO): 1.83-2.09 (10H, m, -CH2SCH3 x 2), 2.53-2.59 (4H, m, -
CH2CH2SCH3 x 2), 3.64 (3H, s, -OCH3), 4.18 (5H, s, unsub. Cp ring), 4.36 (2H, s, Hmeta Cp 
ring), 4.41-4.46 (2H, m, NHCH-), 4.89 (2H, s, Hortho Cp ring), 7.75-7.80 (1H, m, NHCH), 8.39-
8.46 (1H, m, NHCH).   
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13C-NMR (100 MHz) δ (d6 DMSO): 14.47, 15.01, 15.07, 29.86 (-ve DEPT), 30.25 (-ve DEPT), 
30.78 (-ve DEPT), 31.56 (-ve DEPT), 51.23, 52.13, 52.34, 68.70, 68.77, 70.40, 70.57, 76.17, 
169.53, 169.61, 172.60.  
 
N-ferrocenoyl-L-methionine-L-tyrosine methyl ester (106) 
  0.36g of N-ferrocenoyl-L-methionine and 0.23g of L-tyrosine methyl ester hydrochloride were 
used in the synthesis.  
Yield 0.34g (63%), orange solid, m.p. 119-120°C.  
E1/2 0.162mV (Vs. Fc/Fc+), [α]D20 -20° (EtOH), UV-Vis (λmax) (EtOH): 305, 443 nm (ε = 174 M-
1 cm-1), I.R. υmax (KBr): 3277, 2918, 1744, 1655, 1638, 1542, 1401, 1220, 825 cm-1. 
1H-NMR (400MHz) δ (d6 DMSO):  1.94-2.09 (5H, m, -CH2SCH3), 2.53-2.58 (2H, m, - 
CH2CH2SCH3), 2.79 (2H, m, -NHCH(CH2PhOH), 3.40 (3H, s, OCH3), 4.17 (5H, s, unsub. Cp 
ring), 4.34-4.44 (3H, m, Hmeta Cp ring, -NHCH-), 4.54-4.59 (1H, m, -NHCH-), 4.88 (2H, br. s, 
Hortho Cp ring), 6.50 (2H, d, J = 8.0 Hz, ArH), 7.00 (2H, d, J = 8.0 Hz, ArH), 7.72, 7.76 (1H, two 
doublets, J = 8.0 Hz, -NHCH-), 8.28, 8.36 (1H, two doublets, J = 8.0 Hz, -NHCH-), 9.21 (1H, s, 
PhOH). 
13C-NMR (100 MHz) δ (d6 DMSO):  15.04, 30.21 (-ve DEPT), 31.56 (-ve DEPT), 36.15 (-ve 
DEPT), 51.95, 52.12, 54.36, 68.58, 68.87, 69.72, 70.04, 76.21, 115.42, 127.25, 130.35, 156.37, 
169.48, 172.18, 172.32. 
 
N-ferrocenoyl-L-methionine-L-threonine methyl ester (107) 
  0.36g of N-ferrocenoyl-L-methionine and 0.17g of L-threonine methyl ester hydrochloride were 
used in the synthesis. 
Yield 0.27g (60%), orange solid, m.p 138-141°C. 
E1/2 = 0.166mV (Vs. Fc/Fc+), [α]D20 -24° (EtOH), UV-Vis (λmax) (EtOH): 306, 440 nm (ε = 199 
M-1 cm-1), I.R. υmax (KBr): 3277, 2198, 1744, 1654, 1638, 1542, 1401, 1221, 825 cm-1. 
1H-NMR (400MHz) δ (d6 DMSO):  1.05, 1.10 (3H, two doublets, J = 6.4 Hz, -CH(OH)CH3), 
1.92-2.08 (5H, m, -CH2SCH3), 2.53-2.57 (2H, m, - CH2CH2SCH3), 3.63 (3H, s, OCH3), 4.14-
4.19 (6H, m, -CH(OH)CH3), unsub. Cp ring), 4.30-4.32 (1H, m, -NHCH-), 4.36 (2H, s, Hmeta Cp 
ring), 4.61-4.65 (1H, m, -NHCH-), 4.89 (1H, s, Hortho Cp ring), 4.91 (1H, s, Hortho Cp ring), 5.09 
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(1H, d, J = 5.6 Hz, -CH(OH)CH3), 7.86 (1H, d, J = 8.0 Hz, -NHCH-), 7.92 (1H, d, J = 8.8 Hz, -
NHCH-). 
13C-NMR (100 MHz) δ (d6 DMSO):  15.04, 20.54, 30.38 (-ve DEPT), 31.62 (-ve DEPT), 52.23, 
58.01, 58.12, 66.54, 68.65, 68.78, 69.73, 70.44, 76.25, 169.64, 171.31, 172.56. 
 
N-ferrocenoyl-L-tyrosine-(S-methyl)-L-cysteine methyl ester (108) 
  0.39g of N-ferrocenoyl-L-tyrosine and 0.19g of (S-methyl)-L-cysteine methyl ester 
hydrochloride were used in the synthesis. 
Yield 0.30g (57 %), orange solid, m.p 121-125°C. 
E1/2 = 0.180mV (Vs. Fc/Fc+), [α]D20 -19° (EtOH), UV-Vis (λmax) (EtOH): 302, 441 nm(ε = 178 
M-1 cm-1), I.R. υmax (KBr): 3277, 2365, 1752, 1657, 1625, 1516, 1439, 1221, 823 cm-1. 
1H-NMR (400MHz) δ (d6 DMSO):  2.09 (3H, s, -SCH3), 2.82-2.99 (4H, m, -CH2PhOH, -
CH2SCH3), 3.65 (3H, s, OCH3), 3.96 (5H, s, unsub. Cp ring), 4.30 (2H, s, Hmeta Cp ring), 4.51-
4.54 (1H, m, -NHCH-), 4.70-4.74 (3H, m, Hortho Cp ring, -NHCH-), 6.67 (2H, d, J = 7.6 Hz, 
ArH), 7.20 (2H, d, J = 7.6 Hz, ArH), 7.76 (1H, d, J = 8.0 Hz, -NHCH-), 8.56 (1H, d, J = 8.0 Hz, 
-NHCH-), 9.13 (1H, s, PhOH). 
13C-NMR (100 MHz) δ (d6 DMSO):  15.64, 34.93(-ve DEPT), 36.64(-ve DEPT), 52.29, 52.47, 
54.52, 68.20, 68.93, 69.69, 70.25, 76.24, 115.20, 128.79, 130.42, 156.09, 169.30, 171.51, 172.65. 
 
N-ferrocenoyl -(β-alanine)2 methyl ester (109) 
  0.30g of N-ferrocenoyl- β-alanine and 0.14g of β-alanine methyl ester hydrochloride were used 
in the synthesis. 
Yields:  Route 4, 0.12g (34%).  Route 7, 0.21g, (58%), orange solid, m.p. 150-151°C. 
E1/2 = 0.160mV (Vs. Fc/Fc+), UV-Vis (λmax) (EtOH): 268, 304, 442 nm (ε =187 M-1 cm-1), I.R. 
υmax (KBr): 3257, 3083, 2931, 1741, 1664, 1614, 1552, 1314, 1107 cm-1.   
1H-NMR (400MHz) δ (d6 DMSO): 2.35 (2H, t, J = 6.8 Hz, NHCH2CH2CO-), 2.46 (2H, t, J = 
6.8 Hz, NHCH2CH2CO-), 3.26-3.34 (4H, m, NHCH2CH2CO X 2), 3.56 (3H, s, -OCH3), 4.15 
(5H, s, unsub. Cp ring), 4.32 (2H, s, Hmeta Cp ring), 4.76 (2H, s, Hortho Cp ring), 7.79 (1H, t, J = 
6.4 Hz, (NHCH2CH2-), 8.05 (1H, t, J = 6.4 Hz, NHCH2CH2-). 
 13C-NMR (100 MHz) δ (d6 DMSO): 34.02 (-ve DEPT), 34.97 (-ve DEPT), 35.79 (-ve DEPT), 
35.89 (-ve DEPT), 51.73, 68.44, 69.69, 70.20, 76.95, 169.28, 170.94, 172.11.  
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N-ferrocenoyl-(γ-aminobutyric acid)2 methyl ester (110) 
  0.32g of N-ferrocenoyl-γ-aminobutyric acid and 0.15g of γ-aminobutyric acid methyl ester 
hydrochloride were used in the synthesis. 
Yields:  Route 4, 0.15g (36%). Route 7, 0.25 g, (60%), orange solid, m.p. 150-151°C. 
E1/2 = 0.155mV (Vs. Fc/Fc+), UV-Vis (λmax) (EtOH): 306, 442 nm (ε = 187 M-1 cm-1), I.R. υmax 
(KBr): 3329, 3248, 3070, 2935, 2120, 1735, 1661, 1619, 1551, 1445, 1174, 824 cm-1. 
1H-NMR (400MHz) δ (d6 DMSO): 1.65-175 (4H, m, NHCH2CH2CH2CO X 2), 2.12 (2H, t, J = 
7.6 Hz, NHCH2CH2CH2-), 2.31 (2H, t, J = 7.6 Hz, NHCH2CH2CH2-), 3.03-3.07 (2H, m, 
NHCH2CH2-), 3.13-3.18 (2H, m, NHCH2CH2-), 3.58 (3H, s, -OCH3), 4.15 (5H, s, unsub. Cp 
ring), 4.35 (2H, d, J = 2.0 Hz, Hmeta Cp ring), 4.77 (2H, d, J = 2.0 Hz, Hortho Cp ring), 7.83 (1H, 
t, J = 6.4 Hz, NHCH2CH2-), 7.89 (1H, t, J = 6.4 Hz, NHCH2CH2-).  
13C-NMR (100 MHz) δ (d6 DMSO): 24.89 (-ve DEPT), 26.08 (-ve DEPT), 31.05 (-ve DEPT), 
33.31 (-ve DEPT), 38.09 (-ve DEPT), 38.83 (-ve DEPT), 51.61, 68.44, 69.65, 70.16, 77.14, 
169.16, 172.22, 173.47.   
 
 
N-ferrocenoyl-(valeric acid)2 methyl ester (111) 
  0.36g of N-ferrocenoyl valeric acid-OH and 0.17g of valeric acid methyl ester hydrochloride 
were used in the synthesis. 
Yield 0.22g (52%), orange solid, m.p. 154-155°C. 
E1/2 = 0.151V (Vs. Fc/Fc+), UV-Vis (λmax) (EtOH): 302, 441 nm (ε = 187 M-1 cm-1). 
1H-NMR (400MHz) δ (d6 DMSO):  1.32-1.57 (8H, m, -NHCH2CH2CH2CH2CO- x 2), 2.09 (2H, 
t, J = 7.6 Hz, -CH2CH2CO-), 2.28 (2H, t, J = 7.6 Hz, -CH2CH2CO-), 3.00-3.01 (2H, m, -
NHCH2CH2-), 3.15 (2H, t, J = 6.0 Hz, -NHCH2CH2-), 3.57 (3H, s, -OCH3), 4.15 (5H, s, unsub. 
Cp ring), 4.33 (2H, br. s, Hmeta Cp ring), 4.76 (2H, s, Hortho Cp ring), 7.76-7.80 (2H, m, NHCH- x 
2). 
13C-NMR (100 MHz) δ (d6 DMSO):  22.23 (-ve DEPT), 23.23 (-ve DEPT), 24.82 (-ve DEPT), 
25.67 (-ve DEPT), 28.94 (-ve DEPT), 33.70 (-ve DEPT), 38.27 (-ve DEPT), 38.76 (-ve DEPT), 
51.54, 68.42, 69.62, 70.12, 77.25, 169.00, 172.20, 173.61. 
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Chapter IV 
 
The Synthesis and Characterisation 
of 1, 1’-N-Ferrocenoyl Symmetric 
Dipeptides 
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4.1:  Introduction 
  Introduction of functional groups on both Cp rings of ferrocene is a well established area of 
chemical synthesis, although in some cases, more difficult to achieve than mono substitution.  
For example, due to the electronic communication between the two Cp rings via the central iron 
atom, the introduction of an electron-withdrawing group onto one ring can significantly 
deactivate the second ring towards electrophilic aromatic substitution [1]. 
  Developing conformationally constrained molecules which mimic elements of protein 
secondary structure, i.e. the α-helix, the β-turn, and β-sheet, has been a target of researchers in 
the last twenty years, as these structural motifs have important implications in terms of biological 
function [2].  The β-sheet mimetics have proven the most difficult to obtain, primarily because of 
aggregation problems in solution [3].  Although attempts at overcoming these problems have 
been addressed by the use of square planar copper complexes and dibenzofuran based amino 
acids, the ferrocene moiety offers a unique advantage in this respect, as its inter-ring separation 
of 3.3Å is close to the N-O separation in hydrogen-bonded β-sheets.   This fact has been 
exploited by those groups which have prepared compounds such as 51-53 (section 1.3) [4, 5].  In 
all literature reports, the electrochemical and spectroscopic properties of the disubstituted 
ferrocenes vary greatly with respect to monosubstituted analogues.  
   
4.2:  Synthesis of 1, 1’-N-Ferrocenoyl Symmetric Dipeptides 
  Three different coupling reagents were employed during the synthesis of these compounds, in 
an attempt to optimise the yields.  Despite the difference in reaction stoichiometry employed 
when preparing disubstituted ferrocenes, yields similar to that recorded for the monosubstituted 
derivatives were recorded. 
 
4.2.1:  Synthetic Route 1 
  The first attempt at preparation of these compounds involved the use of the DCC/HOBt 
coupling protocol and ferrocene dicarboxylic acid (112), and the same methodology was 
employed as was used in the synthesis of the monosubstituted compounds discussed in the 
previous two chapters.  The reactions were quenched in all cases after 24 hours, and carried out 
in the dark, as it was believed that these disubstituted ferrocenes might undergo photochemical 
decomposition.  Scheme 1 shows the preparation of 131 by this method.  Interestingly, all the 
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chromophoric bands which were eluted from the column before the isolation of 131 were seen to 
quickly decompose in solution.  No mono- or di- substituted ferrocenoyl-OBt intermediate was 
isolated (there are reports of the former in the literature [6], though the latter could not be found), 
which would suggest that the bis-OBt intermediates are considerably less stable in solution than 
the monosubstituted 60 (section 2.4.2).   
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Scheme 1:  Preparation of 131 using the DCC/HOBt protocol. 
 
4.2.2:  Synthetic Route 2 
  CDI had been employed successfully in the preparation of several monosubstituted ferrocenes 
(section 2.4.2), and it was thought that it could be used to the same effect when preparing the 
disubstituted analogues in a similar manner.  The reactions were carried out in the dark, and the 
temperature was maintained at < 15˚C throughout.  However, attempts to synthesize 116 and 131 
using this route were unsuccessful, and the target molecules were not recovered from the 
reaction mixtures.  TLC analysis, performed at various intervals during the course of the 
reactions, showed that the desired products were not formed at any stage. 
  This may possibly be attributable to the formation of a bis-imidazole intermediate when using 
CDI in conjunction with ferrocene dicarboxylic acid (fig. 1). It will be recalled mono-imidazolic 
ferrocenoyl conjugate (section 2.4.2) was found to decompose readily in solution, and this 
inherent instability could be accentuated by bis substitution.  Certainly, no reports of a bis-
ferrocenoyl-imidazolic conjugate could be found in the literature.  
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Fig. 1: Bis-imidazole intermediate, whose formation and instability may limit the use of CDI as a 
coupling reagent for 1, 1’-disubstituted ferrocenes 
 
  It may also explain why, during the course of these experiments, the only amino acid ester 
which failed to yield the desired coupled product with ferrocene dicarboxylic acid, (112), was L-
histidine methyl ester.  It will be recalled from section 2.8 that a ferrocenoyl-imidazolic adduct, 
80, was formed during preparation of compound 74.  It is possible that a bis-ferrocenoyl-
imidazolic intermediate may have resulted in decomposition, and hence failure to yield the target 
molecule. 
 
4.2.3:  Synthetic Route 3 
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Scheme 2:  Preparation of 123 using TBTU as the coupling reagent 
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  TBTU had been successfully employed in the synthesis of the monosubstituted compounds.  
113 and 131 were both prepared using this reagent, and the yields of these compounds were 
almost identical to that recorded when DCC/HOBt were used.  Given the expensive nature of 
TBTU, it would appear that DCC is a wiser choice of coupling reagent in the preparation of these 
disubstituted ferrocenes.  The synthesis of 131 is shown in scheme 2:  
 
Compound Name M.P. (ºC) Yield (%)
113 1, 1’-N-ferrocenoyl-(L-norleucine methyl ester)2  180-182 73 
114 1, 1’-N-ferrocenoyl-(L-aspartic acid dimethyl ester)2 198-200 68 
115 1, 1’-N-ferrocenoyl-(L-phenylalanine methyl ester)2 211-213 72 
116 1, 1’-N-ferrocenoyl-(L-methionine methyl ester)2 220-223 73 
117 1, 1’-N-ferrocenoyl-(2-isoaminobutyric acid methyl ester)2 201-203 66 
118 1, 1’-N-ferrocenoyl-(L-leucine methyl ester)2 217-220 70 
119 1, 1’-N-ferrocenoyl- ((S-methyl)-L-cysteine methyl ester) 2 186-187 78 
120 1, 1’-N-ferrocenoyl-(L-phenylglycine methyl ester)2. 200-203 72 
121 1, 1’-N-ferrocenoyl-(L-glutamic acid diethyl ester)2 154-157 68 
122 1, 1’-N-ferrocenoyl-(L-threonine methyl ester)2 189-192 76 
123 1, 1’-N-ferrocenoyl-(L-tyrosine methyl ester)2 219-221 69 
124 1, 1’-N-ferrocenoyl-((1S, 2R)-(+)- norephedrine) 2 199-201 74 
125 1, 1’-N-ferrocenoyl-(L-tryptophan methyl ester)2 167-169 64 
126 1, 1’-N-ferrocenoyl-(glycine ethyl ester)2 213-215 71 
127 1, 1’-N-ferrocenoyl- (β-alanine methyl ester)2 146-148 68 
128 1, 1’-N-ferrocenoyl-(γ-aminobutyric acid methyl ester)2 131-132 68 
129 1, 1’-N-ferrocenoyl-(valeric acid methyl ester)2 161-163 65 
130 1, 1’-N-ferrocenoyl-[(glycine)2 ethyl ester]2 227-229 66 
131 1, 1’-N-ferrocenoyl-(L-norvaline ethyl ester)2  168-170 70 
132 1, 1’-N-ferrocenoyl-(L-serine methyl ester)2 168-170 67 
133 1, 1’-N-ferrocenoyl-(sarcosine ethyl ester)2 91-93 67 
 
Table 1:  % Yields and melting points of 1, 1’-N-ferrocenoyl symmetric dipeptides 
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A summary of the yields of the various compounds prepared in this chapter, using synthetic route 
1, is given in table 1. 
 
4.3:  1H-NMR Spectra of 1, 1’-N-Ferrocenoyl Symmetric Dipeptides 
  There are significant differences in the 1H-NMR spectra of all compounds prepared in this 
chapter relative to their monosubstituted analogues.  The most obvious is the absence in the 
spectra of the unsubstituted Cp ring proton signal ca. 4.2 ppm.  There also appears to be 
equivalence by symmetry of the amino acid residues attached to each Cp ring, with all signals in 
the spectra integrating for multiples of two.  This equivalence extends to both the ferrocenoyl 
and amide protons, and recording the spectra in both DMSO and CDCl3, allows for elucidation 
of the conformation adopted by these molecules in solution.  A summary of the 1H-NMR data for 
the 1’1 N-ferrocenoyl symmetric dipeptides is given in table 2. 
 
Compound N-H Hortho Hmeta Hα 
113 8.17(d) 4.84, 4.87 4.31-4.38 4.31-4.38 
114 8.30 (d) 4.80, 4.82 4.37 4.75 
115 8.34(d) 4.49, 4.68 4.10 4.68 
116 8.22(d) 4.82, 4.87 4.38, 4.43 4.50-4.54 
117 8.09(s) 4.79 4.40 - 
118 8.18(d) 4.83 4.43 4.35 
119 8.28(d) 4.86, 4.89 4.41, 4.44 4.58-4.59 
120 8.56(d) 4.90 4.35, 4.39 5.58 
121 8.16(d) 4.83, 4.89 4.38, 4.43 4.38 
122 7.62(d) 4.87, 4.97 4.50 4.50 
123 8.32(d) 4.48, 4.68 4.13, 4.18 4.53-4.59 
124 7.72(d) 4.60, 4.66 4.08-4.14 4.08-4.14 
125 8.22(d) 4.51, 4.65 4.01, 4.06 4.67-4.73 
126 8.31(t) 4.83 4.44 - 
127 7.99(t) 4.70 4.28 - 
128 7.94(t) 4.72 4.39 - 
129 7.73(t) 4.72 4.34 - 
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Compound N-H Hortho Hmeta Hα 
130 8.42(t), 8.60(t) 4.79 4.43 - 
131 8.12(d) 4.82, 4.87 4.37, 4.43 4.32-4.36 
132 7.94(d) 4.83, 4.93 4.41-4.45 4.41-4.45 
133 - 4.76 4.50 - 
 
Table 2:  The 1H-NMR chemical shifts (δ ppm) of the 1, 1’-N-ferrocenoyl symmetric dipeptides 
recorded in d6 DMSO. 
 
4.3.1 1H-NMR Spectrum of 131. 
  The 1H-NMR spectrum of 131 is shown in fig. 2, and is typical of those 1, 1’-symmetrically 
disubstituted dipeptides containing chiral centres, and serves to illustrate the symmetrical nature 
of the conformation adopted by these compounds in solution, with all signals observed in the 
spectrum integrating for multiples of two. 
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Fig. 2:  The 1H-NMR Spectrum of 131 in d6 DMSO. 
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  Two triplets, each integrating for six protons, are observed at 0.89 and 1.22 ppm, and   
correspond to the methyl groups of the norvaline side chains and ethyl ester groups respectively.  
Two multiplets, each integrating for four protons, appear ca. 1.4 and 1.75 ppm, and correspond 
to the two methylene groups of each norvaline side chain.  The methylene protons of the ethyl 
ester groups appear as a quartet at 4.11 ppm, and the protons of each of the chiral α-carbons 
appear as a multiplet at 4.34 ppm.  What is apparent from these results is that corresponding 
protons of each Cp ring substituent are in the same magnetic environment, an observation which 
can be expanded upon when other spectroscopic data is considered in subsequent sections. 
 
 
 
 
Fig. 3:  The ferrocenoyl protons of 63 (left), and 131 (right).  The unsubstituted Cp ring protons 
ca. 4.2 ppm in the spectrum of 63 are absent from the spectrum of 131, in which two separate 
meta-proton signals are observed. 
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  An interesting contrast can be drawn between the ferrocenoyl protons of 131, and those of the 
monosubstituted analogue 63, as illustrated in fig. 3.  While the unsubstituted Cp ring protons are 
naturally absent from the spectrum of 131, the meta-protons of each Cp ring appear as two 
individual singlets at 4.37 and 4.43 ppm, each integrating for two protons (the former of these 
overlaps with the protons of the α-carbons, which is also observed in the spectrum of 63).  The 
ortho-protons of the Cp rings appear as two closely grouped singlets, each integrating for two 
protons, at 4.82 and 4.87 ppm. 
  There are two possible explanations for this pattern of signals for the ferrocenoyl protons of 
131.  The first is that there may be a magnetic non-equivalence between the two Cp rings, and 
each singlet may correspond to two protons from the same Cp ring.  The second is that each of 
the four ferrocenoyl resonances, all of which integrate for two protons, is composed of a proton 
from each Cp ring.  The latter explanation would seem more likely, given the previously 
discussed symmetrical aspects of the 1H-NMR spectrum of 131.  The effect of an adjacent chiral 
centre on the magnetic equivalence of the ferrocenoyl protons (discussed in Ch. 2, section 3.3.1), 
would appear to extend to the meta-protons of the Cp ring in these disubstituted compounds. 
   Only one doublet is observed for the two amide protons, at 8.12 ppm, which is slightly more 
downfield than the resonance observed for the monosubstituted analogue 63 (7.97 ppm).  Unlike 
63, however, the amide protons of 131 appear at almost the exact same downfield shift when the 
spectrum is recorded in CDCl3 (8.10 ppm for 131 vs. 6.34 for 63).  A similar situation is 
observed for the majority of the 1, 1’-symmetrically disubstituted ferrocenoyl dipeptides, 
suggesting that an ordered conformation is adopted by these compounds in non-polar solution, 
via the information of intra-molecular hydrogen bonds.  This topic is discussed further in 
subsequent sections, when other spectroscopic data is taken into account.      
 
4.3.2:  1H-NMR Spectra of 126-129. 
   The achiral compounds 126-129 (fig. 4) vary only in terms of the number of methylene groups 
in their peptide backbones (and of the ester group in the case of 126).  The 1H-NMR spectrum of 
127, recorded in d6 DMSO, is typical of these compounds, and is shown in fig. 5.     
    As was observed with the chiral 1, 1’-disubstituted compounds, the spectrum of 128 appears to 
adopt a symmetrical conformation in solution, with all signals integrating for multiplets of two.  
The protons of the central methylene group of the peptide chains are observed as a multiplet at 
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1.77 ppm.  A triplet, integrating for four protons, and corresponding to the methylene protons 
adjacent to the ester groups, appears at 2.39 ppm, while the methylene protons adjacent to the 
amide groups are observed as a multiplet at 3.19 ppm.  The methyl protons of each ester group 
appear as a singlet, integrating for six protons, at 3.62 ppm. 
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Fig. 4:  The structures of compounds 126-129. 
 
 Fig. 5:  The 1H-NMR Spectrum of 128 in d6 DMSO. 
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  In the absence of chiral centres, only two signals are observed for the ferrocenoyl protons.  All 
four of the meta-protons appear as a singlet at 4.28 ppm, while the four ortho-protons are 
observed as a singlet at 4.70 ppm.  This is in direct contrast to the chiral 1, 1’-disubstituted 
compounds, where four ferrocenoyl proton signals are observed, and this contrast is illustrated in 
fig. 6, which shows the ferrocenoyl protons of both 128 and the chiral 119. 
 
 
 
Fig. 6:  Comparison of the ferrocenoyl proton signals of the chiral 119 (left) and achiral 128 
(right) in d6 DMSO. 
 
  The two amide protons of 128 appear as a triplet at 7.94 ppm in d6 DMSO.  Similar chemical 
shifts were recorded for compounds 126, 127 and 129, suggesting that the ability of these 
compounds to adopt a symmetrical conformation in solution is independent of the length of the 
peptide backbone. 
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4.3.3:  1H-NMR Spectrum of 130. 
  The 1H-NMR spectrum of the tetrapeptide 130, 1, 1’-N-ferrocenoyl-[(glycine)2 ethyl ester]2, is 
shown in fig. 7.   The methyl protons of both ester groups appear as a triplet integrating for six 
protons at 1.20 ppm, while the methylene protons of the peptide backbone appear as doublets at 
3.84 and 3.92 ppm, both integrating for four protons.  The methylene protons of both ester 
groups appear as a quartet at 4.11 ppm.  Only two singlets are observed for the ferrocenoyl 
protons, at 4.43 (meta-) and 4.79 ppm (ortho-).   
 
 
 
Fig. 7:  The 1H-NMR Spectrum of 130 in d6 DMSO. 
 
  Two triplets, each integrating for two protons, appear at 8.42 and 8.60 ppm, corresponding to 
the amide protons.  However, when the spectrum of 130 was recorded in CDCl3, a different 
pattern of signals emerges, as can be seen in fig. 8.  The amide protons of the compounds 
discussed so far in this chapter remain largely unaffected in terms of their chemical shifts, 
whether their spectra is recorded in d6 DMSO or CDCl3.  130, however, shows two amide 
signals in CDCl3, at 6.57 and 8.19 ppm.  As was mentioned in section 2.5, in non-polar solution, 
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hydrogen bonded amide protons tend to appear above 7.5 ppm, while non-hydrogen bonded 
amide protons appear at lower ppm [7].  It would appear that the conformation adopted by 130 in 
non-polar solution only allows for the formation of β-sheet-like hydrogen bonding involving the 
amide groups adjacent to the ferrocenoyl moiety (N-terminal).  The protons of the C-terminal 
amide groups may be incapable of forming intra-molecular hydrogen bonds for steric reasons.   
 
 
 
 
 
Fig. 8:  The ferrocenoyl protons of 130 in d6 DMSO (left) and CDCl3 (right). 
 
 
 
 
Fig. 9:  Intra-molecular hydrogen bonding of 130 in non-polar solution.  The C-terminal amide 
protons do not form such bonds.  
 
 146
4.3.4:  1H-NMR Spectrum of 124 
  Compound 124 (fig. 10) is unusual in that it is derived from (1S, 2R)-(+)- norephedrine, and 
hence does not include any ester groups.  In d6 DMSO, the amide protons of 124 appear at 7.72 
ppm, while in CDCl3, these protons appear at 6.49 ppm, and hence would appear incapable of 
forming the hydrogen bonds typical of the compounds discussed so far in this chapter.  
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Fig. 10: the 1, 3 conformation adopted by 124 in solution 
 
  This observation would suggest that the oxygen atoms of the ester groups function as donors in 
the intra-molecular hydrogen bonding in the 1, 1’-disubstituted dipeptides, and that the hydroxy 
groups of 124 are unable to fulfil a similar function.  It would also suggests that 124 is likely to 
exists in a 1, 3 conformation in solution, rather than the 1, 1’-conformation adopted by those 
compounds with β-sheet like structures.   
 
4.4:  13C-NMR Spectrum of 1, 1’-N-Ferrocenoyl Symmetric Dipeptides 
  As was inferred from the 1H-NMR data recorded for these compounds, where all signals 
integrate for multiples of two, the 13C-NMR spectra also suggest a symmetrical conformation in 
solution, with a maximum of one signal per two carbon atoms being observed.  For example, 119 
contains twenty-two carbon atoms, and eleven signals are present in its 13C-NMR spectrum.  
Similarly, 131 contains twenty six carbon atoms, and thirteen signals are present in its spectrum.   
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  A very similar pattern of signals is observed in the 13C-NMR spectra of the chiral 1, 1’-N-
ferrocenoyl symmetric dipeptides in terms of the ferrocenoyl carbons as well as those of the 
amide and ester carbonyl carbons.  In all cases, two ortho-carbon signals (ca. 70ppm), two meta-
carbon signals (ca. 72 ppm), and one ipso-carbon signal (ca. 77ppm) are observed.  This data is 
summarised in table 3. 
  
Compound C=Oamide C=Oester Cortho Cmeta Cipso 
113 169.48 173.45 69.63, 70.86 72.19, 72.29 77.13
114 168.96 171.02/171.72 69.91, 70.07 72.62, 72.66 76.71
115 169.60 172.76 68.79, 71.74 71.85, 72.32 76.93
116 169.73 173.07 69.67, 70.83 72.30, 72.46 76.93
117 169.02 174.90 70.36 72.03 77.19
118 169.50 173.76 69.50, 70.95 72.14, 72.23 77.12
119 169.35 171.88 69.73, 70.62 72.55, 72.69 76.92
120 169.32 171.56 69.96, 70.87 72.32, 72.46 76.71
121 169.50 172.37/172.58 69.76, 70.53 72.31, 72.46 76.97
122 169.65 171.67 70.01, 70.18 72.62, 72.71 76.89
123 169.85 172.91 68.75, 71.78 72.05, 72.32 76.95
124 168.14 - 68.97, 71.20 71.38, 71.75 78.21
125 169.54 173.18 69.03, 71.37 71.80, 72.23 76.91
126 169.53 170.59 69.98 72.51 77.00
127 169.05 172.31 69.88 72.05 77.81
128 168.78 173.57 69.82 71.80 78.28
129 167.68 173.69 69.86 73.11 78.87
130 169.32, 169.99 171.17 70.31 71.73 76.98
131 169.49 173.07 69.75, 70.73 72.10, 72.28 77.15
132 169.28 171.61 70.07, 70.29 72.48, 72.52 76.89
133  169.69  72.34 77.62
 
Table 3:  The 13C-NMR chemical shifts (δ ppm) of the 1, 1’-N-ferrocenoyl symmetric dipeptides 
recorded in d6 DMSO. 
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4.4.1:  13C-NMR Spectrum of 131 
  The 13C-NMR spectrum of 131 is shown in fig.11.  Two signals, corresponding to the methyl 
carbons of the side chains and ethyl ester groups, appear at 13.78 and 14.47 ppm respectively, 
while the methylene carbons of the side chains appear at 29.29 and 32.70 ppm, both of which are 
seen as negative peaks in the 135DEPT spectrum (fig. 12).    The chiral α-carbon is observed at 
52.34 ppm, while the methylene carbons of the ethyl ester groups appear at 60.86 ppm. 
  In common with all the chiral 1’1 N-ferrocenoyl symmetric dipeptides discussed in this chapter, 
the five resonances for the ten ferrocenoyl carbons of 131 are observed in its 13C-NMR spectrum, 
the ortho-carbons at 69.75 and 70.73, the meta-carbons at 72.10 and 72.28 ppm, with the ipso-
carbons at 77.15 ppm.  A comparison between this pattern of signals, and that recorded in the 
case of the monosubstituted analogue 63, is illustrated in fig. 13.   
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Fig. 11:  The 13C-NMR Spectrum of 131 in d6 DMSO. 
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Fig. 12:  The 135DEPT Spectrum of 131 in d6 DMSO. 
 
 
 
Fig. 13: The ferrocenoyl carbon resonances of 63 (left) and 131 (right). 
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  The 13C-NMR spectrum of 63 shows two closely spaced ortho-carbon signals at 69 ppm, the 
unsubstituted Cp ring carbons at 70 ppm, two closely spaced meta-carbon signals at 71 ppm, and 
the ipso-carbon signal ca. 76 ppm.  What is noticeable from the comparison of these spectra is 
the spacing of the ortho-carbon signals, which, in the case of 63, are ca. 0.2 ppm apart, while the 
difference in chemical shift is in the spectrum of 131 is ca. 1 ppm.  Clearly, the adjacent chiral 
centre has a greater effect on the magnetic environment of these carbons in 131 than in 63.  The 
quaternary carbons of the amide and ester groups appear as signals at 169.49 and 173.07 ppm 
respectively. 
 
4.4.2:  13C-NMR Spectra of 126-129 
  The 13C-NMR spectrum of 128 is shown in fig. 14.  The methylene carbons of the peptide 
backbone appear as signals at 25.01, 31.09, and 38.43 ppm, while a resonance for methyl 
carbons of the ester groups is seen at 51.64 ppm.   
 
 
 
 
Fig. 14:  The 13C-NMR Spectrum of 128 in d6 DMSO. 
 
 151
  The pattern of signals corresponding to the ferrocenoyl carbons is typical of the achiral 
disubstituted ferrocenes 126-129, with only three signals being observed, with an ortho-carbon 
signal at 69.82 ppm, a meta-carbon signal at 71.80 ppm, and the ipso-carbon signal at 78.28 ppm.   
The fact that all four ortho-carbons appear as one signal shows not only the symmetrical nature 
of the conformation adopted by 128 in solution, but also further demonstrates the effect of an 
adjacent chiral centre, as discussed in the previous section.  This is illustrated in fig. 15, which 
compares the ferrocenoyl carbon resonances of 128, and the chiral 119.   
 
 
 
 
Fig. 15: The ferrocenoyl carbon resonances of 119 (left) and 128 (right). 
 
4.5:  InfraRed Spectra of 1, 1’-N-Ferrocenoyl Symmetric Dipeptides 
A summary of the infrared data recorded for compounds 113-133 is given in table 4. 
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 Compound υN-H  υCOOR υCONR υN-H (CH2Cl2) 
113 3294 1735 1630 3349 
114 3302 1739, 1721 1638 3371 
115 3285 1740 1632 3362 
116 3294 1741 1630 3343 
117 3326 1742 1627 3361 
118 3326 1742 1633 3349 
119 3292 1737 1629 3367 
120 3315  1637 3384 
121 3332 1720, 1735  3335 
122 3361  1635 3366 
123 3365 1721 1638 3353 
124 3328 - 1628 3411 
125 3383 1766 1629 3358 
126 3351 1732 1633 3368 
127 3292 1737 1633 3354 
128 3327 1729 1629 3351 
129 3365 1731 1641 3363 
130 3300, 3344 1747 1612, 1638 3367, 3409 
131 3294 1735 1630 3345 
132  1736 1617 3372 
133 - 1744 1617 - 
 
 
Table 4: Infrared data for 113-133 (cm-1) (as KBr discs unless stated) 
 
  Infrared spectra of compounds 113-133 were recorded, both as KBr discs, and in solution as 
thin-film methylene chloride solutions, and further serve to illustrate the equivalence by 
symmetry of the various functional groups within these compounds.   Irrespective of whether the 
spectra were recorded in the solid state or in solution, in general, only one C=O amide band, one 
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ester C=O band, and one N-H amide band is observed.  The latter of these consistently appear 
below 3400 cm-1, which is diagnostic of hydrogen-bonded amide protons.   
  Compound 124 has a N-H amide stretch in its CH2Cl2 spectrum at 3411 cm-1, which is 
consistent with the position of its amide proton in the CDCl3 1H spectrum (6.49 ppm), and 
suggests the absence of an ester oxygen atom is responsible for the inability of 124 to adopt a 
hydrogen bonded conformation in solution.  130 shows two N-H amide stretches in its CH2Cl2 
spectrum, at 3367 and 3409 cm-1, which further supports the idea that only the N-terminal amide 
protons are capable of forming hydrogen bonds in solution.   
 
 
4.6:  UV-Vis Spectra of 1, 1’-N-Ferrocenoyl Symmetric Dipeptides 
  The UV-Vis spectra of all the disubstituted ferrocenes discussed in this chapter differ from their 
mono- substituted analogues in terms of the second low-energy band.  Although the lowest 
energy electronic transition remains unaltered, being observed ca. 405nm, the λmax of this second 
low-energy band undergoes a red shift of ca. 40nm relative to the monosubstituted analogues.  It 
is known that interaction of the Cp rings of ferrocene with other π-systems causes a far greater 
perturbations to the ligand-based orbitals (e1u, e*2u) than to the metal-based HOMOs, [9, 10], 
and results in the low-lying Cp π* orbitals being shifted to lower energy.  Substitution of the both 
Cp rings accentuates this effect.  This would explain why this MLCT band is observed at lower 
energy for the disubstituted compounds.  All the extinction coefficients recorded for the lowest 
energy band are consistent with the values obtained for the monosubstituted analogues.   
 
4.7:  Cyclic Voltammogramms of 1, 1’-N-Ferrocenoyl Symmetric Dipeptides. 
A summary of the UV-Vis and electrochemical data is given in table 5.  The 1, 1’-disubstituted 
ferrocenes exhibit a reversible, one-electron peak in their cyclic voltammograms, due to 
oxidation of the ferrocene moiety to the ferricenium cation, similar to the monosubstituted 
derivatives.  There is, however, a dramatic anodic shift of this peak relative to the 
monosubstituted derivatives, as can be seen in fig. 16, which shows the voltammograms of 131, 
and its mono-substitutes analogue 63. 
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Compound λmax (nm) ε (M-1 cm-1)[α]D20 E1/2(mV) 
113 344, 445 195 - 28° 0.344 
114 342, 444 209 - 26° 0.359 
115 341, 444 211 - 23° 0.348 
116 344, 445 198 - 18° 0.354 
117 343, 446 198 - 0.362 
118 346, 444 200 - 26° 0.349 
119 344, 444 202 - 31° 0.340 
120 343, 445 218 - 32° 0.348 
121 344, 444 187 - 26° 0.348 
122 346, 445 193 - 27° 0.359 
123 343, 444 199 - 27° 0.359 
124 344, 444 199    21° 0.351 
125 345, 444 186 - 18° 0.337 
126 344, 445  206 - 0.344 
127 342, 446 190 - 0.340 
128 344, 444 190 - 0.340 
129 345, 441 176 - 0.330 
130 340, 442 200 - 0.338 
131 344, 445 196 - 22° 0.348 
132 345, 442 172 - 19° 0.353 
133 345, 446 193 -  0.302 
 
Table 5:  The electrochemical, UV-Vis, and optical data for compounds 113-133. All ε values 
refer to lowest energy band. 
 
  Relative to the Fc/Fc+ couple, the redox potential of 63 was recorded at 187 mV, while that of 
131 was determined to be 348mV.  The presence of an electron-withdrawing amide group on the 
second Cp ring obviously has the effect of lowering the energy of the ferrocene e2g orbital even 
further, thus making the molecule more difficult to oxidize (section 1.4).  It has been previously 
 155
established that the redox potential of the ferrocene moiety is sensitive to the number of electron-
withdrawing substituents [9], and it is therefore not surprising that such an anodic shift should be 
observed.   
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Fig. 16:  The cyclic voltammogramms of 63 and 131. 
 
4.8:  Conclusions 
  DCC and TBTU proved effective coupling reagents in the synthesis of compounds 113-133, 
although no active esters could be isolated during column chromatography.  Despite the 
difference in reaction stoichiometry, the yields achieved were comparable to those recorded 
during the preparation of the monosubstituted compounds.  Attempts to prepare 116 and 123 
using CDI as a coupling reagent failed, possibly due to the formation of a presumably unstable 
bis-imidazole intermediate.   
  Both the 1H-NMR and infrared spectra of these compounds clearly show the presence of 
hydrogen-bonded amide protons, with the ester carbonyl oxygen atom acting as a donor (fig. 17), 
with an anti-parallel, β-sheet-like conformation being adopted in solution (section 1.3.1).  
Elongation of the peptide backbone, as seen in the case of 126-129, does not prevent these 
hydrogen bonds being formed.  Addition of further residues to the C-terminal, as in 130, does not 
allow for the formation of further anti-parallel hydrogen-bonding, possibly because this would 
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result in out of plane twisting of the Cp rings.  In this respect, the ferrocene moiety may function 
as a ‘constraining’ unit, limiting the flexibility of the peptide chain [8].  
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Fig. 17:  β-sheet-like Conformation of 131 in solution. 
 
  Both the 1H and 13C-NMR clearly show a more pronounced influence of an adjacent chiral 
centre on the magnetic environments of the ferrocenoyl protons and carbon atoms than was 
observed with the monosubstituted derivatives.  There is also a noticeable red shift in the UV-Vis 
spectra of these compounds, with the second low energy band being observed ca. 340 nm (vs. 
300 nm for the monosubstituted).  Large anodic shifts in the cyclic voltammograms of these 
compounds are observed, with the redox potential being recorded in the 330-350 mV region (vs. 
Fc/Fc+). 
   
4.9:  Experimental 
 
Synthesis of 1, 1’-Ferrocene dicarboxylic acid (112). 
  9.3g (0.05mol) of ferrocene, 20ml (0.05mol) of a 2.5M solution of n-butyl lithium in hexanes, 
and 11.3ml (0.075mol) of tetramethylethylenediamine were added to a 500ml round bottomed 
flask containing 300ml of dry hexane.  The solution was kept in the dark and stirred overnight, 
giving an orange precipitate of the lithiated ferrocene complex.  The reaction mixture was then 
cooled to 0°C, and a vigorous stream of dry CO2 was bubbled through the mixture for 20 
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minutes, giving a brown precipitate.  The hexane solution was then extracted with water (3 x 
250ml), and the aqueous portions were combined, acidified to pH 1-2 with conc. HCl, and the 
precipitate was collected by vacuum filtration, and dried for ca. 24 hrs at 80°C affording the title 
product as a light brown powder (scheme 3).   
 
Yield 10.14g (74%), m.p. > 300°C.  
1H-NMR (400MHz) δ (CDCl3): 4.40 (4H, br. s, Hmeta Cp ring), 4.77 (2H, s, Hortho Cp ring), 4.89 
(2H, s, Hortho Cp ring), 12.11 (2H, br. s, FcCOOH). 
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Scheme 3:  Preparation of ferrocene dicarboxylic acid. 
 
Synthesis of 1, 1’-N-Ferrocenoyl Symmetric Dipeptides 
 
Route 1, General Procedure 
  DCC (0.4g , 2.4mmol), 2mmol of the appropriate amino acid ester, 0.38mls (2.4mmol) Et3N 
and 1-hydroxybenzotriazole (0.14g , 1mmol) were added to a slurry of ferrocene dicarboxylic 
acid (0.27g, 1 mmol) in 20mls DCM, at 0˚C.  The reaction was raised to room temperature after 
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30 mins, and allowed to proceed for 24 hrs.  The precipitated N,  N - dicyclohexylurea was 
removed by filtration, and the solvent evaporated in vacuo.  The crude product was then eluted 
from a column of silica gel, using a mobile phase of 2:1 ethyl acetate/ hexane. 
 
Route 2, General Procedure 
  2mmol of the appropriate amino acid ester, CDI (0.39g, 2.4mmol), 0.38mls (2.4mmol) Et3N, 
were added to a slurry of ferrocene dicarboxylic acid (0.27g, 1 mmol) in 20mls THF, at 0˚C.  
The reaction was raised to room temperature after 30mins, and allowed to proceed for 24 hrs.  
No target compounds were recovered using this method. 
 
Route 3, General Procedure 
  0.83 g of O- (1H-benzotriazol-1-yl) - N, N, N’, N’, - tetramethyluronium tetrafluoroborate 
(2.5mmol) and 0.4 ml (2.4mmol) of triethylamine were added  to slurry of ferrocene dicarboxylic 
acid (0.27g, 1mmol) in dimethylformamide (30mls), at ambient temperature.  After 30 mins, 
2.4mmol of the appropriate amino acid ester hydrochloride salt was added, and stirring was 
continued for 24 hrs.  The solvent evaporated in vacuo, and the crude product was purified by 
silica gel column chromatography using a mobile phase of 2:1 ethyl acetate/hexane. 
 
1, 1’- N-ferrocenoyl-(L-norleucine methyl ester)2  (113) 
  0.36g of L-norleucine methyl ester hydrochloride was used in the synthesis. 
Yields:  Route 1, 0.41g (73%), Route 2 0.43g (75%), m.p. 180-182°C. 
E1/2 = 0.344mV (Vs. Fc/Fc+), [α]D20 = - 28° (EtOH), (UV-Vis (λmax) (EtOH): 344, 445 nm (ε = 
195 M-1 cm-1), I.R. υmax (KBr):  3099, 2972, 1932, 1735, 1630, 1442, 1427, 1413, 1320, 1185, 
1140, 1027, 486, cm-1.    
1H-NMR (400MHz) δ (d6 DMSO):  0.90 (6H, t, J = 6.0 Hz, -CH2CH2CH2CH3 x 2), 1.24-1.41 
(8H, m, -CH2CH2CH2CH3 x 2), 1.69-1.81 (4H, m, -CH2CH2CH2CH3 x 2) 3.67 (6H, s, -OCH3 x 
2), 4.31-4.38 (4H, m, -NHCH- x 2 + Hmeta Cp ring), 4.43 (2H, s, Hmeta Cp ring), 4.84 (2H, s, 
Hortho Cp ring), 4.87 (2H, s, Hortho Cp ring), 8.17 (2H, d, J = 7.6 Hz, -NHCH- x 2). 
13C-NMR (100 MHz) δ (d6 DMSO):  14.16, 22.02 (-ve DEPT), 28.22 (-ve DEPT), 30.37 (-ve 
DEPT), 52.24, 52.46, 69.63, 70.86, 72.19, 72.29, 77.13, 169.48, 173.45. 
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1, 1’-N-ferrocenoyl-(L-aspartic acid dimethyl ester)2 (114) 
  0.39g of L-aspartic acid dimethyl ester hydrochloride was used in the synthesis.  
Yield 0.38g (68%), m.p.198-200°C. 
E1/2 = 0.359mV (Vs. Fc/Fc+), [α]D20 = - 26° (EtOH), (UV-Vis (λmax) (EtOH): 342, 444 nm (ε = 
209 M-1 cm-1), I.R. υmax (KBr):  3302, 3102, 2954, 1739, 1638, 1544, 1439, 1310, 1275, 1225, 
1002, 663, 507, cm-1.    
1H-NMR (400MHz) δ (d6 DMSO):  2.82 (2H, dd, Ja = 8.0 Hz, Jb = 16.0 Hz, NHCH(CH2-)), 2.96 
(2H, dd, Ja = 5.2 Hz, Jb = 16.0 Hz,   NHCH(CH2-)), 3.61 (6H, s, -OCH3 x 2), 3.66 (6H, s, -
OCH3 x 2), 4.37 (4H, br. s, Hmeta Cp ring), 4.75 (2H, m, -NHCH- x 2), 4.80 (2H, s, Hortho Cp 
ring), 4.82 (2H, s, Hortho Cp ring), 8.30 (2H, d, J = 7.6 Hz, -NHCH- x 2). 
13C-NMR (100 MHz) δ (d6 DMSO):  29.10 (-ve DEPT), 49.16, 52.05, 52.62, 69.91, 70.07, 72.62, 
72.66, 76.71, 168.96, 171.02, 171.72. 
 
1, 1’-N-ferrocenoyl-(L-phenylalanine methyl ester)2 (115) 
  0.43g of L-phenylalanine methyl ester hydrochloride was used in the synthesis. 
Yield 0.43g (72%), , m.p. 211-213°C. 
E1/2 = 0.348mV (Vs. Fc/Fc+), [α]D20 = - 23° (EtOH), (UV-Vis (λmax) (EtOH): 341, 444 nm (ε = 
211 M-1 cm-1), I.R. υmax (KBr):  3219, 2952, 1740, 1632, 1540, 1271, 1223, 1195, 1097, 1043, 
811, 740, 487, cm-1.    
1H-NMR (400MHz) δ (d6 DMSO):  3.04 (2H, dd, Ja = 12.0 Hz, Jb = 12.4 Hz,   NHCH(CH2-)), 
3.18 (2H, dd, Ja = 11.2 Hz, Jb = 12.4 Hz,   NHCH(CH2-)), 3.69 (6H, s, -OCH3 x 2), 4.10 (4H, d, 
J = 7.6 Hz, Hmeta Cp ring), 4.49 (2H, s, Hortho Cp ring), 4.68 (4H, m, Hortho Cp ring + NHCH- x 
2), 7.22-7.35 10H, m, ArH), 8.34 (2H, d, J = 8.0 Hz, -NHCH- x 2). 
13C-NMR (100 MHz) δ (d6 DMSO):  36.49 (-ve DEPT), 52.41, 54.09, 68.79, 71.74, 71.85, 72.32, 
76.93, 126.90, 128.65, 129.42, 138.19, 169.60, 172.76. 
 
1, 1’-N-ferrocenoyl-(L-methionine methyl ester)2 (116) 
  0.04g of L-methionine methyl ester hydrochloride was used in the synthesis. 
Yield 0.41g (73%), m.p. 220-223°C. 
E1/2 = 0.354mV (Vs. Fc/Fc+), [α]D20 = - 18° (EtOH), (UV-Vis (λmax) (EtOH): 344, 445 nm (ε = 
198 M-1 cm-1), I.R. υmax (KBr):  1543, 1460, 1381, 1302, 1186, 1027, 671, 487 cm-1.    
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1H-NMR (400MHz) δ (d6 DMSO):  2.02-2.07 (10H, m, -CH2SCH3 x 2), 2.54-2.64 (4H, m, -
CH2CH2SCH3 x 2), 3.67 (6H, s, -OCH3 x 2), 4.38 (2H, s, Hmeta Cp ring), 4.43 (2H, s, Hmeta Cp 
ring), 4.50-4.54 (2H, m, -NHCH- x 2), 4.82 (2H, s, Hortho Cp ring), 4.87 (2H, s, Hortho Cp ring), 
8.22 (2H, d, J = 7.2 Hz, -NHCH- x 2). 
13C-NMR (100 MHz) δ (d6 DMSO):  14.86, 30.16 (-ve DEPT), 30.21 (-ve DEPT), 51.43, 52.41, 
69.67, 70.83, 72.30, 72.46, 76.93, 169.73, 173.07. 
 
1, 1’-N-ferrocenoyl-(2-isoaminobutyric acid methyl ester)2 (117) 
  0.31g of 2-isoaminobutyric acid methyl ester hydrochloride was used in the synthesis. 
Yield 0.31g (66%), orange solid, m.p. 201-203°C. 
E1/2 = 0.362mV (Vs. Fc/Fc+),  (EtOH), UV-Vis (λmax) (EtOH): 343, 446 nm (ε = 198 M-1 cm-1), 
I.R. υmax (KBr): 1538, 1438, 1314, 1277, 1150, 933, 507 cm-1.   
1H-NMR (400MHz) δ (d6 DMSO):  1.44 (12H, s, –NHC(CH3)2- x 2),  3.62 (6H, s, -OCH3 x 2), 
4.40 (4H, s, Hmeta Cp ring), 4.79 (4H, s, Hortho Cp ring), 8.09 (2H, s, –NHC(CH3)2- x 2).  
13C-NMR (100 MHz) δ (d6 DMSO):  25.32, 52.21, 55.68, 70.36, 72.03, 77.19, 169.02, 174.90. 
 
1, 1’-N-ferrocenoyl-(L-leucine methyl ester)2 (118) 
  0.36g of L-leucine methyl ester hydrochloride was used in the synthesis. 
Yield 0.37g (70%), orange solid, m.p. 217-220°C. 
E1/2 = 0.349mV (Vs. Fc/Fc+), [α]D20 =   –26° (EtOH), UV-Vis (λmax) (EtOH): 346, 444 (ε = 200 
M-1 cm-1), I.R. υmax (KBr): 3326 2930, 2363, 2121, 1742, 1633, 1538, 1437, 1301, 1221, 1148, 
670, 509 cm-1.   
1H-NMR (400MHz) δ (d6 DMSO):  0.90 (6H, d, J = 6.4 Hz, -CH2CH(CH3)2), 0.95 (6H, d, J = 
6.4 Hz, -CH2CH(CH3)2), 1.22-1.26 (2H, m, -CH2CH(CH3)2 x 2), 1.71-1.77 (4H, m, -
CH2CH(CH3)2 x 2), 3.67 (6H, s, -OCH3 x 2), 4.35 (2H, br. s, , -NHCH- x 2), 4.43 (4H, s, Hmeta 
Cp ring), 4.83 (4H, s, Hortho Cp ring), 8.18 (2H, d, J = 8.0 Hz, -NHCH- x 2). 
13C-NMR (100 MHz) δ (d6 DMSO):  21.31, 23.29, 24.77, 39.44 (-ve DEPT), 52.28, 69.50, 70.95, 
72.10, 72.33, 77.12, 169.50, 173.76.  
 
1, 1’-N-ferrocenoyl- ((S-methyl)-L-cystine methyl ester)) 2 (119) 
  0.37g of (S-methyl)-L-cystine methyl ester hydrochloride was used in the synthesis. 
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Yield 0.42g (78%), orange microcrystalline solid.  m.p. 186-187°C. 
E1/2 = 0.340mV (Vs. Fc/Fc+), [α]D20 = - 31° (EtOH), (UV-Vis (λmax) (EtOH): 344, 444 nm (ε = 
202 M-1 cm-1), I.R. υmax (KBr):  3292, 2920, 2366, 1737, 1629, 1545, 1434, 1381, 1312, 1217, 
1103, 673, 497 cm-1.     
1H-NMR (400MHz) δ (d6 DMSO):  2.13 (6H, s, -SCH3 x 2), 2.90-3.00 (4H, m, -CH2SCH3 x 2), 
3.69 (6H, s, -OCH3 x 2), 4.41 (2H, s, Hmeta Cp ring), 4.44 (2H, s, Hmeta Cp ring), 4.58-4.59 (2H, 
m, –NHCH- x 2), 4.86 (2H, s, Hortho Cp ring), 4.89 (2H, s, Hortho Cp ring), 8.28 (2H, d, J = 7.6 
Hz, –NHCH- x 2). 
13C-NMR (100 MHz) δ (d6 DMSO):  15.36, 34.61 (-ve DEPT), 51.92, 52.50, 69.73, 70.62, 72.55, 
72.69, 76.92, 169.35, 171.88. 
 
 
1, 1’-N-ferrocenoyl-(L-phenylglycine methyl ester)2. (120) 
  0.40g of L-phenylglycine methyl ester hydrochloride was used in the synthesis. 
Yield 0.41g (72%), orange solid, m.p. 200-203°C. 
E1/2 = 0.348mV (Vs. Fc/Fc+), [α]D20 = - 32° (EtOH), (UV-Vis (λmax) (EtOH): 343, 445 nm (ε = 
218 M-1 cm-1), I.R. υmax (KBr): 3315, 2953, 2363, 2342, 1637, 1527, 1499, 1219, 1173, 1100, 
1026, 698, 506 cm-1.    
1H-NMR (400MHz) δ (d6 DMSO):  3.67 (6H, s, -OCH3 x 2), 4.35 (2H, s, Hmeta Cp ring), 4.39 
(2H, s, Hmeta Cp ring), 4.90 (4H, br. s, Hortho Cp ring), 5.58 (2H, d, J = 5.6Hz, NHCH- x 2), 7.39-
7.48 (10H, m, ArH), 8.56 (2H, d, J = 5.6 Hz, -NHCH- x 2). 
13C-NMR (100 MHz) δ (d6 DMSO):  52.61, 56.97, 65.29, 69.96, 70.87, 72.32, 72.46, 76.71, 
128.54, 128.64, 128.88, 136.64, 169.32, 171.56. 
 
1, 1’-N-ferrocenoyl-(L-glutamic acid diethyl ester)2 (121) 
  0.39g of L-glutamic acid dimethyl ester hydrochloride was used in the synthesis.  
Yield 0.38g (68%), orange solid, m.p. 154-157°C. 
E1/2 = 0.348mV (Vs. Fc/Fc+), [α]D20 = - 26° (EtOH), (UV-Vis (λmax) (EtOH): 344, 444 nm (ε = 
187 M-1 cm-1), I.R. υmax (KBr):  3332, 3090, 2991, 1735, 1720, 1539, 1291, 1167, 1027, 772, 
667, 490 cm-1.   
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1H-NMR (400MHz) δ (d6 DMSO):  1.15-1.24 (12 h, m, OCH2CH3 x 4), 1.93-1.96 (2H, m, -
CH2CH2COOEt), 2.08-2.10 (2H, m, -CH2CH2COOEt), 2.50 (4H, t, J = 6.8 Hz, -
CH2CH2COOEt x 2), 4.04-4.14 (8H, m, OCH2CH3 x 4), 4.38 (4H, br. s, Hmeta Cp ring + -
NHCH- x 2), 4.43 (2H, br. s, Hmeta Cp ring), 4.83 (2H, s, Hortho Cp ring), 4.89 (2H, s, Hortho Cp 
ring), 8.16 (2H, d, J = 7.2 Hz, -NHCH- x 2). 
13C-NMR (100 MHz) δ (d6 DMSO):  14.43, 25.97 (-ve DEPT), 30.49 (-ve DEPT), 51.81, 60.31 
(-ve DEPT), 61.02 (-ve DEPT), 69.76, 70.53, 72.31, 72.46, 76.97, 169.50, 172.37, 172.58. 
 
1, 1’-N-ferrocenoyl-(L-threonine methyl ester)2 (122) 
  0.34g of L-threonine methyl ester hydrochloride was used in the synthesis. 
Yield 0.38g (76%), orange solid.  m.p. 189-192°C.  
E1/2 = 0.359mV (Vs. Fc/Fc+), [α]D20 = - 27° (EtOH), UV-Vis (λmax) (EtOH): 346, 445 nm (ε = 
193 M-1 cm-1), I.R. υmax (KBr):  3361, 3096, 2929, 2365, 1677, 1665, 1635, 1543, 1309, 1211, 
1192, 1036, 685 cm-1.   
1H-NMR (400MHz) δ (d6 DMSO):  1.16 (6H, d, J = 6.4 Hz, -CH(OH)CH3 x 2), 3.68 (6H, s, -
OCH3 x 2), 4.50 (6H, br. s, Hmeta Cp ring + –NHCH- x 2), 4.87 (2H, s, Hortho Cp ring), 4.97 (2H, 
s, Hortho Cp ring), 5.06 (2H, d, J = 7.6 Hz, -CH(OH)CH3 x 2), 7.62 (2H, d, J = 8.4 Hz, –NHCH- 
x 2). 
13C-NMR (100 MHz) δ (d6 DMSO):  20.60, 52.33, 58.69, 66.63, 70.01, 70.18, 72.62, 72.71, 
76.89, 169.65, 171.67. 
 
1, 1’-N-ferrocenoyl-(L-tyrosine methyl ester)2 (123) 
  0.46g of L-tyrosine methyl ester hydrochloride was used in the synthesis.  
Yields:  Route 1 0.43g (69%), Route 30.43g (69%), orange microcrystalline solid.  m.p. 219-
212°C.  
E1/2 = 0.359mV (Vs. Fc/Fc+), [α]D20 = - 27° (EtOH), UV-Vis (λmax) (EtOH): 343, 444 nm (ε = 
199 M-1 cm-1), I.R. υmax (KBr):  3365, 2367, 1721, 1638, 1550, 1517, 1270, 1222, 1109, 1043, 
830, 767, 489 cm-1.    
1H-NMR (400MHz) δ (d6 DMSO):  2.91 (2H, dd, Ja = 13.6 Hz, Jb = 12.4 Hz, –NHCH(CH2)-), 
3.06 (2H, dd, Ja = 13.6 Hz, Jb = 4.0 Hz, –NHCH(CH2)-), 3.67 (6H, s, -OCH3 x 2), 4.13 (2H, s, 
Hmeta Cp ring), 4.18 (2H, s, Hmeta Cp ring), 4.48 (2H, s, Hortho Cp ring), 4.53-4.59 (2H, m, -
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NHCH- x 2), 4.68 (2H, s, Hortho Cp ring), 6.72 (4H, d, J = 8.4 Hz, ArH), 7.15 (4h, d, J = 8.4 Hz, 
ArH), 8.32 (2H, d, J = 8.0 Hz, –NHCH- x 2), 2H, s, Ph-OH x 2). 
13C-NMR (100 MHz) δ (d6 DMSO):  35.73 (-ve DEPT), 52.38, 54.52, 68.75, 71.78, 72.05, 72.32, 
76.95, 115.41, 128.15, 130.35, 156.28, 169.85, 172.91.   
 
 
1, 1’-N-ferrocenoyl-((1S, 2R)-(+)- norephedrine) 2 (124) 
  0.37g of norephedrine hydrochloride was used in the synthesis.  
Yield 0.40g (74%), orange solid.  m.p. 199-201°C.  
E1/2 = 0.351mV (Vs. Fc/Fc+), [α]D20 =   21° (EtOH), UV-Vis (λmax) (EtOH): 344, 444 nm (ε = 
199 M-1 cm-1), I.R. υmax (KBr): 3328, 2930, 2854, 2366, 1628, 1543, 1401, 1312, 1281, 1185, 
1028, 998, 745, 701, 490 cm-1.   
1H-NMR (400MHz) δ (d6 DMSO):  1.14 (6H, d, J = 6.4 Hz, –NHCH(CH3)-, x 2), 4.08-4.14 (6H, 
m, Hmeta Cp ring + –NHCH(CH3)- x 2), 4.36 (2H, s, Hortho Cp ring), 4.60 (2H, s, Hortho Cp ring), 
4.66 (2H, m, –NHCH(CH3)CH(OH)Ph, x 2), 4.66 (2H, d, J = 4.0 Hz, CH(OH)Ph, x 2), 7.23, 2H, 
d, J = 7.6 Hz, ArH), 7.33 - 7.36 (4H, m, ArH), 7.43 (4H, d, J = 7.6 Hz, ArH), 7.72 (2H, d, J = 8.8 
Hz, –NHCH- x 2). 
13C-NMR (100 MHz) δ (d6 DMSO):  16.23, 50.97, 68.97, 71.20, 71.38, 71.75, 75.06, 78.21, 
126.81, 127.17, 128.13, 144.38, 168.14. 
 
1, 1’- N-ferrocenoyl-(L-tryptophan methyl ester)2 (125) 
  0.51g of L-tryptophan methyl ester hydrochloride was used in the synthesis. 
Yield 0.42g (64%), red microcrystalline solid.  m.p. 167-169°C.  
E1/2 = 0.337mV (Vs. Fc/Fc+), [α]D20 =   - 18° (EtOH), UV-Vis (λmax) (EtOH): 345, 444 nm (ε = 
186 M-1 cm-1), I.R. υmax (KBr): 3383, 2930, 2365, 1766, 1629, 1543, 1437, 1228, 1103, 743, 499, 
427 cm-1.   
1H-NMR (400MHz) δ (d6 DMSO):  3.16-3.22 (2H, m, –NHCH(CH2)-), 3.27-3.32 (2H, m, –
NHCH(CH2)-), 3.69 (6H, s, -OCH3 x 2), 4.01 (2H, s, Hmeta Cp ring), 4.06 (2H, s, Hmeta Cp ring), 
4.51 (2H, s, Hortho Cp ring), 4.65 (2H, s, Hortho Cp ring), 4.67-4.73 (2H, m, -NHCH- x 2), 6.99-
7.02 (2H, m, Hindole), 7.05-7.09 (2H, m, Hindole), 7.28 (2H, s, Hindole), 7.35 (2H, d, J = 8.0 Hz, 
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Hindole), 7.61 (2H, d, J = 7.6 Hz, Hindole), 8.22 (2H, d, J = 7.6 Hz, –NHCH- x 2), 10.92 (2H, s, N-
H indole). 
13C-NMR (100 MHz) δ (d6 DMSO):  26.92 (-ve DEPT), 52.38, 53.61, 69.03, 71.37, 71.80, 72.23, 
76.91, 110.34, 111.89, 111.89, 121.36, 124.16, 127.36, 136.53, 169.54, 173.18.  
 
1, 1’-N-ferrocenoyl-(glycine ethyl ester)2 (126) 
  0.28g of glycine ester hydrochloride was used in the synthesis.  
Yield 0.32g (71%), orange solid, m.p. 213-215°C.  
E1/2 = 0.344mV (Vs. Fc/Fc+), (UV-Vis (λmax) (EtOH): 344, 445 nm (ε = 206 M-1 cm-1), I.R. υmax 
(KBr): 3351, 3091, 2904, 1732, 1633, 1540, 1432, 1388, 1317, 1167, 1035, 813, 690, 587 cm-1. 
1H-NMR (400MHz) δ (d6 DMSO):  1.23 (6H, t, J = 6.0 Hz, -OCH2CH3 x 2), 3.91 (4H, d, J = 6.4 
Hz, -NHCH2COOEt x 2), 4.15 (4H, q, J = 6.0Hz, -OCH2CH3 x 2) 4.44 (4H, s, Hmeta Cp ring), 
4.83 (4H, s, Hortho Cp ring), 8.31 (2H, t, J = 6.4Hz, -NHCH2- x 2). 
 13C-NMR (100 MHz) δ (d6 DMSO): 14.48, 41.32 (-ve DEPT), 60.86 (-ve DEPT), 69.98, 72.51, 
77.00, 169.53, 170.59. 
 
 
1, 1’-N-ferrocenoyl- (β alanine methyl ester)2 (127) 
  0.29g of β alanine methyl ester hydrochloride was used in the synthesis. 
Yield 0.30g (68 %), orange solid.  m.p. 146-148°C. 
E1/2 = 0.340mV (Vs. Fc/Fc+), UV-Vis (λmax) (EtOH): 342, 446 nm (ε = 190 M-1 cm-1), I.R. υmax 
(KBr):  3292, 2301, 1737, 1633, 1549, 1445, 1379, 1327, 1207, 1177, 1085, 678, 484 cm-1.  
1H-NMR (400MHz) δ (d6 DMSO):  2.59 (4H, t, J = 6.0 Hz, -NHCH2CH2CO- x 2), 3.14 (4H, br. 
s, -NHCH2CH2CO- x 2), 3.62 (6H, s, -OCH3 x 2), 4.28 (4H, s, Hmeta Cp ring), 4.70 (4H, s, Hortho 
Cp ring), 7.99 (2H, t, J = 6.0Hz,  –NHCH2- x 2).  
13C-NMR (100 MHz) δ (d6 DMSO):  34.14 (-ve DEPT), 35.57 (-ve DEPT), 51.75, 69.88, 72.05, 
77.81, 169.05, 172.31. 
 
1, 1’-N-ferrocenoyl-(γ-aminobutyric acid methyl ester)2 (128) 
  0.31g of γ-aminobutyric acid methyl ester hydrochloride was used in the synthesis. 
Yield 0.32g (68%), orange solid.  m.p. 131-132°C. 
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E1/2 = 0.340mV (Vs. Fc/Fc+), UV-Vis (λmax) (EtOH): 344, 444 nm (ε = 190 M-1 cm-1), I.R. υmax 
(KBr):  3327, 2929, 2851, 2362, 1729, 1629, 1538, 1437, 1229, 1103, 743, 670, 487 cm-1.   
1H-NMR (400MHz) δ (d6 DMSO):  1.75-1.78 (4H, m, -NHCH2CH2CH2CO- x 2), 2.39 (4H, t, J 
= 6.8Hz, -NHCH2CH2CH2CO- x 2), 3.19 (4H, m, -NHCH2CH2CH2CO- x 2), 3.60 (6H, s, -
OCH3 x 2), 4.39 (4H, s, Hmeta Cp ring), 4.72 (4H, s, Hortho Cp ring), 7.94 (2H, t, J = 5.2 Hz, –
NHCH2- x 2). 
13C-NMR (100 MHz) δ (d6 DMSO):  25.01 (-ve DEPT), 31.09 (-ve DEPT), 38.43 (-ve DEPT), 
51.64, 69.82, 71.80, 78.28, 168.78, 173.57. 
 
1, 1’-N-ferrocenoyl-(valeric acid methyl ester)2 (129) 
  0.33g of valeric acid methyl ester hydrochloride was used in the synthesis. 
Yield 0.33g (65%), orange solid, m.p. 161-163°C. 
E1/2 = 0.330mV (Vs. Fc/Fc+), (UV-Vis (λmax) (EtOH): 345, 441 nm (ε = 176 M-1 cm-1), I.R. υmax 
(KBr):  3365, 2950, 2343, 1731, 1641, 1519, 1418, 1221, 1101, 1043, 777, 543 cm-1.    
1H-NMR (400MHz) δ (d6 DMSO):  1.40-1.52 (8H, m, -NHCH2CH2CH2CH2CO- x 2), 2.27 (4H, 
t, J = 7.2 Hz, -CH2CH2CO- x 2), 3.06-3.09 (4H, m, -NHCH2CH2- x 2), 3.63 (6H, s, -OCH3 x 2), 
4.34 (4H, s, Hmeta Cp ring), 4.72 (4H, s, Hortho Cp ring), 7.73 (2H, t, J = 5.6 Hz, -NHCH- x 2).   
13C-NMR (100 MHz) δ (d6 DMSO):  22.31 (-ve DEPT), 29.10 (-ve DEPT), 33.35 (-ve DEPT), 
38.64 (-ve DEPT), 51.60, 69.86, 73.11, 78.87, 167.68, 173.69.  
 
1, 1’-N-ferrocenoyl-[(glycine)2 ethyl ester]2 (130) 
  0.39g of glycine-glycine ethyl ester was used in the synthesis.  
Yield 0.36g (66%), orange microcrystalline solid.  m.p. 227-229°C.  
E1/2 = 0.338mV (Vs. Fc/Fc+), (UV-Vis (λmax) (EtOH): 340, 442 nm (ε = 200 M-1 cm-1), I.R. υmax 
(KBr): 3449, 3412, 3344, 3300, 2363, 2343, 1747, 1612, 1546, 1416, 1382, 1324, 1184, 1013, 
949, 772 cm-1. 
1H-NMR (400MHz) δ (d6 DMSO):  1.20 (6H, t, J = 7.6 Hz, -OCH2CH3 x 2), 3.84 (4H, d, J = 5.6 
Hz, -NHCH2CO- x 2), 3.92 (4H, d, J = 5.2 Hz, -NHCH2CO- x 2), 4.11 (4H, q, J = 7.6 Hz, -
OCH2CH3 x 2), 4.43 (4H, s, Hmeta Cp ring), 4.79 (4H, s, Hortho Cp ring), 8.42 (2H, t, J = 5.6 Hz, -
NHCH2- x 2) 8.60 (2H, t, J = 5.2 Hz, -NHCH2- x 2). 
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13C-NMR (100 MHz) δ (d6 DMSO):  14.40, 41.17, 42.07, 60.85, 70.31, 71.73, 76.98, 169.32, 
169.99, 171.17.  
 
 
 1, 1’-N-ferrocenoyl-(L-norvaline ethyl ester)2 (131) 
  0.33g of L-norvaline ethyl ester hydrochloride was used in the synthesis. 
Yield 0.35g (70%), orange solid, m.p. 168-170°C. 
E1/2 = 0.348mV (Vs. Fc/Fc+), [α]D20 = - 22° (EtOH), (UV-Vis (λmax) (EtOH): 344, 445 nm (ε = 
196 M-1 cm-1), I.R. υmax (KBr):  3294, 3099, 2972, 2932, 1735, 1630, 1542, 1185, 1140, 1027, 
486 cm-1.   
1H-NMR (400MHz) δ (d6 DMSO):  0.89 (6H, t, J = 7.2 Hz, -CH2CH2CH3 x 2), 1.22 (6H, t, J = 
7.6Hz, -OCH2CH3 x 2), 1.35-1.49 (4H, m, -CH2CH2CH3 x 2) 1.72-1.78 (4H, m, -CH2CH2CH3 
x 2) 4.11 (4H, q, J = 7.6Hz, -OCH2CH3 x 2), 4.32-4.37 (2H, m, -NHCH- x 2), 4.37 (2H, s, Hmeta 
Cp ring),  4.43 (2H, s, Hmeta Cp ring), 4.82 (2H, s, Hortho Cp ring), 4.87 (2H, s, Hortho Cp ring), 
8.12 (2H, d, J = 7.6 Hz, -NHCH- x 2). 
13C-NMR (100 MHz) δ (d6 DMSO):  13.78, 14.47, 19.29 (-ve DEPT), 32.70 (-ve DEPT), 52.34, 
60.86 (-ve DEPT), 69.75, 70.73, 72.10, 72.28, 77.15, 169.49, 173.07. 
 
1, 1’-N-ferrocenoyl-(L-serine methyl ester)2 (132) 
  0.32g of L- serine methyl ester hydrochloride was used in the synthesis. 
Yield 0.32g (67%), orange solid, m.p. 168-170°C. 
E1/2 = 0.353mV (Vs. Fc/Fc+), [α]D20 = - 19° (EtOH), (UV-Vis (λmax) (EtOH): 345, 442 nm (ε = 
172 M-1 cm-1), I.R. υmax (KBr):   3406, 3112, 2941, 1736, 1617, 1542, 1459, 1341, 1228, 1066, 
492 cm-1.   
1H-NMR (400MHz) δ (d6 DMSO):  3.68 (6H, s, -OCH3 x 2), 3.79 (4H, br. s, -CH2OH x 2), 4.41-
4.45 (6H, m, Hmeta Cp ring + -NHCH- x 2), 4.83 (2H, s, Hortho Cp ring), 4.93 (2H, s, Hortho Cp 
ring), 5.11 (2H, t, J = 6.0 Hz, -CH2OH x 2), 7.94 (2H, d, J = 8.4 Hz, -NHCH- x 2). 
13C-NMR (100 MHz) δ (d6 DMSO):  52.29, 55.47, 61.37 (-ve DEPT), 70.07, 70.29, 72.48, 72.52, 
76.89, 169.28, 171.61. 
 
1, 1’-N-ferrocenoyl-(sarcosine ethyl ester)2 (133) 
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  0.30g of sarcosine ethyl ester hydrochloride was used in the synthesis. 
Yield 0.32g (67%), orange solid, m.p. 91-93°C. 
E1/2 = 0.302mV (Vs. Fc/Fc+), (UV-Vis (λmax) (EtOH): 345, 446 nm (ε = 193 M-1 cm-1), I.R. υmax 
(KBr):   2938, 2883 2362, 2342, 1744, 1617, 1402, 1200, 1097, 914, 608 cm-1.   
1H-NMR (400MHz) δ (d6 DMSO):  1.21 (6H, t, J = 11.2 Hz, -OCH2CH3 x 2), 3.28 (6H, br. s, -
NCH3 x 2),  4.13 (8H, br. s,  N(CH3)CH2- x 2 + -OCH2CH3 x 2), 4.50 (4H, br. s, Hmeta Cp ring), 
4.76 (4H, br. s, Hortho Cp ring). 
13C-NMR (100 MHz) δ (d6 DMSO):  14.44, 38.16, (-ve DEPT), 50.81, 60.85, 72.34, 77.62, 
169.69. 
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Chapter V 
 
The Synthesis and Characterisation 
of 1, 1’-N-Ferrocenoyl Asymmetric 
Dipeptides 
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5.1:  Introduction 
  The synthesis of asymmetric disubstituted ferrocenes presents a unique synthetic challenge, 
with complex transformations and low overall yields reported [1].  The most common synthetic 
methods involve either the stepwise introduction of different functional groups to each of the Cp 
rings, or selective modification of one of two identical functional groups [2].  As an example of 
the latter methodology, the group of Li and co-workers have prepared several compounds of the 
type 134, via the selective hydrolysis of the corresponding dimethyl ester (scheme 1) [3]. 
 
 
O
OMe
Fe
O
OMe
O
OH
Fe
O
OMe
O
Cl
Fe
O
OMe
O
N
H
O
N
H
n
 
Fe
O
OMe
Fe
O
MeO
(i)
(ii)
(iii)
134  
 
(i) NaOH/MeOH (ii) Oxalyl Chloride/MeOH (iii) H2N-(CH2)n-NH2 
 
Scheme 1:  The selective hydrolysis of 1, 1’-ferrocene dimethyl ester, resulting in different 
functional groups on each of the Cp rings, allowing for the synthesis of 134. 
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Scheme 2:  Preparation of 135 from 59. 
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  Using a stepwise approach, Barisic et al. have reported the synthesis of several ferrocene-amino 
acid derivatives of the type 135, using multi-step synthetic procedures, and isolation of all the 
intermediates, but with overall yields typically under 30% [4].   
  Many of these unsymmetric ferrocenes reported in the literature are obtained as side products 
during the preparation of various target molecules.  A typical example would be 137, isolated by 
Patti et al., during the enzymatically-catalysed alcoholysis of 136 (scheme 3) [5]. 
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Scheme 3:  The enantiospecific alcoholysis of 136, resulting in the formation of 137 among the 
products isolated. 
 
  There are few reports of 1, 1’-N-ferrocenoyl asymmetric dipeptides in the literature, and these 
are only possible with the isolation of unstable intermediates.  Typical examples would be the 
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asymmetric ferrocenoyl oligopeptide 50, prepared by Xu et al [6], and the cyclic ferrocene 
pentapeptide 57, prepared by Frejd and co-workers [7] (Ch. 1, 1.7).  The following work 
describes the synthesis of seven novel 1, 1’-N-ferrocenoyl asymmetric dipeptides, as well as a 
convenient one-pot synthetic method for these compounds. 
 
5.2:  Synthesis of 1, 1’-N-Ferrocenoyl Asymmetric Dipeptides 
 Three different routes were used to synthesise compound 140, 1, 1’-N-ferrocenoyl-(L-threonine 
methyl ester)-(L-valine methyl ester), and optimization of these conditions allowed for facile 
synthesis of the remainder of the unsymmetric ferrocenes (141-146).  In all cases, traces of 
symmetrically disubstituted ferrocenoyl dipeptides were isolated from the reaction mixtures, 
although column chromatography on silica gel allowed for facile isolation of the target 
molecules.  
 
5.2.1:  Synthetic Route 1 
  The first of these synthetic routes was based on the previously reported method of Kraatz et al 
for stepwise introduction of different peptides onto each Cp ring, which involves the isolation of 
a mono O-benzotriazole active ester [8].  Reaction of ferrocene dicarboxylic with one molar 
equivalent of L-valine methyl ester hydrochloride using DCC and two molar equivalents of 1-
hydroxy benzotriazole in dichloromethane, led to the formation of the active ester 139, with a 
yield of 30%, and the product was isolated via silica gel column chromatography.  The 
symmetricly disubstituted 1, 1’-N-ferrocenoyl-(L-valine methyl ester)2, 138, which has 
previously been reported by Herrick and co-workers, was formed in minor amounts (18%) [9].  
The symmetrically disubstituted bis-benzotriazole product was not observed to be formed in any 
amount, although this could be a function of this compound’s stability, either thermal or 
photochemical.  Compound 139 was characterized by 1H-NMR, but its instability in deuterated 
solvent meant that a clear 13C-NMR spectrum could not be obtained.  Even when the 13C-NMR 
spectrum was recorded immediately after preparation of the sample, decomposition of the 
product was apparent, with an unsubstituted Cp ring peak appearing ca. 70 ppm. 
  Having isolated the intermediate 139, this was then reacted with a molar equivalent of L-
threonine methyl ester hydrochloride in an attempt to prepare the unsymmetric disubstituted 140.  
However, the intermediate 139 proved too unstable in DCM solution, even at 0˚C, to be useful 
synthetically, and 140 was not isolated from the reaction mixture.     
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Scheme 4:  Preparation of the active mono-OBt ester 139. 
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Scheme 5:  Attempted synthesis of 140 using the active ester 139.  The latter proved too unstable 
in solution to be useful synthetically. 
 
5.2.2:  Synthetic Route 2 
  Reaction of ferrocene dicarboxylic acid (112) with one molar equivalent of L-threonine methyl 
ester hydrochloride and one molar equivalent of DCC in dichloromethane (i.e. a 2:1 ratio of 
carboxyl groups to amine groups), it was hoped, would lead to the formation of the mono acid 
derivative (scheme 6).  The remaining free carboxyl group could then be coupled to another 
amino acid.  In order to minimize the number of possible side products formed, and hence make 
the work up more convenient, HOBt was not used in this synthesis.  It was hoped that extraction 
of the dichloromethane reaction mixture into a solution of K2CO3, followed by acidification with 
0.1M HCl would precipitate the desired compound.  Instead, the only product extracted in this 
way was the starting material 112.  After column chromatography of the remainder of the 
reaction mixture on silica gel, the symmetricly disubstituted 122 was the only product isolated. 
  Several attempts were made to prepare the mono acid, and quenching of the reactions over a 
time range of 12-48 hrs still failed to yield the desired product.  No improvement on this 
situation was observed when CDI was employed as the coupling reagent.  Based on these 
observations, it is possible that the coupling of the first amino acid ester to one of the ferrocene 
carboxyl groups could be the rate limiting step in such reaction schemes, with coupling of the 
second amino acid ester being facilitated by forces such as hydrogen bonding in solution.   
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Scheme 6:  Attempted preparation of the ferrocenoyl mono acid. 
 
 
5.2.3:  Synthetic Route 3 
   Reaction of ferrocene dicarboxylic acid with one molar equivalent of L-valine methyl ester 
hydrochloride in the presence of two molar equivalents of DCC/HOBt in dichloromethane, 
followed by subsequent addition of a molar equivalent of L-threonine methyl ester hydrochloride 
(scheme 7), gave the unsymmetricly disubstuted N-ferrocenoyl dipeptide 140, in good yield (50-
55%). 
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Scheme 7:  Preparation of 140. 
 
  Fundamental to optimizing the yields in this process was the time difference between the 
additions of the two amino acid esters to the reaction mixture.  Table 1 shows the effect of 
‘staggering’ their addition on the yield of 140, as well as the symmetric compounds 138 and 122.  
In all cases, the reaction was allowed to proceed for a further 24 hrs after addition of L-threonine 
methyl ester hydrochloride. 
 
Δ t (hrs) %Yield 140 %Yield 122 %Yield 138 
0 28 13 11 
6 34 4 10 
12 46 3 10 
18 55 <1 9 
24 50 <1 12 
 
Table 1:  The effect of staggering the addition of L-valine methyl ester hydrochloride and L-
threonine methyl ester hydrochloride on the yield of 140. 
 
  It was found that 18 hrs was the optimum time to stagger the addition of the two amino acid 
esters, and this resulted in a yield of 55%, which compares extremely well to any previously 
reported yields for asymmetric ferrocene peptides, nor could a one-pot synthesis for compounds 
of this type be found in the literature.  All compounds were prepared in similar quantities, with 
yields in the 50-60% range.  A summary of these yields is given in table 2.   
  With the exception of 140 and 146, which were collected as red solids after evaporation of the 
hexane/EtOAc mobile phase, these asymmetric compounds were isolated as viscous red oils, and 
could not be crystallized from the usual solvent combinations.   
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Compound Name M.P. (ºC) Yield (%) 
140 1, 1’-N-ferrocenoyl-(L-threonine methyl ester)-(L-
valine methyl ester) 
90-91 55 
141 1, 1’-N-ferrocenoyl-(L-serine methyl ester)-(L-
norleucine methyl ester) 
 56 
142 1, 1’-N-ferrocenoyl-(L-threonine methyl ester)-(L-
methionine methyl ester) 
- 58 
143 1, 1’-N-ferrocenoyl-(L-threonine methyl ester)-(L-
glutamic acid diethyl ester) 
- 51 
144 1, 1’-N-ferrocenoyl-(L-threonine methyl ester)-(β-
alanine methyl ester) 
- 54 
145 1, 1’-N-ferrocenoyl-(L-threonine methyl ester)-(γ-
aminobutyric acid methyl ester) 
- 59 
146 1, 1’-N-ferrocenoyl-(L-phenylalanine methyl 
ester)-(L-aspartic acid dimethyl ester) 
100-103 55 
 
Table 2:  % Yields of 1, 1’-N-ferrocenoyl asymmetric dipeptides using synthetic route 3, with a 
Δt of ca. 18 hrs. 
 
3.3:  1H-NMR Spectra of 1, 1’-N-Ferrocenoyl Asymmetric Dipeptides 
  The 1H-NMR spectrum of the 1, 1’-symmetricly disubstituted compounds are, as would be 
expected, a good deal more complex than any of those observed for their symmetricly 
disubstituted analogues.  For example, substitution of each of the Cp rings with a different amino 
acid reside results, in several cases, of four individual signals being observed for the ortho-
protons (a maximum of two signals was observed in the case of the symmetric compounds 113-
133).  Similarly, two individual and well resolved amide signals were consistently observed, 
although these could only be unambiguously assigned in compounds incorporating a threonine 
residue (as this signal invariably appears below 7.7 ppm).  The positions of these amide signals 
in CDCl3 solution, similar to their symmetric analogues, remains largely unaltered relative to 
that observed in d6 DMSO.  
.  
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3.3.1:  1H-NMR Spectrum of 140 
  The 1H-NMR spectrum of 140 is shown in fig. 1, and serves to illustrate this complexity of the 
spectra of the 1, 1’-asymmetricly disubstituted compounds.  Three doublets, each integrating for 
three protons, are observed at 0.87, 0.90, and 1.17 ppm, the first two of which correspond to the 
two methyl groups of the valine side chain, while the latter corresponds to the methyl group of 
the threonine side chain.  The proton attached to the tertiary carbon of the valine side chain 
appears as a multiplet ca. 2.2 ppm, while the methyl protons of both ester groups appear as a six-
proton singlet at 3.68 ppm.  The protons of both α-carbons appear as a convoluted multiplet ca. 
4.2 ppm, while the proton attached to the tertiary carbon of the threonine side chain is observed 
as a multiplet ca. 4.4 ppm. 
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Fig. 1:  The 1H-NMR Spectrum of 140 in d6 DMSO. 
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  The signals observed for the ferrocenoyl protons in the spectrum of 140 serve to illustrate the 
different effect each individual amino acid can have upon the magnetic environment of the 
protons of the Cp rings.  The meta protons appear as two singlets at 4.41 and 4.45 ppm, each 
integrating for two protons.  This is in contrast to the symmetric threonine derivative, 122, where 
the meta protons appear as one singlet, convoluted with the protons of the α-carbons.  The ortho-
protons of 140 appear as four individual, closely grouped singlets ca. 4.9 ppm, each integrating 
for one proton, while only two singlets are observed for 122.  This contrast is illustrated in fig. 2. 
 
 
 
 
Fig 2:  Comparison of the ferrocenoyl protons of 122 (left) and 140 (right). 
 
  The amide protons of 140 are observed as two doublets, at 7.70 and 8.01 ppm.  Given the 
positions of the amide protons in the spectra of 71 (N-ferrocenoyl-L-threonine ethyl ester, 7.46 
ppm) and 122 (1, 1’-N-ferrocenoyl-(L-threonine methyl ester)2, 7.62 ppm), it is likely that the 
former of these doublets can be assigned to the amide proton of the threonine residue.  One 
possible reason for the more upfield position of the threonine amide protons could be the 
shielding effect provided by the lone pairs of the adjacent oxygen atom of the threonine side 
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chain.  Similar large separation of the amide signals are observed for all those 1’1’-N-
ferrocenoyl asymmetric dipeptides containing a threonine residue.  When the spectra of 140 was 
recorded in CDCl3, the chemical shifts of these protons were observed at 7.68 and 8.00 ppm. 
 
5.3.2:  1H-NMR Spectrum of 144 
  Compound 144, 1, 1’-N-ferrocenoyl-(L-threonine methyl ester)-(β-alanine methyl ester), 
incorporates two amino acid esters of unequal length in terms of their respective peptide 
backbones, which could potentially affect the intra-molecular interactions of this compound 
relative to compounds 140-146.  The 1H-NMR spectrum of 144 is shown in fig. 3.  
   
 
 
 
Fig 3:  The 1H-NMR Spectrum of 144 in d6 DMSO. 
 
  The methyl group protons of the threonine side chain appear as a doublet at 1.17 ppm, while the 
methylene protons adjacent to the ester functionality of the β-alanine moiety appear as a triplet at 
2.60 ppm.  The protons of the methylene group adjacent to the amide group of the β-alanine 
residue are observed as a broadened singlet at 3.27 ppm, and two three-proton singlets, 
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corresponding to the two methyl ester groups, appear at 3.63 and 3.69 ppm.  The proton of the 
tertiary carbon of the threonine side chain appears as a multiplet at 4.18 ppm. 
  Two singlets, corresponding to two of the meta protons of the Cp rings, appear at 4.29 and 4.34 
ppm, while the other two meta- protons are observed as a multiplet ca. 4.4 ppm, the signal being 
convoluted with that corresponding to the α-hydrogen of the threonine residue.  The ortho-
protons of 144 appear as a one-proton singlet at 4.71 ppm, a two-proton broadened singlet at 
4,83 ppm, and a further one proton singlet at 4.97 ppm.  The hydroxy proton of the threonine 
side chain appears as a doublet at 5.02 ppm.  The amide proton of the threonine residue is 
observed as a doublet at 7.63 ppm, while that of the β-alanine residue appears as a triplet at 7.97 
ppm.  As was observed to be the case with 140, the positions of these protons are virtually 
unchanged when the spectrum is recorded in CDCl3, which would suggest that 144 is able to 
adopt a similar intra-molecular hydrogen bonded conformation to those 1, 1’-disubstituted 
ferrocenoyl derivatives of α-chiral amino acids.  
                                                                         
5.3.3:  1H-NMR Spectrum of 145 
  Compound 145, 1, 1’-N-ferrocenoyl-(L-threonine methyl ester)-(γ-aminobutyric acid methyl 
ester), like 144, incorporates two amino acid esters of unequal length in terms of their peptide 
backbones.  Its 1H-NMR spectrum is shown in fig. 4, and shares many similar features with the 
spectrum of 144.  The methyl group protons of the threonine side chain appear as a doublet at 
1.16 ppm, while the signals for the three methylene groups of the γ-aminobutyric acid residue 
appear at 1.77, 2.34, and 3.19 ppm.  Two three-proton singlets, corresponding to the methyl 
protons of the ester groups are observed at 3.60 and 3.68 ppm, although, as was the case with 
144, it is not possible to unambiguously assign these peaks. Also in common with the spectrum 
of 144 is the appearance of the proton of the tertiary carbon of the threonine side chain as a 
multiplet ca. 4.18 ppm. 
  The ferrocenoyl signals of 145 are remarkably similar to those of 144, as can be seen in fig. 5, 
with two singlets being observed for the meta-protons of the Cp ring appearing at 4.28 and 4.33 
ppm, while the signal for the α-proton of the threonine residue can just about be resolved from 
the signal for the other two meta-Cp protons, the former being observed as a one-proton 
multiplet at 4.39 ppm, the latter as a broadened singlet at 4.43 ppm.  A sharp, one-proton singlet, 
corresponding to an ortho-proton of a Cp ring is observed at 4.71 ppm, with the other three 
ortho-protons appearing as a multiplet in the 4.85 ppm region.  The hydroxy proton of the 
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threonine side chain appears as a doublet at 5.00 ppm.  The similarities between the spectra of 
144 and 145 are shown in fig. 5. 
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Fig. 4:  The 1H-NMR spectrum of 145. 
 
  The signals for the amide protons of 145 differ from those observed in the spectrum of 144, 
with two closely grouped doublets, each with J = 8.4 Hz, being observed at 7.65 and 7.69 ppm, 
between them integrating for one proton, and corresponding to the amide proton of the threonine 
residue.  The signal for the amide proton of the γ-aminobutyric acid residue appears as a triplet at 
7.97 ppm.  This contrast is illustrated in fig. 6. 
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Fig. 5:  The ferrocenoyl protons in the1H-NMR spectrum of 144 (right) and 145 (left). 
 
 
Fig. 6:  The amide protons in the 1H-NMR spectrum of 144 (left) and 145 (right). 
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  Such ‘shoulder’ peaks for amide protons were previously observed for several N-ferrocenoyl 
mono-substituted dipeptides, and were attributed to the presence of more than one particular 
conformer in d6 DMSO at ambient temperature (section 3.4.1).  In order to confirm this, a 
spectrum of 145 was recorded at 80˚C, where the two doublets at 7.65 and 7.69 ppm were seen 
to converge.  When the spectrum was recorded in CDCl3, only a broadened singlet was observed 
at 7.66 ppm.  A summary of the 1H-NMR data obtained for these asymmetric compounds is 
given in table 3. 
 
Compound N-H Hortho Hmeta Hα 
140 7.70 (d),  
8.01 (d) 
4.86, 4.88 
4.94, 4.96 
4.41, 4.45 4.18-4.25 
141 7.94 (d) 
8.11 (d) 
4.82, 4.91 4.34-4.39 4.34-4.39 
142 7.61 (d) 
8.16 (d) 
4.83 , 4.86  
4.90 , 4.98  
4.41 
4.45-4.48 
4.45-4.48 
4.50-4.53 
143 7.60 (d) 
8.16 (d) 
4.83, 4.88 
4.90, 4.97 
4.39-4.49 4.39-4.49 
144 7.63 (d) 
7.97 (t) 
4.71, 4.83 
4.97 
4.29, 4.34 
4.39-4.48 
4.39-4.48 
145 7.65, 7.69 (d) 
7.90 (t) 
4.71 
4.79-4.87 
4.28, 4.33 
4.38-4.44 
4.38-4.43 
146 8.25 (d) 
8.32 (d) 
4.66-4.73 
4.74-4.76 
4.10, 4.32 
4.35 
4.66-4.73 
4.74-4.76 
 
Table 3:  The 1H-NMR chemical shifts (ppm) of the 1, 1’-N-ferrocenoyl asymmetric dipeptide 
derivatives recorded in d6 DMSO. 
 
5.4:  13C-NMR Spectra of 1, 1’-N-Ferrocenoyl Asymmetric Dipeptides 
  As was observed to be the case when the 1H-NMR spectra of these compounds were considered 
in the preceding sections, the 13C-NMR of these compounds are considerably more detailed than 
their symmetric analogues.  Modification of each of the Cp rings with a different amino acid 
ester results, in all cases, in two individual signals for both the amide and ester carbonyl carbons 
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being observed (only one signal was observed for each of these carbons in the spectra of the 1, 
1’-symmetricly disubstituted analogues).  Also, two individual signals appear for each of the 
ipso- carbons, as well as a considerably more complex pattern of resonances for the ferrocenoyl 
meta- and ortho-carbons. 
 
5.4.1:  13C-NMR Spectrum of 140 
    The 13C-NMR spectrum of compound 140 is shown in fig. 7, and incorporates many of the 
features common to the spectra of these unsymmetric compounds.  Two signals for the methyl 
groups of the valine side chain appear at 18.9 and 19.1 ppm, along with the resonance for the 
methyl group of the threonine side chain which appears at 20.1 ppm.  The tertiary carbon of the 
valine side chain is observed at 29.1ppm. 
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Fig. 7: The 13C-NMR spectrum of compound 140. 
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  Two individual signals appear for each of the methyl carbons of the ester groups, at 51.6 and 
51.8 ppm, while the resonances for the chiral α-carbons of the threonine and valine residues are 
observed at 58.1 and 58.3 ppm.  The pattern of signals in the spectrum of 140, corresponding to 
the ferrocenoyl carbons, is considerably more detailed than any of the symmetric disubstituted 
analogues, where a total of five ferrocenoyl carbons were invariably observed in the spectra of 
chiral compounds (two -meta, two -ortho, one –ipso), and three in that of the achiral analogues 
(one -meta, one -ortho, one -ipso).  This contrast is illustrated in fig. 8, which shows the 
ferrocenoyl carbons of both 140, and the symmetric 119. 
 
 
Fig 8:  The ferrocenoyl carbons in the 13C-NMR spectra in d6 DMSO of 122 (right) and 140(left). 
 
  Four distinguishable signals, at 69.3, 69.5, 70.1, and 70.3 ppm, corresponding to the ortho-
carbons, appear in the spectrum of 140, while only two signals are observed in the case of 122.  
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Like 122, two individual meta-carbon signals are seen in the spectrum of 140, at 71.8 and 72.0 
ppm, but unlike 122, the quaternary ipso-carbons appear as two individual, narrowly spaced 
signals at 76.5 and 76.7 ppm.  Similarly, a more complex pattern of signals is observed for the 
other quaternary carbons in the spectrum of 140 relative to that of 122, with individual signals 
being recorded for each of the two amide carbonyl carbons at 169.02 and 169.20 ppm, and ester 
carbonyl carbons at 171.23 and 172.34 ppm, as illustrated in fig. 9.  All the aforementioned 
quaternary signals are, as would be expected, absent from the 135DEPT spectrum (fig. 10). Also, 
as 140 includes no methylene carbons, no negative peaks appear. 
 
 
 
Fig 9:  The quaternary carbonyl carbons in the 13C-NMR spectra in d6 DMSO of 140 (left) and 
122 (right). 
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Fig. 10: The 135DEPT Spectrum of 140 in d6 DMSO 
 
  What is apparent from the results obtained in table 4, is that each individual amino acid ester, 
when coupled to the Cp ring, has its own particular effect on the chemical shifts on both the 
ferrocenoyl and the carbonyl carbons.  For example, in the 13C-NMR spectrum of 146, ten 
individual signals, corresponding to the ten ferrocenoyl carbons (four -meta, four -ortho, two -
ipso), are observed, i.e. each of these carbons is in a different magnetic environment. 
  Like the all the asymmetric disubstituted ferrocenes discussed in this chapter, the 13C-NMR 
spectra of compounds 142 (1, 1’-N-ferrocenoyl-(L-threonine methyl ester)-(L-methionine methyl 
ester)) and 143 (1, 1’-N-ferrocenoyl-(L-threonine methyl ester)-(L-glutamic acid diethyl ester)) 
also show two amide and two ester carbonyl carbon resonances, as well as multiple signals for 
the ortho- and meta-carbons of the Cp ring.  However, as can be seen from table 4, only one 
ipso-carbon signal is observed in the spectra of both 142 and 143, at 76.92 and 76.95 
respectively.  The symmetric analogues of these compounds, 122 (1, 1’-N-ferrocenoyl-(L-
threonine methyl ester)2), 116 (1, 1’-N-ferrocenoyl-(L-methionine methyl ester)2), and 121 (1, 
1’-N-ferrocenoyl-(L-glutamic acid diethyl ester)2) all show ipso-carbon signals in a very narrow 
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range, at 76.89, 76.93, and 76.97 ppm respectively.  It is therefore likely that the appearance of 
only one signal in the spectra of 142 and 143 is due to the convolution of the two Cipso 
resonances due to both these carbons being in equivalent magnetic environments.  Certainly, the 
intensity of the Cipso signals of 142 and 143, in terms of peak height, is greater than was observed 
for any of the other asymmetric ferrocenes prepared.  This can be seen in fig. 11, which 
compares the Cipso signals of 141 and 142.   A summary of the 13C-NMR data for compounds 
140-146 is given in table 4. 
 
 
Fig. 11.  The Cipso  resonances of 141 (left) and 142(right) at ca. 77 ppm.  They appear in the 
spectrum of 141 as two closely-grouped signals, while only one signal is observed in the 
spectrum of 142.   
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Compound C=Oamide C=Oester Cortho Cmeta Cipso 
140 169.06 
169.20 
171.23 
172.34 
69.26, 69.46 
70.10, 70.33 
71.84 
72.02 
76.52 
76.71 
141 169.38 
169.84 
172.00 
171.38 
69.14, 69.90 
70.15, 70.26 
70.99, 71.67 
71.99, 72.09 
77.68 
77.77 
142 169.51 
169.62 
171.85 
173.07 
69.83, 69.93 
70.39 
72.39 
72.58 
76.92 
143 169.43 
169.58 
171.82 
172.36 
69.85, 69.94 
70.28/70.35 
72.38 
72.57 
76.95 
144 168.94 
169.54 
171.73, 172.09 
172.27 
69.87, 70.00 
70.17 
71.97, 72.24 
72.67 
76.69 
77.93 
145 168.76 
169.18 
171.67 
173.12 
69.83, 70.00 
70.17 
71.19 
72.67 
76.99 
78.31 
146 169.18 
169.22 
170.99/171.73 
172.73 
69.32, 69.45 
70.59, 70.78 
72.31, 72.41 
72.47, 72.60 
76.59 
76.94 
 
Table 4:  The 13C-NMR chemical shifts (ppm) of the 1, 1’-N-ferrocenoyl asymmetric dipeptide 
derivatives recorded in d6 DMSO. 
 
5.5:  InfraRed Spectra of 1, 1’-N-Ferrocenoyl Asymmetric Dipeptides 
  As the majority of these asymmetric compounds were obtained as oils, only thin-film 
methylene chloride solution spectra were recorded.  In agreement with the 1H and 13C-NMR data 
reviewed thus far, the infrared spectra of these compounds clearly showed the presence of two 
distinct C=O amide stretches, two C=O ester stretches, and two υN-H stretches.  This is in contrast 
to the symmetricly disubstituted compounds, where only one band was observed for each of 
these groups.  The N-H stretches are observed in the 3400-3900 cm-1 range, which, as has been 
discussed in sections 3.6 and 4.6, indicates that each amide proton participates in an intra-
molecular hydrogen bonding interaction.  It is therefore likely that a similar, β-sheet-like 
conformation is adopted by these compounds in non-polar solution, as was seen in the case of the 
1, 1’-N-ferrocenoyl symmetric compounds, with hydrogen bonding occurring in an anti-parallel 
fashion.   
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Compound υN-H υCOOR υCONR 
140 3351, 3375 1729, 1736 1639, 1644 
141 3350, 3378 1735, 1725 1631, 1639 
142 3359, 3370 1730, 1747 1639, 1645 
143 3357, 3371 1740, 1751 1636, 1645 
144 3362, 3389 1730, 1742 1641, 1648 
145 3349, 3367 1728, 1739 1633, 1641 
146 3358, 3390 1740, 1750 1630, 1640 
 
Table 5: Infrared data for 140-146 (cm-1) (as CH2Cl2 thin-film solutions) 
 
5.6:  UV-Vis Spectra of 1, 1’-N-Ferrocenoyl Asymmetric Dipeptides 
  The UV-Vis spectra of compounds 140-146 show minimal differences from those recorded for 
the symmetricly disubstituted analogues, with similar values for the λmax extinction coefficients 
being recorded. As has been noted in previous chapters, that modification of the ferrocenoyl 
group with different amino acid esters, while having a noticeable effect in the NMR spectra, has 
minimal effect on the electronic behaviour of the ferrocene moiety.  It was thought that 
compounds 141 and 142, which incorporate two amino acid esters of unequal length in terms of 
their peptide backbones, might adopt a conformation which resulted in out-of-plane bending of 
the Cp rings, thus altering the electronic properties of these compounds.  This proved not to be 
the case, with all compounds showing two low energy bands in the 440 and 340nm range, while 
extinction coefficients are in the 200 A.U. range.   
 
5.7:  Cyclic Voltammograms of 1, 1’-N-Ferrocenoyl Asymmetric Dipeptides 
  As was seen to be the case with the symmetrically disubstituted ferrocenes discussed in section 
4.8, the presence of an electron-withdrawing amide group on each Cp ring has the effect of 
lowering the energy of the ferrocenoyl HOMO, making the molecule more difficult to oxidize 
relative to the mono-substituted derivatives discussed in sections 2.8 and 3.8.   The E1/2 values 
are consistent with those obtained for the symmetric analogues, indicating that, as was noted in 
the previous section, the individual substituent amino acid esters have minimal effect on the 
electrochemical properties of these compounds.  The cyclic voltammogram of compound 140 is 
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shown in fig. 12, and a summary of the electrochemical and UV-Vis data for compounds 140-
146 is given in table 6. 
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Fig. 12:  The cyclic voltammogram of 140 
 
Compound λmax (nm) ε (M-1 cm-1)[α]D20 E1/2 (mV) 
140 345, 445 168 - 24° 0.341 
141 340, 441 196 - 16° 0.338 
142 343, 442 189 - 17° 0.344 
143 343, 445 189 - 20° 0.350 
144 343, 442 189 - 9° 0.334 
145 340, 444 163 - 11° 0.328 
146 344, 444 212 - 22° 0.352 
 
 
Table 6:  The electrochemical, UV-Vis, and optical rotation data for compounds 140-146. All ε 
values refer to lowest energy band. 
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5.8:  Conclusions 
  In a one-pot process, using the DCC/HOBt coupling protocol, 1, 1’-N-ferrocenoyl asymmetric 
dipeptides were prepared in good yield (>50% in all cases) by staggering the addition of the 
corresponding amino acid esters, and the optimal time difference between the two additions was 
determined to be 18 hrs.   Attempted preparation of these compounds via the isolation of a 
ferrocenoyl mono O-benzotriazole active ester proved unsuccessful, with this compound proving 
unstable in solution at room temperature. 
  The 1H-NMR spectra of all compounds show the presence of two separate amide proton 
signals, the downfield shift of which in CDCl3 indicate they are involved in intra-molecular 
hydrogen bonding.  The ferrocenoyl protons appear as a complex pattern of signals, with up to 
four individual ortho-proton resonances being observed.  Similarly, up to four individual signals 
are observed for the ortho-carbons in the 13C-NMR spectra.  The infrared spectra also show the 
presence of two distinct amide and ester groups within each compound, which appear to be 
involved, like their symmetric analogues, in a β-sheet-like conformation, forming hydrogen 
bonds in an anti-parallel fashion.   
 
5.9:  Experimental 
1, 1’-N-ferrocenoyl-(L-valine methyl ester)-(OBt) (139) 
  0.82g (3mmol) of 122, 0.84g (6 mmol) of 1-hydroxybenzotriazole, and 1.2g (3.6mmol) DCC 
were dissolved in 40mls dichloromethane at 0˚C.  0.57mls (3.6mmol) Et3N, and 0.50 (3mmol) of 
L-valine methyl ester hydrochloride were then added, and the reaction was brought to room 
temperature after 30mins, and allowed to proceed for a further 24 hrs.  The solvent was 
evaporated in vacuo, and the crude product was then eluted from a column of silica gel, using a 
mobile phase of 1:1 hexane/ethyl acetate.    
Yield 0.33g (22%), red viscous oil. 
1H-NMR (400MHz) δ (d6 dmso):  0.88 (6H, br. s, -CH(CH3)2), 2.18 (1H, br. s, -
CH(CH3)2), 3.68 (3H, s, OCH3), 4.20-4.25 (1H, m, -NHCH-), 4.44 (2H, br. s, Hmeta Cp 
ring), 4.73 (2H, br. s, Hmeta Cp ring), 4.90 (2H, br. s, Hortho Cp ring), 5.14 (2H, br. s, 
Hortho Cp ring), 7.51-7.61 (3H, m, ArH), 8.05 (1H, br. s, NHCH-), 8.14 (1H, br. s, ArH). 
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1, 1’-N-Ferrocenoyl Asymmetric Dipeptides 
 
General Procedure  
0.27g (1mmol) of 112, 0.28g (2mmol) of 1-hydroxybenzotriazole, and 0.5g (2.4mmol) DCC 
were dissolved in 15mls dichloromethane at 0˚C.  0.19mls (1.2mmol) Et3N, and 1mmol of the 
first amino acid ester hydrochloride were then added, and the reaction allowed to rise to room 
temperature, and proceed for a further 18hrs.  0.19mls (1.2mmol) Et3N, and 1mmol of the 
second amino acid ester hydrochloride were then added, and the reaction allowed to proceed for 
a further 24 hrs.  The solvent was evaporated in vacuo, and the crude product was then eluted 
from a column of silica gel, using a mobile phase of 1:1 hexane/ethyl acetate.    
m-1.   
 
 
 1, 1’-N-ferrocenoyl-(L-threonine methyl ester)-(L-valine methyl ester) (140) 
  0.17g of L-threonine methyl ester hydrochloride and 0.17g of L-valine methyl ester 
hydrochloride were used in the synthesis. 
Yield 0.28g (55%), red solid, m.p. 90-91°C. 
E1/2 = 0.341mV (Vs. Fc/Fc+), [α]D20 = - 24°, (EtOH) (UV-Vis (λmax) (EtOH): 345, 445 
nm (ε = 168 M-1 cm-1 ), I.R. υmax (CDCl3):   3378, 3350, 3193, 2958, 1744, 1731, 1639, 
1631, 1547, 1382, 1320, 1261, 1017, 522, 512 c
1H-NMR (400MHz) δ (d6 dmso):  0.87 (3H, d, J = 6.4 Hz, -CH(CH3)2), 0.90 (3H, d, J = 
6.4 Hz, -CH(CH3)2), 1.17 (3H, d, J = 6.4 Hz, -CH(OH)CH3), 2.15-2.20 (1H, m, -
CH(CH3)2), 3.68 (6H, s, OCH3 x 2), 4.18-4.25 (2H, m, -NHCH- x 2), 4.37-4.40 (1H, m, -
CH(OH)CH3), 4.41 (2H, s, Hmeta Cp ring), 4.45 (2H, s, Hmeta Cp ring), 4.86 (1H, s, Hortho 
Cp ring), 4.88 (1H, s, Hortho Cp ring), 4.94 (1H, s, Hortho Cp ring), 4.96 (1H, s, Hortho Cp 
ring), 5.03 (1H, d, J = 7.6 Hz, -CH(OH)CH3), 7.70 (1H, d, J = 7.6 Hz, NHCH-), 8.01 
(1H, d, J = 8.0 Hz, NHCH-). 
13C-NMR (100 MHz) δ (d6 dmso):  18.95, 19.11, 20.18, 29.14, 51.57, 51.82, 58.08, 
58.30, 66.18, 69.26, 69.46, 70.10, 70.33, 71.84, 72.02, 76.52, 76.71, 169.06, 169.20, 
171.23, 172.34.  
 
1, 1’-N-ferrocenoyl-(L-serine methyl ester)-(L-norleucine methyl ester) (141) 
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  0.16g of L-serine methyl ester hydrochloride and 0.18g of L-norleucine methyl ester 
hydrochloride were used in the synthesis. 
Yield 0.28g (56%), red viscous oil. 
E1/2 = 0.338mV (Vs. Fc/Fc+), [α]D20 = - 16° (EtOH), (UV-Vis (λmax) (EtOH): 340, 441 
nm (ε = 196 M-1 cm-1), I.R. υmax (CDCl3):  3375, 3351, 2360, 1736, 1729, 1645, 1639, 
1549, 1418, 1350, 1232, 1191, 1040, 485 cm-1.   
1H-NMR (400MHz) δ (d6 dmso):  0.88 (3H, d, J = 6.8 Hz, -CH2CH2CH2CH3), 1.30-1.37 
(4H, m, -CH2CH2CH2CH3), 1.76-1.79 (2H, m, -CH2CH2CH2CH3), 3.61 (6H, s, OCH3 x 
2), 3.78 (2H, br. s, -CH2OH), 4.34-4.39 (6H, m, -NHCH- x 2 + Hmeta Cp ring), 4.82 (2H, 
s, Hortho Cp ring), 4.91 (2H, s, Hortho Cp ring), 7.94 (1H, d, J = 7.6 Hz, NHCH-), 8.11 
(1H, d, J = 7.2 Hz, NHCH-). 
m-1.   
13C-NMR (100 MHz) δ (d6 dmso):  18.99, 28.41 (-ve DEPT), 33.21 (-ve DEPT), 36.29 (-
ve DEPT), 57.54, 57.78, 60.71 (-ve DEPT), 69.14, 69.90, 70.15, 70.26, 70.99, 71.67, 
71.99, 72.09, 77.68, 77.77, 169.38, 169.84, 171.38, 172.00.  
 
1, 1’-N-ferrocenoyl-(L-threonine methyl ester)-(L-methionine methyl ester) (142) 
  0.17g of L-threonine methyl ester hydrochloride and 0.17g of L-methionine methyl ester 
hydrochloride were used in the synthesis. 
Yield 0.31g (58%), red viscous oil. 
E1/2 = 0.344mV (Vs. Fc/Fc+), [α]D20 = - 17° (EtOH), (UV-Vis (λmax) (EtOH): 343, 442 
nm (ε = 189 M-1 cm-1), I.R. υmax (CDCl3):   3370, 3359, 3193, 2993, 1747, 1730, 1649, 
1639, 1544, 1428, 1336, 1248, 822, 500 c
1H-NMR (400MHz) δ (d6 dmso):  1.16 (3H, d, J = 6.0 Hz, -CH(OH)CH3), 2.02-2.07 (5H, 
m, -CH2SCH3), 2.56-2.64 (2H, m, -CH2CH2SCH3), 3.69 (6H, s, OCH3 x 2), 4.17-4.21 
(1H, m, -CH(OH)CH3), 4.41 (2H, s, Hmeta Cp ring), 4.45-4.48 (3H, m, Hmeta Cp ring + -
NHCH-), 4.50-4.53 (1H, m, -NHCH-), 4.83 (1H, s, Hortho Cp ring), 4.86 (1H, s, Hortho Cp 
ring), 4.90 (1H, s, Hortho Cp ring), 4.98 (1H, s, Hortho Cp ring), 5.02 (1H, d, J = 7.6 Hz, -
CH(OH)CH3), 7.61 (1H, d, J = 8.8 Hz, NHCH-), 8.16 (1H, d, J = 8.0 Hz, NHCH-). 
13C-NMR (100 MHz) δ (d6 dmso):  14.89, 20.63, 30.15 (-ve DEPT), 30.26 (-ve DEPT), 
51.46, 52.35, 52.42, 58.65, 66.62, 69.83, 69.93, 70.39, 72.39, 72.58, 76.92, 169.51, 
169.62, 171.85, 173.07. 
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1, 1’-N-ferrocenoyl-(L-threonine methyl ester)-(L-glutamic acid diethyl ester) (143) 
  0.17g of L-threonine methyl ester hydrochloride and 0.24g of L-glutamic acid diethyl 
ester hydrochloride were used in the synthesis. 
Yield 0.29g (51%), red viscous oil. 
E1/2 = 0.350mV (Vs. Fc/Fc+), [α]D20 = - 20° (EtOH), (UV-Vis (λmax) (EtOH): 343, 445 
nm (ε = 189 M-1 cm-1), I.R. υmax (CDCl3):   3371, 3357, 2989, 1751, 1740, 1645, 1636, 
1544, 1429, 1353, 1312, 1220, 814, 528 cm-1.  
1H-NMR (400MHz) δ (d6 dmso):  1.16 (3H, d, J = 7.2 Hz, -CH(OH)CH3), 1.19-1.24 (6H, 
m, -OCH2CH3 x 2) 1.92-1.97 (1H, m, -CH2CH2COOEt), 2.06-2.13 (1H, m, -
CH2CH2COOEt),  2.55 (2H, t, J = 7.2 Hz,  CH2CH2COOEt), 3.68 (3H, s, OCH3), 4.06 
(2H, q, J = 7.6 Hz, -OCH2CH3), 4.12-4.38 (3H, m, -OCH2CH3 + -CH(OH)CH3), 4.39-
4.49 (6H, m, Hmeta Cp ring + -NHCH- x 2), 4.83 (1H, s, Hortho Cp ring), 4.88 (1H, s, 
Hortho Cp ring), 4.90 (1H, s, Hortho Cp ring), 4.97 (1H, s, Hortho Cp ring), 5.01 (1H, d, J = 
7.6 Hz, -CH(OH)CH3), 7.60 (1H, d, J = 7.2 Hz, -NHCH-), 8.16 (1H, d, J = 8.0 Hz, 
NHCH-). 
13C-NMR (100 MHz) δ (d6 dmso):  14.44, 20.63, 25.90 (-ve DEPT), 30.49, 51.82, 52.31, 
55.27 (-ve DEPT), 58.65, 60.30 (-ve DEPT), 61.04 (-ve DEPT), 66.62, 69.85, 69.94, 
de and 0.14g of β-alanine methyl ester 
esis. 
62, 3098, 2993, 1742, 1730, 1648, 1641, 
70.28, 70.35, 72.38, 72.57, 76.95, 169.43, 169.58, 171.82, 172.09, 172.36.  
1, 1’-N-ferrocenoyl-(L-threonine methyl ester)-(β-alanine methyl ester) (144) 
  0.17g of L-threonine methyl ester hydrochlori
hydrochloride were used in the synth
Yield 0.26g (54%), red viscous oil. 
E1/2 = 0.334mV (Vs. Fc/Fc+), [α]D20 = - 9° (EtOH), (UV-Vis (λmax) (EtOH): 343, 442 (ε 
= 189 M-1 cm-1), I.R. υmax (CDCl3):  3389, 33
1540, 1461, 1310, 1259, 1141, 1011, 689 cm-1. 
1H-NMR (400MHz) δ (d6 dmso):  1.17 (3H, d, J = 5.6 Hz, -CH(OH)CH3), 2.60 (2H, t, J 
= 6.8 Hz, -NHCH2CH2CO-), 3.27 (2H, br. s, -NHCH2CH2CO-), 3.63 (3H, s, OCH3), 
3.69 (3H, s, OCH3), 4.16-4.19 (1H, m, -CH(OH)CH3), 4.29 (1H, s, Hmeta Cp ring), 4.34 
(1H, s, Hmeta Cp ring), 4.39-4.48 (3H, m, Hmeta Cp ring + -NHCH-), 4.71 (1H, s, Hortho Cp 
ring), 4.83 (2H, br. s, Hortho Cp ring), 4.97 (1H, s, Hortho Cp ring), 5.02 (1H, d, J = 6.8 Hz, 
-CH(OH)CH3), 7.63 (1H, d, J = 8.4 Hz, -NHCH-), 7.97 (1H, t, J = 6.0 Hz, -NHCH2-). 
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13C-NMR (100 MHz) δ (d6 dmso):  20.64, 34.17 (-ve DEPT), 35.57 (-ve DEPT), 51.73, 
52.29, 58.72, 66.64, 69.87, 70.00, 70.17, 71.97, 72.24, 72.67, 76.69, 77.93, 168.94, 
169.54, 171.73, 172.27. 
 
1, 1’-N-ferrocenoyl-(L-threonine methyl ester)-(γ-aminobutyric acid methyl ester) 
(145) 
  0.17g of L-threonine methyl ester hydrochloride and 0.15g of γ-aminobutyric methyl 
ester hydrochloride were used in the synthesis. 
Yield 0.29g (59%), red viscous oil. 
E1/2 = 0.328mV (Vs. Fc/Fc+), [α]D20 = - 11° (EtOH), (UV-Vis (λmax) (EtOH): 340, 444 
nm (ε = 163 M-1 cm-1), I.R. υmax (CDCl3):  3367, 3349, 2911, 2362, 1731, 1718, 1641, 
1633, 1540, 1441, 1319, 1238, 1160, 1014, 673, 501 cm-1. 
1H-NMR (400MHz) δ (d6 dmso):  1.16 (3H, d, J = 6.0 Hz, -CH(OH)CH3), 1.76-1.79 (2H, 
m, -NHCH2CH2CH2CO-), 2.34 (2H, t, J = 7.2 Hz, -NHCH2CH2CH2CO-), 3.19 (2H, m, 
-NHCH2CH2-), 3.60 (3H, s, OCH3), 3.68 (3H, s, OCH3), 4.18 (1H, m, -CH(OH)CH3), 
4.28 (1H, s, Hmeta Cp ring), 4.33 (1H, s, Hmeta Cp ring), 4.38-4.42 (1H, m, -NHCH-), 
4.43, (2H, br. s, Hmeta Cp ring), 4.71 (1H, s, Hortho Cp ring), 4.79-4.87 (3H, m, Hortho Cp 
ring), 5.00 (1H, d, J = 4.8 Hz, -CH(OH)CH3), 7.65, 7.69 (1H, two doublets, J = 8.4 Hz, -
NHCH-), 7.90 (1H, t, J = 5.4 Hz, -NHCH2-).  
cm-1. 
13C-NMR (100 MHz) δ (d6 dmso):  20.65, 25.02 (-ve DEPT), 31.10 (-ve DEPT), 38.46 (-
ve DEPT), 51.64, 52.29, 58.79, 66.63, 69.83, 70.00, 70.17, 71.19, 72.67, 76.99, 78.31, 
168.76, 169.18, 171.67, 173.12. 
 
 1, 1’-N-ferrocenoyl-(L-phenylalanine methyl ester)-(L-aspartic acid dimethyl ester) 
(146) 
  0.20g of L-aspartic acid dimethyl ester hydrochloride and 0.22g of L-phenylalanine 
methyl ester hydrochloride were used in the synthesis. 
Yield 0.32g (55%), orange solid, m.p. 100-103°C.  
E1/2 = 0.352mV (Vs. Fc/Fc+), [α]D20 = - 22° (EtOH), (UV-Vis (λmax) (EtOH): 344, 444 
nm (ε = 212 M-1 cm-1), I.R. υmax (KBr):  3390, 3358, 2932, 1810, 1750, 1740, 1640, 
1630, 1561, 1509, 1408, 1221, 811, 541 
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1H-NMR (400MHz) δ (d6 dmso):  2.81 (1H, dd, Ja = 8.4 Hz, Jb   = 12.0 Hz, 
CH2COOMe), 2.97 (1H, dd, Ja = 5.4 Hz, Jb   = 12.0 Hz, CH2COMe), 3.03 (1H, dd, Ja = 
11.2 Hz, Jb   = 12.8 Hz, -CH2Ph), 3.18 (1H, dd, Ja = 4.0 Hz, Jb   = 12.8 Hz, -CH2Ph), 3.64 
(3H, s, OCH3), 3.66 (3H, s, OCH3), 3.68 (3H, s, OCH3), 4.10 (2H, s, Hmeta Cp ring), 4.32 
(1H, s, Hmeta Cp ring), 4.35 (1H, s, Hmeta Cp ring), 4.66-4.73 (3H, m, Hortho Cp ring + -
NHCH-), 4.74-4.76 (3H, m, Hortho Cp ring + -NHCH-), 7.21 (1H, d, J = 6.4 Hz, ArH), 
7.30-7.36 (4H, m, ArH), 8.25 (1H, d, J = 7.6 Hz, -NHCH-), 8.32 (1H, d, J = 8.0 Hz, -
NHCH-). 
13C-NMR (100 MHz) δ (d6 dmso):  35.74 (-ve DEPT), 36.48 (-ve DEPT), 49.21, 52.06, 
52.37, 52.62, 53.97, 69.32, 69.45, 70.59, 70.78, 72.31, 72.41, 72.47, 72.60, 76.59, 76.94, 
26.63, 128.63, 129.43, 138.17, 169.18, 169.22, 170.99, 171.73, 172.73. 
au-Bossuet, E. Manoury, G. Balovoine, Organometallics, 15, (1996), 
. Rapic, H. Pritskow, G. Pavlovic, I. Nemet, J. Organometallic Chem., 682, 
, (2001), 335. 
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Chapter VI 
 
Anion Binding Studies 
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6.1:  Introduction 
 Anions are ubiquitous substances in biological and chemical processes, as well as playing a 
major role in environmental pollution [1].  Not only are the majority of enzyme substrates 
and co-factors anionic, DNA itself is anionic, and the development of DNA biosensors has, 
allowed for the successful detection of mutations [2].   The field of anion coordination 
chemistry has come to prominence in recent years, with electrochemically active anionic 
receptors of particular interest, as they allow binding of guest anions to be detected by a 
response at the metal centre [3]. 
  Although the first redox centre-containing receptors were based around the cobaltocenium 
cation, the bulk of recent work has shifted the emphasis towards ferrocene-based sensors, 
which offer the possibility to modulate the anion-receptor interaction according to the 
oxidation state of the iron centre [4].  Structurally, these compounds range from the rather 
simple ones such as 10 and 11 (section 1.5.2), to larger dendritic structures, such as 147, 
prepared by Stone and co-workers [5].  
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  The ability of compounds such as 147 to co-ordinate halide anions at the core through 
hydrogen bonding with the amide protons was poor, due to steric restrictions (determined via 
1H-NMR titrations).  There was, however, significant anion binding observed in the oxidised 
ferricenium form, due to electrostatic interactions. 
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  The presence of the amide proton is crucial to the ability of ferrocene-based receptors to 
coordinate anions, as unsubstituted ferrocene in its neutral form has no inherent attraction for 
anions, and displays no change in electrochemical behaviour even in the presence of a large 
excess of anions [6].  Oxidation of amide substituted ferrocenes, however, increases the 
acidity of the amide proton, making it a better acceptor for electron pairs, and thus there 
exists a synergy between the electrostatic and hydrogen bonding coordination of guest 
species [7].   
  Cyclic amide-substituted ferrocenes such as 148 prepared by Reynes and co-workers, offer 
a potential advantage in anion sensing, in the respect that they can introduce steric 
restrictions to the species of anion detected, effectively developing a ‘molecular pocket’, and 
hence achieve a greater degree of selectivity [8].     
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  The two principal methods of anion detection with ferrocene-based receptors in the 
literature are 1H-NMR titrations, and cyclic voltammetry, and these techniques were used to 
determine the effectiveness of the compounds prepared in the previous chapters.  As the 
amide protons of large peptides and proteins are the principal hydrogen bond acceptors in 
biological systems [9], the choice of ferrocenoyl amino acid derivatives as anionic sensors 
would seem logical. 
 
6.2:  1H-NMR Titration Studies 
  As has been discussed in previous chapters, a downfield shift in the 1H-NMR spectrum is 
observed for amide protons that are involved in hydrogen bonding interactions.  Plotting this 
downfield shift of amide protons against the molar equivalent of anion added can give an 
indication of the affinity of anionic receptors for various anions.  Previous work in this area 
has indicated that steric factors play an important role here [10], so the compounds chosen 
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for these experiments were those which have the least bulky substituents vicinal to the amide 
group. 
 
6.2.1:  1H-NMR Titration Studies of N-Ferrocenoyl Amino Acid 
Derivatives  
  Three N-ferrocenoyl amino acid derivatives were chosen for this series of experiments, 81, 
82, and 88, as these compounds have the least sterically hindered amide protons (fig. 6, Ch. 
2, section 2.5.3).  The downfield shift of their respective amide protons was plotted against 
the molar equivalent of various anions (Cl-, Br-, NO3-, HSO4-), as their tetra butyl ammonium 
salts) in CDCl3.  Fig. 1 shows the response of 81, N-ferrocenoyl-β-alanine methyl ester, to 
these anions.  
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Fig. 1:  The downfield shift of the amide proton of 81 vs. molar equivalent of anion, in 
CDCl3. 
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  What is noticeable from fig. 1 is the far greater response to halide anions than to either 
nitrate or hydrogen sulphate.  Both nitrate and hydrogen sulphate anions are poor bases, and 
so would have little affinity for the moderately acidic amide proton.  The halide anions have 
a relatively high charge density, and as such are capable of producing a relatively large 
response in the 1H-NMR spectrum.  The chloride ion has a smaller ionic radius relative to 
bromide, and therefore a higher charge density, and thus produces a greater response.  
Similar responses to these anions were recorded with compound 82.  What is also noteworthy 
from fig. 1 is the absence of a ‘plateau’ in the response to these anions, and as such, no true 
selectivity can be claimed for these receptors. 
  It will be recalled from section 2.5.3 that the amide proton of compound 88 appears at 7.71 
ppm in its 1H-NMR spectrum in CDCl3 (vs. 6.26 and 6.29 ppm for 81 and 82 respectively), 
i.e. this proton is already engaged in intra-molecular hydrogen bonding, and as such, the 
presence of even a five-fold excess of anions produces minimal response in terms of 
chemical shift.  This can be seen in fig. 2, which compares the downfield shift of the amide 
protons of 81, 82 and 88 to various molar equivalents of chloride anion.      
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Fig. 2:  The downfield shift of the amide proton of 81, 82, and 88  vs. molar equivalent of Cl-, 
in CDCl3. 
 
  What is apparent from fig. 2 is that the stable conformation adopted by 88 in solution is 
largely unperturbed in the presence of anions, therefore making it a poor candidate for anion 
binding studies.  A summary of the results obtained is given in the experimental section. 
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6.2.2: 1H-NMR Titration Studies of N-Ferrocenoyl Monosubstituted 
Dipeptides. 
  For this series of experiments, the dipeptides 109-111 were chosen as candidates for anion 
receptors.  It will be recalled from section 3.4.2 and 3.6 that in CDCl3, the N-terminal amide 
protons of 109 and 110 form intra-molecular hydrogen bonds with the C-terminal ester 
oxygen atoms, and even in the absence of anions, show considerable downfield shifts (7.5 
and 7.7 ppm respectively).  In each case, it is only the C-terminal amide proton which shows 
any response towards various concentrations.  Fig. 3 shows the downfield shift of C-terminal 
amide proton of 109 in the presence of various concentrations of the same anions as were 
employed in the previous section. 
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Fig. 3:  The downfield shift of the C-terminal amide proton of 109 vs. molar equivalent of 
anion, in CDCl3. 
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  The extent to which the chemical shift of each amide proton is affected in the presence of 
chloride ions can be seen in fig. 4.   
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Fig. 4: The downfield shifts of the C- and N- terminal amide protons of 109 in the presence 
of chloride ions. 
 
    Figures 3 and 4 show a clear plateau region in response to both chloride and bromide ions, 
which is indicative of selectivity towards these species.  110 show a similar response to these 
anions, with only the C-terminal amide proton showing significant downfield shifts, and 
plateaus being observed for both the halide ions.  Again, both nitrate and hydrogen sulphate 
anions produce minimal response in the chemical shift.  
  As discussed in section 3.4.2, the amide protons of 111 appear as a convoluted signal in the 
1H-NMR spectrum in CDCl3 at 7.7 ppm, which suggests that they both participate in intra-
molecular hydrogen bonds.  It would appear that, as was the case with the amino acid ester 
analogue 88, the conformation adopted by 111 remains unaltered in the presence of these 
anions, with neither substantial downfield chemical shifts (< 0.12 ppm), nor any divergence 
of the convoluted signal being recorded. 
 
 6.2.3: 1H-NMR Titration Studies of 1, 1’-N-Ferrocenoyl Symmetric 
Dipeptides.   
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  Compounds 126-129, as well as the tetra-peptide 130, were chosen for this series of 
experiments.  It will be recalled from section 3.3.3 that the amide protons in 126-129 all 
appear ca. 8 ppm in their 1H-NMR spectrum in CDCl3, i.e. they already form intra-molecular 
hydrogen bonds, and, without exception, show minimal response to even a ten-fold excess of 
ions, making them poor candidates for ion recognition. 
  Only the N-terminal amide protons of the tetra-peptide 130 participate in intra-molecular 
hydrogen bonds, with those of the C-terminal appearing at 6.57 ppm in its 1H-NMR spectrum 
in CDCl3.  These latter protons show large downfield shifts in the presence of halide ions (> 
1.0 ppm), as can be seen in fig. 5. 
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Fig. 5:  The downfield shift of the C-terminal amide protons of 130 vs. molar equivalent of 
anion, in CDCl3. 
 
  The C-terminal amide protons show the greatest response towards halide ions of any 
compound investigated, although no plateau region is observed for any of the ions used, and 
as such no selectivity can be claimed for this compound.  It should be also noted that in the 
1H-NMR spectrum of 130 in CDCl3, C-terminal amide protons appear as one signal 
integrating for two protons, and this remains the case even in a large excess of halide ions, 
i.e. both of these C-terminal protons contribute equally toward the binding of anions, and 
there is no divergence of this signal.   
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6.3:  Electrochemical Anion Binding Studies 
    As mentioned in section 1.5.2, the FeII/FeIII redox system can show significant cathodic 
shifts in the presence of excess amounts of certain simple anions.  The same compounds 
which were used in the 1H-NMR experiments were employed as potential electrochemical 
sensors in this work.  The ions chosen were chloride, nitrate, iodide, tetrafluoroborate, and 
hydrogen sulphate (as their tetrabutyl ammonium salts).  As the redox potential of the 
bromide anion is too close to that of the ferrocene/ferricenium redox couple, it was not a 
suitable candidate for these studies.   
 
6.3.1: Electrochemical Anion Binding Studies of N-Ferrocenoyl Amino 
Acid Derivatives 
  It should be stressed here again that the three N-ferrocenoyl amino acid derivatives selected 
for these studies, 81, 82 and 88, were chosen because their structure in the vicinity of the 
amide proton would be unlikely to impede anionic complexation.  All three showed cathodic 
shifts ca. 40 mV in the presence of a ten-fold excess of chloride and iodide, and minimal 
response in the presence of nitrate, tetrafluoroborate, and hydrogen sulphate.  The results are 
summarized in table 1.   
 
 
Compound HSO4- Cl- NO3- BF4- I- 
81 -4 -41 +2 +1 -24 
82 -6 -40 +5 +4 -20 
88 -1 -37 +5 +6 -21 
 
Table 1:  The Δ E1/2 in redox potential of 81, 82 and 88 in the presence of a ten-fold excess of 
various ions (cathodic shifts are assigned –ve values). 
 
  The previous anion binding studies performed with ferrocenoyl peptide derivatives only 
made use of linear sweep voltammetry (i.e. the oxidation wave) [11], and while cathodic 
shifts in the presence of various anions were noted, the effect on the corresponding reduction 
wave was not recorded.  Disappearance of the reduction wave is indicative of an irreversible 
oxidation, and hence strong guest-host interaction. 
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    All three compounds showed very similar responses to each anion.   The voltammograms 
of 81, in the presence of chloride and iodide anions are shown in fig. 6.  It can be clearly seen 
from fig. 6 is that there is a noticeable cathodic shift in the cyclic voltammogram of 81 
caused by the presence of chloride anion.  
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Fig. 6:  The cyclic voltammograms of 81, anion free and in the presence of chloride ions. 
 
  There is little if any reduction in the intensity of the reduction wave (the portion of the wave 
which gives positive values of the response current).  In other words, the one electron 
oxidation of the ferrocenoyl group remains reversible in the presence of these anions, even 
though an anion would tend to stabilize the ferricenium cation, thus inhibiting reduction.  It 
has previously been reported that anionic sensors incorporating the ferrocene moiety can 
undergo irreversible oxidation in the presence of anionic species, with a subsequent 
disappearance of the reduction wave in the cyclic voltammogram [12].  This, however, does 
not appear to be the case with compounds 81, 82 and 88.  This would be suggestive of weak 
guest-host interaction. Chloride ions induce a greater cathodic shift in the voltammograms of 
81, 82 and 88, than do iodide anions.  This is not surprising, due to the smaller chloride anion 
having a greater charge density than the larger iodide.   
  Hydrogen sulphate anion had minimal effect on the redox potential of 81, 82 and 88.  As 
stated previously, this ion is a poor base, and has less attraction for the amide proton.  This is 
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in agreement with the results recorded during the 1H-NMR titration experiments.  These 
observations would suggest that the amide proton plays a crucial role in ‘anchoring’ the 
anionic species in close proximity to the iron centre of the ferrocene moiety, thus inducing a 
change in its electrochemical behaviour.   
  An interesting observation in this series of experiments is the induction of a slight anodic 
shift in the cyclic voltammograms of 81, 82 and 88 by nitrate and tetrafluoroborate anions.  A 
possible explanation for this observation is the fact that not only do these anions have very 
little affinity for the amide protons of 81, 82 and 88, but each of these anions has a central 
atom with a relatively high positive charge density, the proximity of which to the iron centre 
could destabilize the ferricenium cation, i.e. make oxidation more difficult.  
 
6.3.2: Electrochemical Anion Binding Studies of N-Ferrocenoyl 
Monosubstituted Dipeptides 
    It has already been noted that, in the presence of various anions, similar downfield shifts in 
the C-terminal amide protons were observed in the case of the dipeptides 109-111, than was 
recorded for the amino acid derivatives 81, 82 and 88, although the N-terminal protons 
remained largely unaffected.  However, the presence of two hydrogen-bond-accepting amide 
protons can potentially alter the ability of the receptor to complex an anion, and hence affect 
the electrochemical behaviour of the ferrocene moiety.   
    The receptors 109-111 showed very similar responses to each anion, with the halides 
producing significant cathodic shifts in the oxidation portion of their cyclic voltammograms, 
and these results are summarised in table 2.  These responses were, however, radically 
different to that observed the amino acid derivatives, as can be seen in fig. 7. 
 
 
Compound HSO4- Cl- NO3- BF4- I- 
109 -4 -42* +0 +1 -28* 
110 -8 -37* +4 +4 -26* 
111 -1 -39* +2 +6 -25* 
 
Table 2:  The Δ E1/2 in redox potential of 109-111, in the presence of a five-fold excess of 
various ions (cathodic shifts are assigned –ve values). 
*Values calculated from the difference in oxidation peaks due to loss of reduction peak.  
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   What is most obvious from these voltammograms is the complete disappearance of the 
reduction wave caused by the complexation of the halide ions.  This is indicative of an 
irreversible oxidation having taken place.  In order to investigate this observation further, the 
scan rate was reduced from 0.1V/sec to 0.02V/sec.  It is known that a reduction in scan rate 
can, in some cases, cause the reappearance of a reduction wave by allowing the electroactive 
species more time to diffuse towards the electrode [13].  Even at this reduced scan rate, no 
reduction wave was observed in the voltammograms of 109-111 in the presence of halide 
ions.  Fig. 7 shows the voltammograms of 109, both in the absence and presence of iodide 
ions. 
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Fig. 7:  The loss in reduction peak in the cyclic voltammogram of 109 in the presence of 
iodide ions. 
 
  A similar disappearance of the reduction wave was observed in the voltammograms of 110 
and 111 in the presence of halide ions.  This is indicative of an EC mechanism, i.e. after the 
electron loss upon oxidation, a chemical process occurs whereby reduction is inhibited (e.g. 
adsorption of the ion pair onto the surface of the working electrode [14].  These results would 
suggest that the presence of two amide protons does indeed result in much stronger 
complexation of halide anions with compounds 109-111 than was seen to be the case with 
their amino acid derivative analogues 81, 82 and 88.   Previous work in this area has shown 
the strength of complexation to be sensitive to the number of both ferrocene groups and 
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amide protons [15].  Although the chemical shifts of the N-terminal amide protons of these 
dipeptides were shown to remain largely unaltered in the presence of halide ions in the 1H-
NMR titration studies, the electrochemical investigations would suggest that they do play a 
role in the ‘anchoring’ of the anion close to the ferrocene moiety’s iron centre. 
  What is also apparent is that, given the very similar behaviour of 109-111 in the presence of 
each individual anion, altering the length of the peptide backbone does not induce any 
noticeable difference in binding ability of these receptors. 
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Fig. 8:  Interaction of the two amide protons of 109 with anionic species, which may account 
for the irreversible oxidation observed in the cyclic voltammograms. 
 
  As was the case with 81, 82 and 88, minimal response was observed in the voltammograms 
of 109-111 in the presence of hydrogen sulphate, nitrate, or tetrafluoroborate anions.  
Clearly, the presence of the second amide proton does not affect their lack of affinity for 
complexation.  In the case of the latter two anions, once again a small anodic shift is induced 
in the voltammograms of each N-ferrocenoyl dipeptide.    
 
6.3.3:  Electrochemical Anion Binding Studies of 1, 1’-N-Ferrocenoyl 
Symmetric Dipeptides 
    As is the case with the monosubstituted N-ferrocenoyl dipeptides, the 1, 1’-N-ferrocenoyl 
dipeptides have two amide protons available for hydrogen-bonding to an anion, the 
difference being their relative spatial arrangement.  These protons are located closer to the 
iron centre of the ferrocenoyl group, and could, in theory, complex anions in such a way as to 
cause a greater electrochemical response than was observed with 109-111.  It should be 
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reiterated, however, that none of these compounds showed significant downfield shifts in the 
presence of anions during the 1H-NMR titration studies.  The 1, 1’-N-ferrocenoyl derivatives 
of glycine, β-alanine, γ-aminobutyric acid, and valeric acid methyl esters, 126-129 
respectively, were chosen for these investigations.  The results obtained are summarised in 
table 3. 
 
 
Compound HSO4- Cl- NO3- BF4- I- 
126 -1 -32* +1 +2 -20* 
127 -3 -33* +7 +0 -19* 
128 
129 
130 
0 
-5 
0 
-30* 
-31* 
-31* 
+2 
+0 
+1 
+5 
+4 
+1 
-17* 
-21* 
-19* 
 
Table 3:  The Δ E1/2 in redox potential of 126-129 in the presence of a five-fold excess of 
various ions (cathodic shifts are assigned –ve values). 
*Values calculated from the difference in oxidation peaks due to loss of reduction peak.  
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Fig. 9:  The loss in reduction peak in the cyclic voltammogram of 127 in the presence of 
chloride ions. 
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  The cyclic voltammograms of 127, on its own and in the presence of chloride ions, is shown 
in fig. 9.  As was observed in the case of the monosubstituted N-ferrocenoyl dipeptides, an 
irreversible oxidation of the ferrocenoyl group occurs in the presence of both chloride and 
iodide ions.  This observation further reinforces the argument that the presence of two amide 
protons is crucial to the strength of anion complexation.  The cathodic shift in the oxidation 
wave recorded is slightly less pronounced for the 1, 1’-N-ferrocenoyl dipeptides than was 
observed for any of the mono substituted N-ferrocenoyl receptors. These results would 
suggest that the anion is, upon complexation, not held in as close proximity to the iron centre, 
due to the spatial arrangement of these amide protons within each receptor.  Again, the loss 
of the reduction portion of the cyclic voltammogram is evidence of an EC mechanism.   
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Fig. 10:  Interaction of the two amide protons of 127 with anionic species. 
 
  As previously mentioned, in the 1H-NMR titration experiments, the amide protons of 
compounds 126-129 appear as one triplet, and remain so, even in the presence of a ten-fold 
excess of anion.  This would suggest that both protons, although relatively unperturbed in 
terms of their downfield chemical shifts, contribute equally in complexation of the anion.  
What is likely, however, given the ionic radius of the chloride and iodide anions (1.67 and 
2.07 Å respectively [15]), and the spacing of the cyclopentadienyl rings of ferrocene (3.3 Å – 
the amide protons would be expected to remain roughly co-planar with the Cp rings in 
solution [16]), is that the 1, 1’-conformation could still be maintained during the binding of 
these anions to both protons, though exactly what conformation is adopted is difficult to 
unambiguously assign.   
      As was the case with the monosubstituted receptors, minimal response was observed in 
the voltammograms of 109-111 in the presence of hydrogen sulphate, nitrate, or 
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tetrafluoroborate anions.  Clearly, the presence of the second amide proton does not affect 
their lack of affinity for complexation.  This is illustrated in fig. 11, which shows the 
voltammograms of 127, both in the presence and absence of hydrogen sulfate.  In the case of 
the latter two anions, once again a small anodic shift is induced in the voltammograms of 
each 1, 1’-N-ferrocenoyl dipeptide, as can be seen from fig. 11.    
 
-1.00E-04
-8.00E-05
-6.00E-05
-4.00E-05
-2.00E-05
0.00E+00
2.00E-05
4.00E-05
6.00E-05
0.1 0.2 0.3 0.4 0.5 0.6 0.7
Potential (V)
C
ur
re
nt
 (A
)
 
HSO4-
 
Fig. 11:  The cyclic voltammograms of 127, both anion free and in the presence of hydrogen 
sulphate ions. 
 
  The N-ferrocenoyl tetrapeptide 130 shows a very similar pattern of responses to that which 
is observed for its dipeptide analogue 126.  It was shown during the 1H-NMR titration studies 
that the C-terminal amide protons clearly interact with halide ions, though anion binding here 
may occur too far away from the electroactive iron centre to be sensed in the cyclic 
voltammograms. 
 
6.4:  Conclusions 
  A total of ten potential receptors were tested for their 1H-NMR and voltammetric behaviour 
in the presence of various anions, and in all cases, only the halide ions produced a significant 
response.  The anions BF4-, NO3-, and HSO4-, being poor bases, appear to have little affinity 
for the amide protons of these compounds, the net result of which is very weak guest-host 
interactions. 
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  In the 1H-NMR titration studies, only those amide protons which do not participate in intra-
molecular hydrogen bonds show any significant downfield shifts in the presence of halide 
ions.  These include the single amide protons of 81 and 82, and those of the C-terminal of 
109 and 111.  The C-terminal protons of compound 130, 1, 1’-N-ferrocenoyl-((glycine)2 
ethyl ester)2, show the largest response of all to halide ions, although the only encouraging 
results in terms of selectivity was found in the case of 109 and 111, whose titration plots 
showed a ‘plateau’ in response to increasing concentration of halide ions.    
  Halide ions also induce noteworthy perturbations in the cyclic voltammograms of all 
compounds tested, with cathodic shifts of ca. 40mV being observed for the monosubstituted 
compounds in the presence of chloride ions, and ca. 30mV for the 1, 1’-disubstituted 
compounds.  Due to its larger ionic radius, and hence more diffuse charge density, iodide 
ions produced smaller cathodic shifts.   
  Those compounds which include two amide protons (the N-ferrocenoyl monosubstituted 
dipeptides and the 1, 1’-N-ferrocenoyl symmetric dipeptides) showed a loss of the reduction 
portion of the wave in their cyclic voltammograms in the presence of halide ions, indicative 
of irreversible binding and an EC mechanism at work.  It is clear that these two protons play 
a crucial role in the complexation of the halides, even if the response is almost undetectable 
in the 1H-NMR titrations.  It is also clear that the number of methylene groups in the peptide 
backbone has little effect on the ability of these compounds to complex anions, either in 
terms of voltammetric response, or selectivity of one anion over another. 
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Appendix I 
 
Experimental Section: 
 
  All reagents were purchased from Sigma/Aldrich, and were used as received without further 
purification. All solvents were used without drying unless stated.  No attempt to exclude air 
from reactions was made unless stated. 
  Melting points were determined using a Steward Scientific melting point apparatus.  1H-NMR 
and 13C NMR spectra were recorded on a Bruker AC 400 NMR spectrometer, operating at 
400MHz for 1H-NMR and 100MHz for 13C NMR.    All chemical shifts (δ) are reported in ppm 
relative to tetramethylsilene.  Coupling constants (J) are reported in Hertz.  All infrared spectra 
were recorded on a Nicolet – Impact 410 FT-IR spectrophotometer. 
  All UV-Vis spectra were recorded on a Varian Cary 50 Scan UV-Vis spectrophotometer. 
  All optical rotations were recorded on a Perkin-Elmer polarimeter, model 343, (598nm, 1x 104 
ppm in EtOH)   
  All cyclic voltammogramms were recorded on a CH Instruments electrochemical workstation, 
model 660, with a 0.1M solution of TBABF4 in CH3CN as a supporting electrolyte, at a scan 
rate of 0.1V/sec, using an Ag/Ag+ (10mM AgNO3 in CH3CN) reference electrode. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix II 
 
Abbreviations: 
 
AA Amino Acid 
Ac. Acetyl 
Ar. Aryl 
Bn. Benzyl 
BOC tert-Butyloxycarbonyl 
CDI Carbonyldiimidazole 
DCC Dicyclohexylcarbodiimide 
DCM Dichloromethane 
DMF Dimethylformamide 
Conc. Concentrated 
DNA Deoxyribonucleic Acid 
E1/2 Half-Wave Potential 
Equiv. Equivalent 
Et3N Triethylamine 
HOBt 1-Hydroxybenzotriazole 
HBr Hydrobromic Acid 
HCl Hydrochloric Acid 
hr. Hour 
IR InfraRed 
M Molar 
ml Millilitre 
mmol Millimole 
mol Mole 
m.p. Melting Point 
NMR Nuclear Magnetic Resonance 
RNA Ribonucleic Acid 
r.t. Room Temperature 
SOCl2 Thionyl Chloride 
TBTU O- (1H-benzotriazol-1-yl)-N, N, N’, N’, -
tetrmethlyuronium tetrafluoroborate 
TFA Trifluoroacetic Acid 
TLC Thin Layer Chromatography 
Z Benzyloxycarbonyl 
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